{
    "testId": 395519578,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 76,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 24,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 2,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3081,
    "averageTimeSpentInSeconds": 103,
    "otherAverageTimeSpentInSeconds": 61,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 14377,
            "questionIndex": 15786,
            "questionText": "<p>A 62-year-old man is brought to the office by his wife due to recent personality changes and cognitive impairment.&nbsp; The symptoms began 4 months ago with abrupt-onset depression and profound sleepiness.&nbsp; Soon after, the patient began having difficulty remembering names and events.&nbsp; He now cannot prepare his own meals or care for himself.&nbsp; The patient has a history of herpes simplex virus type 1 and takes acyclovir occasionally for recurrent symptoms; medical history is otherwise unremarkable.&nbsp; He has no history of psychiatric disease but has a family history of dementia from his father.&nbsp; The patient has a 40-pack-year smoking history.&nbsp; Temperature is 37.7 C (99.9 F), blood pressure is 118/79 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; The patient is oriented only to self.&nbsp; Montreal Cognitive Assessment score is 10/30 (normal: &#8805;26).&nbsp; Near the end of the examination, the patient startles and jerks his arms when a door closes loudly.&nbsp; Lumbar puncture is recommended.&nbsp; Which of the following findings would be expected in this patient&#39;s cerebrospinal fluid?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47159\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Creutzfeldt-Jakob disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Rapidly progressive dementia</li><li>Myoclonus (provoked by startle)</li><li>Cerebellar signs (eg, ataxia)</li><li>Upper motor neuron signs (eg, hyperreflexia)</li><li>Extrapyramidal signs (eg, hypokinesia)</li><li>Mood &amp;/or sleep disturbances</li></ul></td></tr><tr><td><p align=\"center\"><strong>Findings</strong></p></td><td><ul><li>MRI: widespread atrophy (cerebrum &amp; cerebellum), cortical enhancement (ie,&nbsp;cortical ribboning), enhancement of putamen &amp; caudate head (hockey stick sign)</li><li>CSF: normal routine analysis, positive 14-3-3 protein titers, positive RT-QuIC test</li><li>EEG: sharp, triphasic, synchronous discharges</li><li>Neuropath: spongiform degeneration without inflammation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management &amp; prognosis</strong></p></td><td><ul><li>Symptomatic treatment, counseling, social services referral</li><li>No effective disease-modifying therapy, fatal in &lt;12 months</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CSF</strong> = cerebrospinal fluid; <strong>EEG</strong> = electroencephalography; <strong>RT-QuIC</strong> = real-time quaking-induced conversion.</p></td></tr></tbody></table></div><p>This previously healthy patient has developed <strong>rapidly progressive dementia, myoclonus</strong> (eg, startle-induced arm jerking), mood symptoms (eg, depression), and hypersomnia.&nbsp; This presentation is concerning for <strong>Creutzfeldt-Jakob disease</strong> (CJD), a rapidly fatal disease transmissible by an abnormally folded protein (ie, prion).&nbsp; Cerebrospinal fluid (CSF) findings in patients with CJD may include:</p><ul><li><strong>Elevated 14-3-3 protein</strong> titers (a marker of neuronal cell death not specific for CJD)</li><li>Elevated tau protein (also seen in other neurodegenerative diseases)</li><li>No white blood cells, normal glucose, normal or elevated protein (ie, <strong>noninflammatory</strong>)</li></ul><p>In addition, real-time quaking-induced conversion (RT-QuIC) is a newer assay performed on CSF in which the abnormally folded proteins are isolated, amplified, and then incubated with normally folded proteins.&nbsp; A prion-induced conformational change in the normal proteins can be observed via fluorescence detection in real time.&nbsp; The RT-QuIC test has greater sensitivity and specificity compared to 14-3-3 and tau analyses, but it is not widely available.</p><p><strong>(Choice B)</strong>&nbsp; Anti-Hu encephalitis is a paraneoplastic syndrome most commonly associated with small cell lung cancer (more common in patients who smoke).&nbsp; It may present with rapid-onset dementia, including personality and behavior changes; however, patients also typically have seizures, hallucinations, and brainstem symptoms (eg, dizziness, nausea), and myoclonus is not usually present.</p><p><strong>(Choice C)</strong>&nbsp; Although anti-NMDA receptor encephalitis can present with rapidly progressive behavior changes, memory dysfunction, and abnormal movements (eg, dyskinesia, chorea, facial twitching), it is also usually accompanied by hallucinations and autonomic instability.&nbsp; In addition, it is most commonly associated with ovarian teratomas.</p><p><strong>(Choice D)</strong>&nbsp; Herpes simplex viral encephalitis can present with rapidly worsening mental status.&nbsp; However, it typically manifests much faster (ie, &lt;1 week) than CJD and is usually accompanied by fever, headache, seizures, and focal neurologic deficits.</p><p><strong>(Choice E)</strong>&nbsp; Low alpha-synuclein may be seen in Parkinson disease (PD) and Lewy body dementia (LBD).&nbsp; Although both can cause behavior changes and cognitive impairment, PD is typified by bradykinesia, resting tremor, and rigidity, and LBD is characterized by hallucinations and parkinsonism.</p><p><strong>(Choice F)</strong>&nbsp; Low hypocretin (also known as orexin) levels are found in patients with narcolepsy type 1.&nbsp; Although narcolepsy can present with excessive daytime sleepiness and movement abnormalities in response to a startle, the movements are typically a transient loss of muscle tone (ie, cataplexy).&nbsp; Patients generally do not have dementia or a decline in ability to care for themselves.</p><p><strong>Educational objective:</strong><br>Creutzfeldt-Jakob disease is a fatal prion disease that presents with rapidly progressive dementia, myoclonus, mood changes, and sleep disturbances.&nbsp; Cerebrospinal fluid findings are typically noninflammatory and often include high levels of 14-3-3 protein.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 17883,
            "topic": "Prion disease",
            "titleId": 17883,
            "title": "Prion disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "High 14-3-3 protein titers",
                    "choiceNumber": 1,
                    "correctTaken": 13410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High anti-Hu antibody titers",
                    "choiceNumber": 2,
                    "correctTaken": 757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High anti-NMDA receptor antibody titers",
                    "choiceNumber": 3,
                    "correctTaken": 1026,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High herpes simplex viral DNA titers",
                    "choiceNumber": 4,
                    "correctTaken": 2015,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low alpha-synuclein titers",
                    "choiceNumber": 5,
                    "correctTaken": 1040,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low hypocretin titers",
                    "choiceNumber": 6,
                    "correctTaken": 466,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1268,1353,true,-1,1*1836,1964,true,-1,1*710,769,true,-1,1*103,248,true,-1,1*249,277,true,-1,5*469,524,true,-1,1*292,440,true,-1,1*530,570,true,-1,1*582,626,true,-1,1*1354,1376,true,-1,1*1976,2353,true,-1,1*2366,2693,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27016008",
                    "mediaDataId": 0,
                    "title": "CSF biomarkers in neurodegenerative and vascular dementias.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27016008",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25947081",
                    "mediaDataId": 0,
                    "title": "Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25947081",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 18714,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2150,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2350,
            "questionIndex": 2350,
            "questionText": "<p>A 78-year-old man comes to the office due to disturbed sleep.&nbsp; He describes being unable to sleep well for the past few months and says that it is making him feel &#x22;slowed down&#x22; and without energy.&nbsp; The patient used to get 7-8 hours of restful sleep each night.&nbsp; Now his sleep is restless: he describes needing 45-60 minutes to fall asleep and frequently awakening during the night.&nbsp; On average, he sleeps a total of 5-6 hours each night.&nbsp; He often gets up at 4:30 AM as he is unable to return to sleep.&nbsp; The patient has a history of hypertension treated with amlodipine.&nbsp; He does not drink caffeinated beverages or smoke cigarettes.&nbsp; He used to drink 2 beers with friends during his weekly golf and card games but has canceled these activities of late as he is too tired and no longer enjoys them.&nbsp; The patient is retired and has lived alone since his wife died a year ago.&nbsp; He admits to mild forgetfulness and says that his appetite and concentration &#x22;aren&#39;t what they used to be.&#x22;&nbsp; Height is 180 cm (5 ft 11 in) and weight is 93 kg (205 lb).&nbsp; Physical examination is noncontributory apart from a 5.4-kg (12-lb) weight loss since his last visit 6 months ago.&nbsp; Which of the following is the most likely explanation for this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>The majority of <strong>older adults</strong> with <strong>depression</strong> initially present to primary care providers and focus more on <strong>somatic complaints</strong> than on subjective changes in mood and interest.&nbsp; This patient is concerned with his sleep disturbance, but further history indicates associated symptoms of depression that raise concern for a major depressive disorder (MDD).&nbsp; In addition to <strong>initial and middle insomnia</strong> and <strong>early-morning awakening</strong>, the patient is experiencing <strong>loss of interest</strong> in both socializing and previously pleasurable activities (anhedonia), <strong>low energy</strong>, <strong>impaired concentration</strong>, and <strong>weight loss</strong> (ie, he has 5 of 9 symptoms of a major depressive episode, sufficient for diagnosis).&nbsp; His weight loss and increasing social isolation are particularly concerning and should not be dismissed as normal age-related changes.&nbsp; His forgetfulness and impaired concentration are consistent with reversible cognitive impairment commonly seen in elderly depression.</p><p>Common sleep changes in depression include multiple awakenings and early-morning awakening (as in this patient), as well as decreased REM latency and restorative sleep.&nbsp; This patient would be appropriately treated with antidepressants and/or cognitive-behavioral therapy, not sleep medication.</p><p><strong>(Choice A)</strong>&nbsp; Normal age-related sleep changes include decreased total sleep time, increased nighttime awakenings, and phase advance (becoming sleepy earlier in the evening and awakening earlier), not anhedonia or weight loss, making MDD the more likely diagnosis.</p><p><strong>(Choice B)</strong>&nbsp; Although acute grief often involves symptoms that overlap with depression, it has been a year since the death of the patient&#39;s wife, and his depressive symptoms have been present for only a few months.</p><p><strong>(Choice C)</strong>&nbsp; Insomnia disorder involves persistent difficulties initiating or maintaining sleep, resulting in clinically significant distress or impairment.&nbsp; It is diagnosed only when coexisting mental disorders and medical conditions do not adequately explain the predominant symptom of insomnia.</p><p><strong>(Choice E)</strong>&nbsp; Sleep patterns are often disrupted in people with mild neurocognitive impairment.&nbsp; However, this patient&#39;s mild forgetfulness and impaired concentration are common symptoms of elderly depression; together with his other depressive symptoms, they suggest a clinical picture of MDD.</p><p><strong>(Choice F)</strong>&nbsp; Depressed patients with insomnia often experience restlessness at night.&nbsp; However, restless leg syndrome involves a specific urge to move the legs in response to uncomfortable sensations.&nbsp; It tends to worsen at night, but it can also occur during the day.</p><p><strong>Educational objective:</strong><br>Sleep disturbances are commonly seen in depression.&nbsp; New-onset insomnia in elderly patients who have associated symptoms of depression should raise concern for major depressive disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age-related sleep changes",
                    "choiceNumber": 1,
                    "correctTaken": 1807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bereavement",
                    "choiceNumber": 2,
                    "correctTaken": 612,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insomnia disorder",
                    "choiceNumber": 3,
                    "correctTaken": 496,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 12892,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mild neurocognitive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 229,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Restless leg syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 29,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "980,1148,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20141704",
                    "mediaDataId": 0,
                    "title": "Differential diagnoses and assessment of depression in elderly patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20141704",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25766706",
                    "mediaDataId": 0,
                    "title": "Sleep related cognitions in individuals with symptoms of insomnia and depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25766706",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24319642",
                    "mediaDataId": 0,
                    "title": "Aging, circadian rhythms and depressive disorders:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24319642",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 120,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16065,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 566,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 17757,
            "questionIndex": 19217,
            "questionText": "<p>A 65-year-old man comes to the office for evaluation of slowly progressive right-hand weakness for the past 3 months.&nbsp; The patient has no pain or numbness.&nbsp; Medical history is significant for degenerative joint disease in both his hips and hypertension.&nbsp; Vital signs are normal.&nbsp; Physical examination shows atrophy of right thenar eminence and first and second web spaces.&nbsp; Muscle strength testing reveals decreased right grip strength and moderate weakness of the finger abduction.&nbsp; Tendon reflexes are 3+ in the right arm and 1+ in the left arm and lower limbs.&nbsp; Sensory examination shows no abnormalities.&nbsp; Electrophysiologic studies reveal widespread fibrillations and positive sharp waves in bilateral upper and lower extremity muscle groups.&nbsp; The underlying mechanism of this patient&#39;s disease most likely involves an abnormality in which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2299\" src=\"https://www.uworld.com/media/L13908.jpg\" ></p><p>This patient has hand weakness associated with hyperreflexia, an upper motor neuron (UMN) sign, and atrophy, a lower motor neuron (LMN) sign.&nbsp; This presentation is strongly suggestive of <strong>amyotrophic lateral sclerosis</strong> (ALS), a progressive, fatal neurodegenerative disease.&nbsp; Symptoms result from deterioration of UMNs (eg, corticospinal neurons located in the primary motor cortex) and LMNs (eg, cranial nerves, <strong>anterior horn cells</strong>).</p><p>The diagnosis of ALS is typically made clinically in a patient who displays both UMN and LMN signs.&nbsp; However, early in the disease process, only a few muscle groups may be affected (as in this patient), and electrodiagnostic studies can be helpful to rule out other neuromuscular diseases.&nbsp; Electrodiagnostic studies typically demonstrate signs of LMN dysfunction, with <strong>denervation in multiple muscle groups</strong> (even asymptomatic muscle groups).&nbsp; The denervated fibers upregulate acetylcholine receptors (as they no longer receive input from the neuromuscular junction), leading them to become hypersensitive to acetylcholine and spontaneously discharge; this manifests as <strong>widespread fibrillations</strong> and positive sharp waves (reflecting spontaneous depolarization) on electrophysiologic studies.&nbsp; Classically, sensory nerve testing is normal.</p><p><strong>(Choice B)</strong>&nbsp; Degeneration of dorsal spinal roots would lead to sensory dysfunctions, not motor dysfunctions, as seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Diseases of the neuromuscular junction such as myasthenia gravis (MG) or Lambert-Eaton myasthenic syndrome (LEMS) are characterized by weakness that either worsens (MG) or improves (LEMS) with repetition; UMN signs are unexpected.&nbsp; Repetitive nerve stimulation tests demonstrate progressive decline (or improvement) in the amplitude of complex motor action potentials.</p><p><strong>(Choice D)</strong>&nbsp; Although peripheral nerve disorders (eg, hereditary motor and sensor neuropathy) may present with weakness and widespread electrodiagnostic changes consistent with denervation, patients would not have hyperreflexia (an UMN sign).</p><p><strong>(Choice E)</strong>&nbsp; Diseases affecting the skeletal muscle include dermatomyositis and polymyositis.&nbsp; Although fibrillation potentials can be seen on insertion of the needles for electromyography (EMG), inflammatory myopathies typically affect symmetric proximal skeletal muscles, and EMG changes are limited to muscles that are affected rather than the widespread changes seen in this patient.&nbsp; In addition, these myopathies do not cause UMN signs.</p><p><strong>Educational objective:</strong><br>Amyotrophic lateral sclerosis leads to degeneration of cells in the anterior horn of the spinal cord.&nbsp; It is characterized by often asymmetric weakness with upper and lower motor neuron signs.&nbsp; Electrodiagnostic studies often show characteristics of both acute and chronic denervation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3838,
            "topic": "Amyotrophic lateral sclerosis",
            "titleId": 3838,
            "title": "Amyotrophic lateral sclerosis",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anterior horn cell",
                    "choiceNumber": 1,
                    "correctTaken": 10344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dorsal spinal root",
                    "choiceNumber": 2,
                    "correctTaken": 1357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuromuscular junction",
                    "choiceNumber": 3,
                    "correctTaken": 1070,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral nerve",
                    "choiceNumber": 4,
                    "correctTaken": 3127,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Skeletal muscle",
                    "choiceNumber": 5,
                    "correctTaken": 713,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "304,463,true,-1,1*755,1301,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23523708",
                    "mediaDataId": 0,
                    "title": "Electrodiagnosis in persons with amyotrophic lateral sclerosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23523708",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16611,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1428,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4400,
            "questionIndex": 4400,
            "questionText": "<p>A 53-year-old man comes to the office due to occasional shaking of the right hand for the last 3 months.&nbsp; The patient frequently notices the shaking while resting in an armchair and watching television.&nbsp; It often stops when he reaches for the remote.&nbsp; The shaking becomes more pronounced when the patient is engaged in mental tasks.&nbsp; He drinks coffee and occasionally has a glass of wine at dinner; these have no effect on the tremor.&nbsp; The left hand has no symptoms.&nbsp; The patient has no weakness, numbness, paresthesia, or gait dysfunction.&nbsp; There is no other significant medical history, and he takes no medications.&nbsp; Which of the following is most likely responsible for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T61344\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of tremors</strong></p></td></tr><tr><td><p align=\"center\"><strong>Essential</strong></p></td><td><ul><li>Bilateral action tremor of the hands</li><li>Head tremor without dystonia</li><li>No other neurologic signs</li><li>Improves with alcohol</li></ul></td></tr><tr><td><p align=\"center\"><strong>Parkinson disease</strong></p></td><td><ul><li>Resting tremor; &#8595; with voluntary movement</li><li>Pill-rolling</li><li>Asymmetric; hands &amp; legs</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cerebellar</strong></p></td><td><ul><li>Usually associated with ataxia &amp;/or dysmetria</li><li>&#8593; Steadily as hand approaches target</li></ul></td></tr><tr><td><p align=\"center\"><strong>Orthostatic</strong></p></td><td><ul><li>Legs &amp; trunk</li><li>Occurs only when standing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physiologic</strong></p></td><td><ul><li>Low amplitude, not visible under normal conditions</li><li>&#8593; With sympathetic activity (eg, drugs, hyperthyroidism, anxiety, caffeine)</li><li>Worse with movement</li><li>Most common cause of action tremor</li></ul></td></tr></tbody></table></div><p>This patient has an asymmetric rest tremor without other neurologic findings.&nbsp; Although a formal clinical diagnosis of idiopathic <strong>Parkinson disease</strong> (PD) requires bradykinesia, tremor is often the initial presenting sign and can remain the only symptom for years (ie, tremor-dominant PD).&nbsp; Certain tremor features are more characteristic of PD, including the following:</p><ul><li><strong>Resting tremor</strong></li><li><strong>Pill-rolling</strong></li><li>Asymmetric (eg, often starts in only 1 hand)</li><li>More pronounced tremor with distractibility (eg, performing mental tasks)</li><li>Lack of significant changes with alcohol or stimulants (eg, caffeine)</li></ul><p>PD is due to a progressive <a href=\"16586\">loss of dopaminergic neurons</a> in the substantia nigra of the <strong>basal ganglia</strong>; this loss interrupts <a href=\"26880\">motor pathways</a> between the basal ganglia, thalamus, and motor cortex.</p><p><strong>(Choice B)</strong>&nbsp; Cerebellar dysfunction causes action tremor, which can be kinetic, postural, or intention (worsens as the hand moves closer to its target, unlike in this patient).&nbsp; Although severe cerebellar dysfunction can cause resting tremor, other accompanying signs (eg, nystagmus, ataxia, dysmetria) usually develop.</p><p><strong>(Choice C)</strong>&nbsp; Essential tremors typically present as action tremors (vs this patient&#39;s resting tremor) in the upper extremities that worsen at the end of goal-directed activities (eg, would worsen when the patient reaches for the remote).&nbsp; These tremors classically improve with alcohol.</p><p><strong>(Choice D)</strong>&nbsp; Orthostatic tremor occurs in the legs and trunk (it does not involve the hands) immediately on standing and is relieved by sitting.&nbsp; It is usually high frequency (14-18 Hz) without other clinical signs or symptoms.</p><p><strong>(Choice E)</strong>&nbsp; Physiologic tremor is the most common cause of action tremor and usually has a medical (vs a neurologic) etiology.&nbsp; Unlike the resting tremor seen in this patient, physiologic tremors are action tremors, which may be kinetic, intention, or postural (eg, holding arms outstretched).&nbsp; Physiologic tremors are usually worsened with emotional or physical stress, toxic/metabolic derangements, caffeine, or drug withdrawal.</p><p><strong>Educational objective:</strong><br>Tremor is often the presenting symptom of Parkinson disease.&nbsp; It is usually a resting, pill-rolling tremor that asymmetrically impacts the hands.&nbsp; It improves with voluntary actions, worsens when patients are distracted, and is not impacted by caffeine or alcohol.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Basal ganglia dysfunction",
                    "choiceNumber": 1,
                    "correctTaken": 6733,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerebellar dysfunction",
                    "choiceNumber": 2,
                    "correctTaken": 544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Essential tremor",
                    "choiceNumber": 3,
                    "correctTaken": 4010,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Orthostatic tremor",
                    "choiceNumber": 4,
                    "correctTaken": 234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Physiologic tremor",
                    "choiceNumber": 5,
                    "correctTaken": 3827,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "106,134,true,-1,1*1017,1135,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22382359",
                    "mediaDataId": 0,
                    "title": "Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22382359",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23591755",
                    "mediaDataId": 0,
                    "title": "What is essential tremor?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23591755",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 15351,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1164,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 4563,
            "questionIndex": 4563,
            "questionText": "<p>A 65-year-old man comes to the office due to tremor in his left hand and stiffness in his left arm for a year.&nbsp; He also noticed generalized slowness in his movements and loses balance when he tries to turn or stop suddenly while walking.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; He does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 36 C (96.8 F), blood pressure is 130/86 mm Hg, and pulse is 72/min.&nbsp; At rest, a low-frequency tremor is noted in the left hand.&nbsp; Muscle tone is increased in the left arm, with stepwise resistance to passive movements.&nbsp; Strength is 5/5 throughout; deep tendon reflexes are 2+ and symmetric.&nbsp; Babinski sign is absent bilaterally.&nbsp; Gait is slow with decreased arm movements.&nbsp; Sensory examination and mental status examination show no abnormalities.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most appropriate next step in confirming the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient likely has <strong>Parkinson disease</strong> (PD), a neurodegenerative disorder associated with the accumulation of alpha-synuclein within neurons of the substantia nigra pars compacta.&nbsp; Cardinal signs are rest tremor, rigidity, and akinesia/bradykinesia.&nbsp; Postural instability and response to a levodopa trial are additional features highly suggestive for PD.</p><p><strong>Diagnosis</strong> is <strong>clinical</strong>.&nbsp; No current imaging or laboratory tests can be used to confirm this diagnosis with any greater accuracy than history and physical examination.&nbsp; To establish the diagnosis, bradykinesia plus tremor or rigidity must be present.&nbsp; However, the most common presenting sign of PD is an asymmetric rest tremor in the distal part of an upper extremity; rigidity and bradykinesia may not be present.</p><p>Physical examination findings contributing to the clinical diagnosis include (mnemonic - <strong>TRAP</strong>) the following:</p><p><strong>T - Tremor</strong></p><ul><li>Resting 4- to 6-Hz tremor with a pill-rolling quality</li><li>Frequently first manifests in 1 hand, which may slowly generalize to the other hand and lower extremities</li></ul><p><strong>R - Rigidity</strong></p><ul><li>Baseline increased resistance to passive movement about a joint, which may be oscillating (cogwheel) or uniform (lead pipe)</li></ul><p><strong>A - Akinesia/bradykinesia</strong></p><ul><li>Difficulty initiating movements, as when starting to walk or rising from a chair</li><li>Narrow-based, shuffling gait with short strides and with decreased arm swing (festination)</li><li>Micrographia (small handwriting)</li><li>Hypomimia (decreased facial expression [&#x22;masked facies&#x22;], lack of blinking)</li><li>Hypophonia (soft speech)</li></ul><p><strong>P - Postural instability</strong></p><ul><li>Flexed axial posture</li><li>Loss of balance during turning or stopping</li><li>Loss of balance when pushed slightly from a stationary (pull test), bipedal stance</li><li>Frequent falls</li></ul><p><strong>(Choices A and B)</strong>&nbsp; No imaging is required for the diagnosis in a typical PD presentation.&nbsp; CT scan of the head is often unremarkable or nonspecific.&nbsp; MRI may be useful for excluding other possible diagnoses (eg, multi-infarct basal ganglia stroke, normal pressure hydrocephalus); a thorough history and physical examination can also usually rule them out.</p><p><strong>(Choice D)</strong>&nbsp; Hyperthyroidism (low serum TSH) commonly causes tremor but not bradykinesia or rigidity.&nbsp; In addition, overt hyperthyroidism typically demonstrates the characteristic symptoms of heat intolerance, palpitations, and weight loss (not seen in this patient).&nbsp; In addition, hyperthyroidism typically causes a symmetric (vs asymmetric) tremor.</p><p><strong>(Choice E)</strong>&nbsp; Slit-lamp examination can be used to evaluate for Kayser-Fleischer rings, which are seen in Wilson disease.&nbsp; Although Wilson disease can present with parkinsonism, it is most commonly diagnosed before age 35; signs of hepatic dysfunction are usually present.</p><p><strong>Educational objective:</strong><br>The cardinal signs of Parkinson disease are rest tremor, rigidity, and bradykinesia.&nbsp; At least 2 of these on physical examination are grounds for a clinical diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the head",
                    "choiceNumber": 1,
                    "correctTaken": 1570,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the head",
                    "choiceNumber": 2,
                    "correctTaken": 4335,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional diagnostic testing needed",
                    "choiceNumber": 3,
                    "correctTaken": 12110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum TSH level",
                    "choiceNumber": 4,
                    "correctTaken": 657,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Slit-lamp examination",
                    "choiceNumber": 5,
                    "correctTaken": 162,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "127,212,true,-1,1*282,387,true,-1,1*930,941,true,-1,1*1174,1219,true,-1,1*1451,1551,true,-1,1*1598,1738,true,-1,1*2456,2715,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 43,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 18834,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 584,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 3074,
            "questionIndex": 3074,
            "questionText": "<p>An 80-year-old retired engineer is brought to the office by his son due to behavioral changes.&nbsp; The patient believes that his son is after his money and is trying to kick him out of the house to get all of his property.&nbsp; His son reports the patient has been more forgetful over the last few years.&nbsp; Medical history is nonsignificant.&nbsp; Vital signs are within normal limits.&nbsp; On physical examination, the patient is oriented to person and place only and is unable to cooperate with much of the cognitive examination.&nbsp; He has very poor short-term recall.&nbsp; He is unable to name the current American president and states, &#x22;I don&#39;t care to follow politics anymore.&#x22;&nbsp; The remainder of the neurologic examination is unremarkable.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32369\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Differential diagnosis of dementia subtypes</strong></p></td></tr><tr><td><p align=\"center\"><strong>Alzheimer disease</strong></p></td><td><ul><li>Early, insidious short-term memory loss</li><li>Language deficits &amp; spatial disorientation</li><li>Later personality changes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Vascular dementia</strong></p></td><td><ul><li>Stepwise decline</li><li>Early executive dysfunction</li><li>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</li></ul></td></tr><tr><td><p align=\"center\"><strong>Frontotemporal dementia</strong></p></td><td><ul><li>Early personality changes</li><li>Apathy, disinhibition &amp; compulsive behavior</li><li>Frontotemporal atrophy on neuroimaging</li></ul></td></tr><tr><td><p align=\"center\"><strong>Dementia with Lewy bodies</strong></p></td><td><ul><li>Visual hallucinations</li><li>Spontaneous parkinsonism</li><li>Fluctuating cognition</li><li>Rapid eye movement behavior disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Normal pressure hydrocephalus</strong></p></td><td><ul><li>Ataxia early in disease</li><li>Urinary incontinence</li><li>Dilated ventricles on neuroimaging</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prion disease</strong></p></td><td><ul><li>Behavioral changes</li><li>Rapid progression</li><li>Myoclonus &amp;/or seizures</li></ul></td></tr></tbody></table></div><p>The insidious onset of memory impairment followed by the development of paranoid ideation in a previously high functioning patient is characteristic of <strong>Alzheimer disease</strong> (AD).&nbsp; AD, the most common cause of dementia, typically begins with <strong>memory loss for recent events </strong>(eg, poor short-term memory, naming current president), executive dysfunction, and impaired visuospatial skills, followed by language difficulties, apraxia, and behavioral changes (eg, apathy, disinhibition, suspiciousness).&nbsp; <strong>Psychotic features</strong> (delusions, hallucinations) may develop in the middle and late course of the disease.&nbsp; Delusions with paranoid themes are common and can be particularly distressing to both patients and caregivers.</p><p>Common disorders in the differential diagnosis of AD include vascular dementia, pseudodementia (cognitive changes due to depression), and other neurodegenerative dementias (eg, dementia with Lewy bodies, frontotemporal dementia).&nbsp; Although the diagnosis of AD is largely clinical, neuropsychological testing, brain imaging, and laboratory testing are typically ordered to rule out reversible causes of dementia.</p><p><strong>(Choice B)</strong>&nbsp; Dementia with Lewy Bodies is characterized by fluctuating cognitive impairment, dysautonomia, parkinsonism, and early development of visual hallucinations.&nbsp; This patient&#39;s early, prominent memory loss and unremarkable neurologic examination are more consistent with AD.</p><p><strong>(Choice C)</strong>&nbsp; Frontotemporal dementia is characterized by early personality changes (eg, euphoria, disinhibition, apathy), compulsive behaviors (eg, peculiar eating habits), hyperorality, and frontotemporal atrophy demonstrated on brain imaging.&nbsp; Behavioral changes often precede memory impairments (in contrast to AD).</p><p><strong>(Choice D)</strong>&nbsp; Pseudodementia (also referred to as dementia syndrome of depression) is seen in older depressed patients who present with cognitive deficits similar to neurodegenerative dementias.&nbsp; It is less likely in this patient who has no history of depression or prominent mood symptoms.</p><p><strong>(Choice E)</strong>&nbsp; Vascular dementia is associated with stroke or small-vessel cerebrovascular disease.&nbsp; The dementia is typically characterized by stepwise cognitive impairments associated with focal neurologic deficits.&nbsp; It is less likely in this patient with no significant cardiovascular risk factors and a normal examination.</p><p><strong>Educational objective:</strong><br>Alzheimer disease, the most common cause of dementia, is characterized by insidious memory loss followed by behavioral changes.&nbsp; Psychotic symptoms (delusions, hallucinations) may develop later in the course of the disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 3503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontotemporal dementia",
                    "choiceNumber": 3,
                    "correctTaken": 913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pseudodementia",
                    "choiceNumber": 4,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 5,
                    "correctTaken": 119,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "92,131,true,-1,1*175,200,true,-1,1*355,380,true,-1,1*537,595,true,-1,1*236,330,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30704681",
                    "mediaDataId": 0,
                    "title": "The Alzheimer&#39;s disease clinical spectrum: diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30704681",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 90,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 5037,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 511,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 4060,
            "questionIndex": 4060,
            "questionText": "<p>A 65-year-old woman comes to the office due to deteriorating memory.&nbsp; She used to pride herself on her sharp memory and is very concerned about its loss, saying, &#x22;Over the last 6 months I have been forgetting the most trivial things.&#x22;&nbsp; The patient has had to delegate tasks such as household chores and cooking to her husband because of her poor memory and &#x22;cloudy thinking.&#x22;&nbsp; &#x22;I have been feeling useless and worthless since retiring last year.&nbsp; Now I just watch TV all day and barely have enough energy to eat.&nbsp; I haven&#39;t felt like gardening in over a year&mdash;I used to love it!&#x22;&nbsp; Both the patient&#39;s mother and father died of complications of Alzheimer disease.&nbsp; She&#39;s lost 5 kg (11 lb) over the last 2 months but her physical examination is within normal limits.&nbsp; On testing with the Montreal Cognitive Assessment, she scores 24/30 (normal &#8805;26) with deficits in delayed recall and attention.&nbsp; Laboratory results, including thyroid function, are unremarkable.&nbsp; MRI of the head is normal.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient exhibits features of <a href=\"17482\">major depressive disorder</a>&mdash;anhedonia (eg, &#x22;used to love&#x22; gardening but hasn&#39;t &#x22;felt like it&#x22;), feelings of worthlessness, weight loss, low energy (eg, &#x22;barely enough energy to eat&#x22;), poor concentration (eg, &#x22;cloudy thinking&#x22;)&mdash;accompanied by memory impairment.&nbsp; Her worsening depressive symptoms over the past year are notable for <strong>predating</strong> the onset of <strong>memory difficulties</strong> 6 months ago.</p><p>Severe depression, especially in older adults, may present with cognitive impairment severe enough to mimic dementia, a condition known as <strong>depression-related cognitive impairment</strong> (sometimes referred to as pseudodementia).&nbsp; During cognitive testing, patients with this condition typically exhibit deficits in attention, concentration, memory, and executive function.&nbsp; They may have difficulty completing testing (eg, Montreal Cognitive Assessment [MoCA]) and frequently put forth poor effort.</p><p>Depression-related cognitive impairment is largely reversible with the treatment of the underlying depression using medications such as <strong>selective serotonin reuptake inhibitors</strong> (eg, escitalopram) and/or psychotherapy.&nbsp; As the patient&#39;s depression improves, cognitive impairment (and MoCA score) should return to premorbid baseline.</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s symptoms are not explained by normal age-related memory impairment, and her depression requires definitive treatment with antidepressant medication and/or psychotherapy.</p><p><strong>(Choice B)</strong>&nbsp; Memory training involves using mnemonic techniques, external cues, and organizational aids to assist patients with mild cognitive impairment.&nbsp; Vitamin E has limited evidence for the treatment of mild-to-moderate Alzheimer disease but has no evidence for the treatment of depression-related cognitive impairment.&nbsp; This patient&#39;s major depressive episode requires appropriate treatment with antidepressant medication and/or psychotherapy.</p><p><strong>(Choice C)</strong>&nbsp; Amantadine is a drug that may be used in the treatment of Parkinson disease.</p><p><strong>(Choices D and F)</strong>&nbsp; Cholinesterase inhibitors (eg, donepezil) and the NMDA receptor antagonist memantine are used in the treatment of dementia (eg, Alzheimer disease) but have not been shown to be helpful for depression-related cognitive impairment.&nbsp; This patient&#39;s cognitive symptoms should improve with treatment of her underlying depression.</p><p><strong>Educational objective:</strong><br>Depression-related cognitive impairment may be so severe in elderly patients that they appear to have dementia.&nbsp; Psychotherapy and/or antidepressant medications are the treatment of choice for elderly patients with depression and frequently result in reversal of cognitive deficits.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Reassure patient that these are expected age-related memory changes",
                    "choiceNumber": 1,
                    "correctTaken": 590,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend memory training and vitamin E",
                    "choiceNumber": 2,
                    "correctTaken": 911,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start amantadine pharmacotherapy",
                    "choiceNumber": 3,
                    "correctTaken": 368,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start donepezil pharmacotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 3096,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start escitalopram pharmacotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 13174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start memantine pharmacotherapy",
                    "choiceNumber": 6,
                    "correctTaken": 730,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "588,671,true,-1,1*2026,2173,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25581234",
                    "mediaDataId": 0,
                    "title": "Depression and cognition in the elderly.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25581234",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25655026",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of depression and cognitive impairment in late life.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25655026",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 128,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 18869,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1563,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 22733,
            "questionIndex": 106786,
            "questionText": "<p>A 69-year-old man comes to the office due to trouble singing.&nbsp; In his youth, the patient was in a barbershop quartet, and the group is trying to get together again, but he is having difficulty because his voice is too quiet.&nbsp; The patient runs out of breath when singing and has trouble hitting the notes.&nbsp; His friends say he is not as funny as he used to be.&nbsp; His wife also says that he takes longer to eat meals and often coughs after drinking.&nbsp; The patient adds, &#x22;Food doesn&#39;t taste as good as it used to.&#x22;&nbsp; He has no other medical conditions and takes no medications.&nbsp; On examination, there is breathiness of the voice, but otherwise, cranial nerves II-XII are grossly intact.&nbsp; There is increased resistance to joint movement of the right, more than the left, arm.&nbsp; Deep tendon reflexes are 2+ in all extremities.&nbsp; Posture is stooped, and gait is slow.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2442\" src=\"https://www.uworld.com/media/highresdefault/L21988.png\"  ></p><p>This patient&#39;s symptoms and neurologic findings raise suspicion for probable idiopathic <strong>Parkinson disease</strong>.&nbsp; Although idiopathic Parkinson disease most often presents with tremor, it can also manifest with primarily <strong>bulbar symptoms</strong>, such as in this patient.&nbsp; Specifically, this patient has the following:</p><ul><li><strong>Hypophonia</strong> (a soft voice)</li><li><strong>Aspiration</strong> of liquids (coughing when drinking)</li><li>Loss of olfactory function (often perceived by patients as change in taste)</li><li>Rigidity of the upper limbs (increased resistance to passive movement around a joint)</li><li>Stooped posture and slow gait</li></ul><p>Diagnostic features such as rigidity, postural instability, and gait changes are often discovered on physical examination instead of through a patient&#39;s report.&nbsp; &#x22;Not being funny&#x22; can sometimes indicate a combination of bradykinesia of the face (masked facies) and/or the voice (hypophonia).</p><p>In patients in whom Parkinson disease is being considered, bulbar symptoms may be considered &#x22;red flags&#x22; because they can be seen with other related conditions; however, the presence of red flags does not exclude the diagnosis of Parkinson disease so long as other supportive features (eg, olfactory dysfunction) are present.</p><p><strong>(Choice A)</strong>&nbsp; Like Parkinson disease, amyotrophic lateral sclerosis can present with predominantly bulbar symptoms such as dysphagia and dysarthria.&nbsp; However, examination would reveal upper and lower motor neuron signs (eg, atrophy, fasciculations, hyperreflexia).&nbsp; Rigidity, loss of olfactory function, and a stooped posture are more consistent with Parkinson disease.</p><p><strong>(Choice B)</strong>&nbsp; Dementia with Lewy bodies can present with parkinsonian features (eg, rigidity).&nbsp; However, dementia, which is not seen in this patient, must also be present.&nbsp; In addition, patients often have hallucinations and fluctuating cognition.</p><p><strong>(Choice D)</strong>&nbsp; Brainstem strokes classically lead to the crossed signs of contralateral weakness with ipsilateral cranial nerve deficits.&nbsp; In the pons, this often manifests as facial weakness because the facial nerve (CN VII) <a href=\"51573\">originates in the pons</a>.</p><p><strong>(Choice E)</strong>&nbsp; Stiff person syndrome, an autoimmune condition, can present with rigidity, but it primarily involves the axial muscles, and patients usually have severe gait disturbances due to stiffness.&nbsp; In addition, the most classic feature is severe, painful muscle spasms that are precipitated by loud noises and usually result in falling.&nbsp; It is much more common in women; patients also typically have comorbid type 1 diabetes mellitus.</p><p><strong>Educational objective:</strong><br>Parkinson disease can present with bulbar symptoms, including aspiration and hypophonia (soft voice).&nbsp; Olfactory dysfunction is also common.&nbsp; Examination often shows rigidity, stooped posture, and typical gait changes (eg, slowness, shuffling).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amyotrophic lateral sclerosis",
                    "choiceNumber": 1,
                    "correctTaken": 1824,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease",
                    "choiceNumber": 3,
                    "correctTaken": 9451,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pontine stroke",
                    "choiceNumber": 4,
                    "correctTaken": 645,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stiff person syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 1889,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "336,484,true,-1,1*762,892,true,-1,1*893,1054,true,-1,1*2299,2421,true,-1,1*2236,2280,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 14106,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 552,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 3631,
            "questionIndex": 3631,
            "questionText": "<p>A 48-year-old man comes to the office due to increased irritability and issues at work.&nbsp; The patient, who is usually outgoing and friendly, began to experience significant irritability 3 months ago and has since gotten in trouble at work for inappropriate and rude behavior on several occasions.&nbsp; His performance as a bank loan officer has suffered, and he has made numerous mathematic errors.&nbsp; The patient is in danger of being fired and is very distressed.&nbsp; Medical history is noncontributory.&nbsp; His parents died in a motor vehicle collision when he was a child.&nbsp; Vital signs are normal.&nbsp; The patient is alert and fully oriented.&nbsp; He cannot sit still during the examination and makes repeated abrupt, involuntary movements that are most prominent in the upper extremities.&nbsp; Muscle strength and tone are normal in the upper and lower extremities.&nbsp; Deep tendon reflexes are 3+ bilaterally in the upper and lower extremities.&nbsp; Gait is normal.&nbsp; He scores 23/30 on the Montreal Cognitive Assessment (normal: &#8805;26).&nbsp; MRI of the head is ordered.&nbsp; Which of the following is most likely to be seen on imaging?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t46869\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:65.0%;\"><p align=\"center\"><strong>Huntington disease</strong></p></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:65.0%;\"><ul><li>Motor: chorea, delayed saccade</li><li>Psychiatric: depression, irritability, psychosis, obsessive-compulsive symptoms</li><li>Cognitive: executive dysfunction</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Findings</strong></p></td><td style=\"width:65.0%;\"><ul><li>Genetic: autosomal dominant CAG trinucleotide repeat expansion disorder</li><li>Neuropathology: loss of GABA-ergic neurons</li><li>Imaging: caudate nucleus &amp; putamen atrophy</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Management &amp; prognosis</strong></p></td><td style=\"width:65.0%;\"><ul><li>Treatment: supportive</li><li>Survival: 10-20 years</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>behavioral change</strong> (eg, irritability, social inappropriateness, rudeness), <strong>cognitive impairment</strong> (eg, mathematic errors, abnormal Montreal Cognitive Assessment), and neurologic signs (eg, <strong>chorea</strong> [repeated, abrupt involuntary movements], hyperreflexia) are consistent with <strong>Huntington disease</strong> (HD).</p><p>HD is an autosomal dominant, CAG trinucleotide repeat expansion disease in which an abnormal version of the huntingtin protein causes preferential <strong>neurodegeneration and atrophy of the caudate nucleus and putamen</strong>.&nbsp; Psychiatric manifestations can include <strong>irritability</strong>, <strong>depression</strong>, <strong>apathy</strong>, obsessive-compulsive behavior, and psychosis.&nbsp; Cognitive impairment is highlighted by a decline in executive function (eg, decision-making, multitasking, flexibility).&nbsp; There is no disease-modifying treatment for HD, and care is supportive.</p><p>HD most often presents around age 40 followed by a progressive functional decline over the next 10-20 years, resulting in death.&nbsp; The number of trinucleotide repeats may increase across generations (particularly with paternal transmission), leading to an anticipation effect whereby offspring present at earlier ages; however, family history may not always be apparent to aid in the diagnosis (eg, parents dying before manifestation).</p><p><strong>(Choice A)</strong>&nbsp; Bilateral temporal lobe lesions, especially involving the hippocampus and amygdala, are seen in Kl&uuml;ver-Bucy syndrome.&nbsp; Inappropriate behaviors (eg, hypersexuality, hyperorality) are common but usually present with a combination of excessive touching, bulimia, placidity, visual agnosia, and amnesia.</p><p><strong>(Choice C)</strong>&nbsp; Frontal lobe degeneration can be seen in behavioral variant frontotemporal dementia.&nbsp; Executive dysfunction and inappropriate behaviors (eg, hyperorality, sexual disinhibition) are common, but apathy and ritualistic behaviors, not chorea, are expected.</p><p><strong>(Choices D and E)</strong>&nbsp; Periventricular white matter lesions and ventriculomegaly without cerebral atrophy are characteristic of normal pressure hydrocephalus.&nbsp; Cognitive impairment with executive dysfunction and diminished attention typically presents with significant gait difficulty and urinary incontinence (ie, &#x22;wet, wobbly, wacky&#x22;).</p><p><strong>Educational objective:</strong><br>Huntington disease is an autosomal dominant, CAG trinucleotide repeat expansion disease presenting with psychiatric symptoms, cognitive impairment, and chorea.&nbsp; It is associated with preferential atrophy of the caudate nucleus and putamen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 1550,
            "topic": "Huntington disease",
            "titleId": 1550,
            "title": "Huntington disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bilateral temporal lobe lesions",
                    "choiceNumber": 1,
                    "correctTaken": 321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Caudate nucleus atrophy",
                    "choiceNumber": 2,
                    "correctTaken": 8851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontal lobe degeneration",
                    "choiceNumber": 3,
                    "correctTaken": 4603,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Periventricular white matter lesions",
                    "choiceNumber": 4,
                    "correctTaken": 255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventriculomegaly without cerebral atrophy",
                    "choiceNumber": 5,
                    "correctTaken": 180,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "292,377,true,-1,1*67,97,true,-1,1*1413,1600,true,-1,1*1729,2028,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28817209",
                    "mediaDataId": 0,
                    "title": "Huntington&#39;s disease: a clinical review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28817209",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 14210,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 847,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 17077,
            "questionIndex": 18528,
            "questionText": "<p>A 70-year-old man with a 10-year history of well-controlled Parkinson disease is brought to the clinic for evaluation of dizziness.&nbsp; He was able to walk 1 mile daily until he developed occasional episodes of dizziness and syncope when standing.&nbsp; His medications include levodopa, carbidopa, and a multivitamin.&nbsp; Seated blood pressure is 120/70 mm Hg with a heart rate of 66/min; standing blood pressure is 89/60 mm Hg with a heart rate of 68/min.&nbsp; Cardiopulmonary examination is normal.&nbsp; Neurologic examination shows mild tremor and bradykinesia.&nbsp; A complete blood count, basic metabolic panel, and ECG are normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s dizziness?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t57146\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Clues to etiology of syncope</strong></p></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Reflex syncope</strong></p></td><td><p align=\"center\"><strong>Vasovagal</strong></p></td><td><ul><li>Trigger (eg, emotional stress, prolonged standing)</li><li>Prodrome (eg, nausea, sweating, warmth)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Situational</strong></p></td><td><ul><li>Occurs with micturition, defecation, swallowing, or coughing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Carotid hypersensitivity</strong></p></td><td><ul><li>Tactile stimulation of carotid sinus while standing</li><li>Advanced age, carotid atherosclerosis</li></ul></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Orthostatic syncope</strong></p></td><td><p align=\"center\"><strong>Medications</strong></p></td><td><ul><li>Vasodilators (eg, alpha-1 blockers, antihypertensives)</li><li>Inotropic/chronotropic blockade (eg, beta blockers)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hypovolemia</strong></p></td><td><ul><li>History consistent with volume loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Autonomic dysfunction</strong></p></td><td><ul><li>Advanced age</li><li>Predisposing disease (eg, DM, Parkinson)</li></ul></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Cardiac syncope</strong></p></td><td><p align=\"center\"><strong>LV outflow obstruction</strong></p></td><td><ul><li>Syncope with exertion</li><li>Systolic ejection murmur</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ventricular tachycardia</strong></p></td><td><ul><li>No warning symptoms</li><li>Cardiomyopathy or ischemic HD (monomorphic)</li><li>QT-interval prolongation (polymorphic)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Conduction impairment*</strong></p></td><td><ul><li>Preceding fatigue or light-headedness</li><li>ECG abnormalities (eg, sinus pauses, dropped QRS complexes)</li></ul></td></tr><tr><td colspan=\"3\"><p>*Sick sinus syndrome or advanced atrioventricular block.</p><p><strong>DM</strong> = diabetes mellitus; <strong>HD</strong> = heart disease; <strong>LV</strong> = left ventricular.</p></td></tr></tbody></table></div><p><strong>Neurogenic orthostatic hypotension</strong> (NOH) is a common complication of <strong>Parkinson disease</strong> and other related neurodegenerative diseases (eg, Lewy body disease, multisystem atrophy), manifesting with <strong>lightheadedness</strong> or <strong>syncope</strong> on standing.&nbsp; In the normal state, standing from a seated or supine position triggers arterial baroreceptors to increase sympathetic drive, causing vasoconstriction (which mobilizes pooled venous blood from the legs) and an increase in heart rate (to aid cardiac output).&nbsp; NOH occurs due to <strong>autonomic dysfunction</strong> that may result from degenerative changes to autonomic ganglia or CNS nuclei; there is impaired release of norepinephrine and consequent failure of vasoconstriction and increased heart rate.</p><p>Therefore, like orthostatic hypotension from other causes, NOH leads to a drop in systolic blood pressure &#8805;20 mm Hg with standing (orthostasis); however, unlike other causes of orthostatic hypotension that occur with an intact autonomic nervous system (eg, hypovolemia), the expected <strong>increase in heart rate</strong>&nbsp;is <strong>absent</strong>.</p><p>Notably, dopamine agonists used to treat Parkinson disease (eg, levodopa) may further contribute to orthostatic hypotension, possibly due to undesired peripheral activity of dopamine that stimulates vasodilation.</p><p><strong>(Choices A and D)</strong>&nbsp; Intravascular volume depletion due to primary adrenal insufficiency (PAI) or other causes (eg, reduced oral intake) can cause orthostatic hypotension and syncope.&nbsp; However, PAI is not an expected complication of Parkinson disease and is usually accompanied by electrolyte abnormalities (eg, hyperkalemia, hyponatremia).&nbsp; In addition, an increase in heart rate is expected with orthostasis that is due to hypovolemia.</p><p><strong>(Choice C)</strong>&nbsp; Carotid sinus hypersensitivity involves an exaggerated vagal response triggered by tactile stimulus of the carotid sinus.&nbsp; Patients often experience syncope with activities such as shaving or putting on a necktie.</p><p><strong>(Choice E)</strong>&nbsp; Sinus node dysfunction commonly manifests as sick sinus syndrome, a potential cause of syncope.&nbsp; Although the heart rate response is often impaired, vascular autonomic innervation and vasoconstriction are intact, making orthostatic symptoms less prominent with sick sinus syndrome.&nbsp; In addition, suggestive ECG abnormalities (eg, sinus pauses) are commonly present.</p><p><strong>Educational objective:</strong><br>Autonomic dysfunction is common with Parkinson disease and can lead to neurogenic orthostatic hypotension, with patients experiencing lightheadedness or syncope on standing.&nbsp; The disorder is typically recognized by a &#8805;20 mm Hg drop in systolic blood pressure with standing and an absence of the expected increase in heart rate.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autonomic insufficiency",
                    "choiceNumber": 2,
                    "correctTaken": 10263,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Baroreceptor hyperreactivity",
                    "choiceNumber": 3,
                    "correctTaken": 1665,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravascular volume depletion",
                    "choiceNumber": 4,
                    "correctTaken": 786,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sinus node dysfunction",
                    "choiceNumber": 5,
                    "correctTaken": 501,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "585,625,true,-1,1*756,838,true,-1,1*1579,1808,true,-1,1*1962,2127,true,-1,1*2137,2340,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31527282",
                    "mediaDataId": 0,
                    "title": "Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31527282",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31456212",
                    "mediaDataId": 0,
                    "title": "Neurogenic orthostatic hypotension in Parkinson disease: a primer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31456212",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12628063",
                    "mediaDataId": 0,
                    "title": "Autonomic nervous system dysfunction in Parkinson disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12628063",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 68,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 13316,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 901,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 20193,
            "questionIndex": 21687,
            "questionText": "<p>A 68-year-old woman with a 3-year history of idiopathic Parkinson disease comes to the office with her husband for follow-up.&nbsp; The patient reports adequate control of motor symptoms with carbidopa-levodopa therapy but states that for the past month she has not spent time with her friends or participated in her church choir due to difficulty focusing.&nbsp; She sleeps restlessly most nights, resulting in daytime naps, and skips dinner because she is not hungry.&nbsp; The patient&#39;s medical history is otherwise noncontributory, and she takes no other medications.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination is significant for reduced facial expressions and mild slowing on repeated finger tapping, but no significant tremors are noted.&nbsp; Posture and gait are normal.&nbsp; Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"52959\" src=\"https://www.uworld.com/media/highresdefault/L81900.png\"  ></p><p>This patient with <strong>Parkinson disease</strong> (PD) reports adequate control of motor symptoms but has developed <strong>nonmotor symptoms</strong> that cause impairment.&nbsp; Her month-long history of decreased interest and enjoyment of social activities (eg, no longer spending time with her friends), impaired concentration (eg, difficulty focusing in church choir limiting participation), sleep disturbance, fatigue, and loss of appetite is consistent with <strong>depression</strong>, a common complication of PD that can affect up to 50% of patients.</p><p>Depression may go unrecognized and undertreated in PD due to <strong>overlapping symptoms</strong>; for example, the PD symptoms of masked facies and bradykinesia are similar to the blunted affect and psychomotor retardation seen in major depressive disorder.&nbsp; In contrast, the presence of sadness and <strong>deliberate social withdrawal</strong> due to anhedonia (difficulty enjoying previously pleasurable activities) <strong>can help differentiate depression</strong> from apathy (decreased motivation to speak or act), a common finding in patients with PD that may occur with or without depression.</p><p>When PD is well controlled (ie, no tremors, normal gait), as in this patient, targeting symptoms of depression with antidepressants and/or cognitive-behavioral therapy is the most appropriate next step.&nbsp; <a href=\"52960\">Selective serotonin reuptake inhibitors</a> are commonly used as first-line antidepressants because of their favorable adverse effect profile.</p><p><strong>(Choice A)</strong>&nbsp; Adding a dopamine agonist would be appropriate if the patient&#39;s motor symptoms were not adequately controlled.&nbsp; A dopamine agonist is unlikely to relieve the patient&#39;s depression and may increase her risk for psychosis and impulse control disorders.</p><p><strong>(Choice B)</strong>&nbsp; Although stimulants may be prescribed to treat fatigue in certain neurologic disorders, there is no established role for their use in the treatment of PD-related depression.</p><p><strong>(Choice D)</strong>&nbsp; Antipsychotic agents have a role in the treatment of psychosis, a frequent complication of PD treatment.&nbsp; They are not first-line treatments for depression.</p><p><strong>(Choice E)</strong>&nbsp; Carbidopa-levodopa can cause somnolence; however, this patient&#39;s daytime naps appear to be due to depressive symptoms because they are associated with restless sleep and anhedonia.&nbsp; Her current dose of carbidopa-levodopa is effectively controlling her motor symptoms, and dose reduction would risk worsening them.</p><p><strong>Educational objective:</strong><br>Depression is a common complication of Parkinson disease (PD) and is often undertreated because the two conditions have overlapping symptoms (eg, psychomotor slowing [bradykinesia], blunted affect [masked facies]).&nbsp; Patients with depression can be treated with antidepressant medication, psychotherapy, or both.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add a dopamine agonist",
                    "choiceNumber": 1,
                    "correctTaken": 522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a stimulant",
                    "choiceNumber": 2,
                    "correctTaken": 143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe an antidepressant",
                    "choiceNumber": 3,
                    "correctTaken": 2811,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe an atypical antipsychotic",
                    "choiceNumber": 4,
                    "correctTaken": 179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduce the carbidopa-levodopa dose",
                    "choiceNumber": 5,
                    "correctTaken": 1294,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "461,539,true,-1,1*796,972,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31622207",
                    "mediaDataId": 0,
                    "title": "Drug choices and advancements for managing depression in Parkinson&#39;s disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31622207",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31120798",
                    "mediaDataId": 0,
                    "title": "Drug treatment strategies for depression in Parkinson disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31120798",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 134,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 5049,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 836,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 4401,
            "questionIndex": 4401,
            "questionText": "<p>A 58-year-old woman comes to the emergency department due to several hours of severe left-sided headache, nausea, and vomiting.&nbsp; She also has blurred vision and sees halos around lights.&nbsp; The patient has a history of hand tremors for which she recently started taking a new medication.&nbsp; She previously smoked, but does not use alcohol or illicit drugs.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 150/90 mm Hg, and pulse is 96/min.&nbsp; The patient is in severe distress.&nbsp; Physical examination reveals left eye circum-corneal injection with a dilated and sluggish pupil.&nbsp; Visual acuity is decreased in the left eye.&nbsp; She has resting hand tremors and increased resistance to passive movements of the extremities.&nbsp; Which of the following medications is most likely causing her current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4699\" src=\"https://www.uworld.com/media/L29399.jpg\" ></p><p>This patient, with acute headache, nausea, blurry vision, and a sluggish/dilated pupil, has features of acute <strong>angle-closure glaucoma (ACG)</strong>.</p><p>Acute ACG is characterized by a sudden rise in intraocular pressure due to impaired drainage of aqueous humor through the pupil into the anterior chamber.&nbsp; Acute ACG can develop spontaneously or be triggered by certain medications (eg, decongestants, antiemetics, anticholinergics) in patients with predisposing anatomy.&nbsp; This patient&#39;s acute ACG was likely precipitated by <strong>trihexyphenidyl</strong>, an <strong>anticholinergic</strong> used in the treatment of symptomatic Parkinson disease (eg, resting tremor, cogwheel rigidity).&nbsp; Anticholinergic medications cause mydriasis, which may precipitate acute ACG.&nbsp; Untreated, acute ACG can damage the optic nerve and result in permanent vision loss within 2-5 hours of symptom onset.&nbsp; Urgent ophthalmologic consultation is required.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; Entacapone increases dopamine stimulation and is often used in patients with Parkinson disease to potentiate the effects of levodopa/carbidopa.&nbsp; Both levodopa, a dopamine precursor, and pramipexole, a dopamine agonist, are commonly used in the initial treatment of symptomatic Parkinson disease.&nbsp; Dopamine stimulation does not typically increase the risk of ACG.&nbsp; Common side effects of these three medications include nausea, orthostatic hypotension, and dizziness.</p><p><strong>(Choice D)</strong>&nbsp; Propranolol is a beta blocker used to treat essential tremor, which is characterized by tremors that disturb goal-directed activities.&nbsp; No other neurologic manifestations (eg, rigidity) are usually present.&nbsp; Propranolol can cause bradycardia and hypotension but is unlikely to cause acute ACG.</p><p><strong>(Choice E)</strong>&nbsp; Selegiline is a monoamine oxidase type B inhibitor used in the treatment of Parkinson disease.&nbsp; Side effects include headache, dizziness, and nausea; selegiline is not typically associated with acute ACG.</p><p><strong>Educational objective:</strong><br>Acute angle-closure glaucoma (ACG) is a vision-threatening condition that may be associated with certain medications (eg, anticholinergics for Parkinson disease) or arise spontaneously.&nbsp; Manifestations include the sudden onset of severe eye pain, nausea, vomiting, unilateral conjunctival injection, and a dilated pupil with poor light response.&nbsp; Untreated, patients with acute ACG can develop permanent vision loss within 2-5 hours of symptom onset.&nbsp; Urgent ophthalmologic consultation is required.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 9422,
            "topic": "Glaucoma",
            "titleId": 9422,
            "title": "Glaucoma",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "6",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Entacapone",
                    "choiceNumber": 1,
                    "correctTaken": 840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levodopa/carbidopa",
                    "choiceNumber": 2,
                    "correctTaken": 2017,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pramipexole",
                    "choiceNumber": 3,
                    "correctTaken": 1774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 4,
                    "correctTaken": 1966,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selegiline",
                    "choiceNumber": 5,
                    "correctTaken": 1543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trihexyphenidyl",
                    "choiceNumber": 6,
                    "correctTaken": 6000,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "327,492,true,-1,1*758,925,true,-1,1*947,990,true,-1,1*1046,1092,true,-1,1*1313,1415,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26535174",
                    "mediaDataId": 0,
                    "title": "A review of drug-induced acute angle closure glaucoma for non-ophthalmologists.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26535174",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 14140,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 761,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 14541,
            "questionIndex": 15951,
            "questionText": "<p>A 72-year-old man is brought to the office by his niece due to medication nonadherence.&nbsp; The patient has type 2 diabetes mellitus that had been well controlled with a basal-bolus insulin regimen, but recently he has not been taking his insulin regularly and his home glucometer readings have been high.&nbsp; In the past, he self-administered his insulin without difficulty, but now he no longer knows how to draw up his insulin or inject it.&nbsp; The patient&#39;s niece says he has been &#x22;letting things go&#x22; around the house since his wife&#39;s death from cancer 3 years ago.&nbsp; He is also reluctant to leave the house after a fall several months prior, and his family has had to help him with grocery shopping and other common errands.&nbsp; On physical examination, the patient appears unkempt and his clothes smell of urine.&nbsp; The lungs are clear on auscultation and heart sounds are normal.&nbsp; The abdomen is soft and nontender.&nbsp; Neurological examination reveals absence of bilateral ankle reflexes, and the patient&#39;s gait is slow with a wide base.&nbsp; Brief cognitive assessment shows short-term memory impairment.&nbsp; Hemoglobin A1c is 10.2%.&nbsp; Which of the following is the best next step in the management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T47802\"><table class=\"table-default-style\" style=\"width:75.0%\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%\"><p align=\"center\"><strong>Normal pressure hydrocephalus</strong></p></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:78.12%\"><ul><li>Gait instability (wide-based) with frequent falls</li><li>Cognitive dysfunction</li><li>Urinary urgency/incontinence</li><li>Depressed affect (frontal lobe compression)</li><li>Upper motor neuron signs in lower extremities</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:78.12%\"><ul><li>Marked improvement in gait with spinal fluid removal: Miller Fisher (lumbar tap) test</li><li>Enlarged ventricles out of proportion to the underlying brain atrophy on MRI</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:78.12%\"><ul><li>Ventriculoperitoneal shunting</li></ul></td></tr></tbody></table></div><p>This elderly patient with <strong>cognitive impairment</strong>, urinary <strong>incontinence</strong>, and <strong>gait abnormalities</strong> (eg, slow, wide-based) has the classic symptom triad of <strong>normal pressure hydrocephalus</strong> (NPH).&nbsp; NPH is a potentially <strong>reversible</strong> cause of dementia characterized by the abnormal accumulation of cerebrospinal fluid.&nbsp; It is often idiopathic and occurs most commonly in older adults (age &gt;60).&nbsp; However, it may occur in any age group due to neurologic trauma, infection, or subarachnoid hemorrhage resulting in scarring of the arachnoid granulations.&nbsp; Although upper motor neuron signs may occur in advanced disease, many elderly patients have diminished lower extremity reflexes (eg, ankles) related to age.</p><p><strong>Neuroimaging</strong> (eg, MRI, CT scan) shows <a href=\"3631\">ventriculomegaly out of proportion to the sulci</a>.&nbsp; The diagnosis is confirmed with lumbar puncture, which demonstrates normal opening pressure and transient clinical improvement following high-volume cerebrospinal fluid removal.&nbsp; Definitive therapy is a ventriculoperitoneal shunt.</p><p><strong>(Choice A)</strong>&nbsp; Although nursing home placement may eventually be required for patients with progressive dementia, this patient&#39;s presentation suggests NPH, which is potentially reversible and should be evaluated with MRI.</p><p><strong>(Choice B)</strong>&nbsp; Depression can cause apathy and signs of cognitive impairment (&#x22;pseudodementia&#x22;), but patients typically have other depressive symptoms (eg, sleep impairment, depressed mood) as well.&nbsp; Treating depression without working up the patient&#39;s focal findings would likely lead to progression of dementia.</p><p><strong>(Choices C and E)</strong>&nbsp; Changing to an oral diabetic regimen and providing patient and family education could be considered after workup and diagnosis of this patient&#39;s cognitive decline.&nbsp; However, diagnosis and treatment of NPH should take priority.</p><p><strong>Educational objective:</strong><br>Normal pressure hydrocephalus is a potentially reversible cause of dementia characterized by cognitive decline, gait impairment, and urinary incontinence.&nbsp; Neuroimaging demonstrates ventriculomegaly out of proportion to the sulci.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 23402,
            "topic": "Normal pressure hydrocephalus",
            "titleId": 23402,
            "title": "Normal pressure hydrocephalus",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arrange placement in a nursing home",
                    "choiceNumber": 1,
                    "correctTaken": 4004,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin therapy for depression-related cognitive impairment",
                    "choiceNumber": 2,
                    "correctTaken": 2651,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Change antidiabetic therapy to oral medications",
                    "choiceNumber": 3,
                    "correctTaken": 575,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain MRI of the brain",
                    "choiceNumber": 4,
                    "correctTaken": 10396,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide diabetes education and reinforce compliance",
                    "choiceNumber": 5,
                    "correctTaken": 216,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "689,718,true,-1,1*279,441,true,-1,1*452,481,true,-1,1*872,1017,true,-1,1*179,268,true,-1,1*1263,1495,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 116,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 17842,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 891,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 3718,
            "questionIndex": 3718,
            "questionText": "<p>A 57-year-old man comes to the office due to involuntary shaking of his hands.&nbsp; It started on the right side, but now his left hand shakes also.&nbsp; The shaking disappears with purposeful activity and worsens with emotional stress.&nbsp; The patient does not have a family history of tremors.&nbsp; Physical examination shows a fine resting tremor in both hands.&nbsp; There is some muscle rigidity of both arms.&nbsp; Gait and posture are normal.&nbsp; Cognitive function is normal.&nbsp; Which of the following is the most appropriate treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81722\"><table class=\"table-default-style\"><tbody><tr><td></td><td><p align=\"center\" style=\"margin-left:31.5pt;\"><strong>Parkinson disease</strong></p></td><td><p align=\"center\"><strong>Essential tremor</strong></p></td></tr><tr><td style=\"width: 22%;\"><p align=\"center\"><strong>Characteristics</strong></p></td><td style=\"width: 41%;\"><ul><li>Rest tremor, decreases with voluntary movement</li><li>&#x22;Pill-rolling&#x22;</li></ul></td><td style=\"width: 41%;\"><ul><li>Action tremor</li></ul></td></tr><tr><td><p align=\"center\"><strong>Distribution</strong></p></td><td><ul><li>Hands, legs</li><li>Often asymmetric</li></ul></td><td><ul><li>Hands, head, voice</li><li>Usually bilateral</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated features</strong></p></td><td><ul><li>Bradykinesia</li><li>Rigidity</li></ul></td><td><ul><li>Family history often present</li><li>Improves with alcohol</li></ul></td></tr></tbody></table></div><p>This patient has an asymmetric resting tremor associated with muscle rigidity, which is strongly suggestive of idiopathic <strong>Parkinson disease</strong> (PD).&nbsp; Tremor is often the first manifestation of PD.&nbsp; The <strong>tremor</strong> of PD characteristically occurs <strong>during rest</strong> and improves with activity.&nbsp; It often occurs asymmetrically or involves one hand before the other.</p><p>There are several categories of medications that can be used for PD, including levodopa, dopamine agonists (eg, pramipexole), and anticholinergic medications (eg, trihexyphenidyl).&nbsp; Medical therapy for PD is individualized.&nbsp; Levodopa has potent antiparkinsonian effects and could be considered; it is associated with a risk of dyskinesias.</p><p>When <strong>tremor</strong> is the dominant symptom of PD (ie, without significant bradykinesia/rigidity), anticholinergic therapy (eg, <strong>trihexyphenidyl</strong>) is often effective.&nbsp; Treatment is typically limited to <strong>younger</strong> patients (ie, &#8804;65), such as in this case, due to the risk of adverse effects in older patients.</p><p><strong>(Choices A, C, and D)</strong>&nbsp; Patients with essential tremor (ET) have tremors (usually of the hands), in contrast to this patient&#39;s tremor, that are decreased at rest, exacerbated by outstretched arms, and more pronounced at the end of goal-directed movements.&nbsp; Propranolol and primidone are often used for ET.&nbsp; Although clonazepam may also be effective for ET, other medications are preferred even in those patients due to the abuse potential of benzodiazepines.</p><p><strong>(Choice B)</strong>&nbsp; Clozapine, an atypical antipsychotic, is sometimes used to treat psychosis due to PD, but not tremor.</p><p><strong>Educational objective:</strong><br>Parkinson disease (PD) should be suspected in patients with an asymmetric resting tremor that is associated with rigidity or bradykinesia.&nbsp; Trihexyphenidyl is an anticholinergic medication sometimes used in the treatment of PD, generally in younger patients where tremor is the primary symptom.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clonazepam",
                    "choiceNumber": 1,
                    "correctTaken": 922,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clozapine",
                    "choiceNumber": 2,
                    "correctTaken": 739,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primidone",
                    "choiceNumber": 3,
                    "correctTaken": 2060,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 4,
                    "correctTaken": 7423,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trihexyphenidyl",
                    "choiceNumber": 5,
                    "correctTaken": 7042,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1019,1174,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 82,
            "othersAvgTimeSpent": 36,
            "notes": null,
            "peopleTaken": 18186,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 562,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2281,
            "questionIndex": 2281,
            "questionText": "<p>A 57-year-old man comes to the office with his wife due to behavior changes.&nbsp; They moved to the city a year ago because the wife&#39;s job relocated.&nbsp; The wife says, &#x22;Since then, he&#39;s not the man I married.&#x22;&nbsp; The patient has been increasingly impolite to her and irritable at work, getting into arguments with coworkers and on a few occasions scratching their cars with his key.&nbsp; He has forgotten to submit numerous assignments and does not seem concerned by deadlines.&nbsp; The wife adds, &#x22;I found his most expensive golf clubs in the trash last week.&nbsp; We used to go golfing every week but haven&#39;t been in months because he doesn&#39;t seem to care for it anymore.&#x22;&nbsp; She also shares that he chews gum &#x22;all the time&#x22; and has been sticking pieces to his bedside table every night before falling asleep.&nbsp; Medical history includes well-controlled hypertension and hyperlipidemia.&nbsp; The patient scores 25/30 on the Montreal Cognitive Assessment (normal: &#8805;26).&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T79666\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100.0%\"><tbody><tr><td colspan=\"2\" style=\"width:70.0%;\"><p align=\"center\"><strong>Frontotemporal dementia</strong></p></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Pathogenesis</strong></p></td><td style=\"width:70.0%;\"><ul><li>TDP-43 mutation</li><li>Tau protein inclusions (eg, Pick bodies)</li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:70.0%;\"><ul><li>Early onset (age 50s-60s)</li><li>Initial behavior or personality changes (3 of 6 needed for diagnosis)<ul style=\"list-style-type:circle;\"><li>Disinhibition</li><li>Apathy</li><li>Loss of empathy</li><li>Compulsions or rituals</li><li>Hyperorality</li><li>Executive dysfunction</li></ul></li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:70.0%;\"><ul><li>Primarily clinical</li><li>Neuroimaging (CT, MRI)<ul style=\"list-style-type:circle;\"><li>Rule out other disorders</li><li>Look for frontal/anterior temporal lobe atrophy</li></ul></li></ul></td></tr><tr><td style=\"width:30.0%;\"><p align=\"center\"><strong>Management</strong></p></td><td style=\"width:70.0%;\"><ul><li>Nonpharmacologic: behavior modification</li><li>Pharmacologic (symptomatic): SSRI, atypical antipsychotic agent</li></ul></td></tr><tr><td colspan=\"2\" style=\"width:70.0%;\"><p><strong>SSRI</strong> = selective serotonin reuptake inhibitor; <strong>TDP-43</strong> = 43 kD transactive response (TAR) DNA-binding protein.</p></td></tr></tbody></table></div><p>This patient most likely has <strong>frontotemporal dementia</strong> (FTD), a neurocognitive disorder that commonly presents at a relatively early age (50s-60s).&nbsp; In many cases, FTD involves abnormal inclusions of hyperphosphorylated tau protein or the 43 kD TAR (ie, transactive response) DNA-binding protein (TDP-43).&nbsp; Neuronal cell death leads to characteristic frontal and temporal lobe atrophy with resulting stereotypic personality and <strong>behavioral symptoms</strong>, including:</p><ul><li><strong>Disinhibition</strong> (eg, scratching coworkers&#39; cars)</li><li><strong>Apathy</strong> (eg, unconcerned by work deadlines, uninterested in golf)</li><li><strong>Loss of empathy</strong> (eg, impolite to wife)</li><li><strong>Compulsions or rituals</strong> (eg, putting gum on nightstand)</li><li><strong>Hyperorality</strong> (eg, incessant gum chewing)</li><li><strong>Executive dysfunction</strong> (eg, Montreal Cognitive Assessment [MoCA] score 25/30)</li></ul><p>Diagnosis is primarily clinical, based on having &#8805;3 of 6 behavioral symptoms.&nbsp; However, neuroimaging with either a CT scan or MRI is often performed to exclude other etiologies (eg, mass, stroke) and look for the expected focal <a href=\"51690\">white matter loss</a>.&nbsp; The prognosis is terminal within 8-10 years after disease onset, and there are no treatments to lessen disease progression.&nbsp; Management aims to reduce behavioral symptoms with both nonpharmacologic (eg, exercise, trigger avoidance, redirection) and pharmacologic (eg, selective serotonin reuptake inhibitors, atypical antipsychotics) options.</p><p><strong>(Choice A)</strong>&nbsp; In adjustment disorder with disturbance of conduct, behavioral symptoms present &lt;3 months after the onset of a stressor.&nbsp; Given the intensity of the personality changes and cognitive decline (MoCA score &lt;26), this patient&#39;s symptoms are better explained by a neurodegenerative process.</p><p><strong>(Choice B)</strong>&nbsp; In contrast to this patient&#39;s presentation, dementia with Lewy bodies presents with early visual hallucinations in addition to parkinsonism, REM sleep behavior disorder, and fluctuating cognition with variations in attention and alertness.</p><p><strong>(Choice C)</strong>&nbsp; The timing of early-onset Alzheimer disease (age &lt;65) overlaps with that of FTD.&nbsp; However, compared to FTD, early-onset Alzheimer disease presents with greater deficits in episodic memory, visuospatial abilities, and motor skills but without early prominent behavioral symptoms.</p><p><strong>(Choice E)</strong>&nbsp; Irritability, cognitive changes, anhedonia, and apathy can be seen in major depressive disorder; however, disinhibitions, oral fixations, ritualistic behaviors, and mounting social indiscretions are not characteristic of depression.</p><p><strong>(Choice F)</strong>&nbsp; Vascular dementia etiologies are described as post-stroke (stroke-correlated cognitive decline) and silent (without recent stroke; progressive course with sufficient cerebrovascular explanation on history, examination, or imaging).&nbsp; This patient&#39;s history of well-controlled risk factors makes post-stroke and silent vascular etiologies less likely.</p><p><strong>Educational objective:</strong><br>Frontotemporal dementia is a type of early-onset (age 50s-60s) dementia.&nbsp; It is characterized by early and progressive personality (apathetic, nonempathetic), behavior (impulsive, compulsive), and executive function abnormalities.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 24755,
            "topic": "Frontotemporal dementia",
            "titleId": 24755,
            "title": "Frontotemporal dementia",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with disturbance of conduct",
                    "choiceNumber": 1,
                    "correctTaken": 1047,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Early-onset Alzheimer disease",
                    "choiceNumber": 3,
                    "correctTaken": 126,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontotemporal dementia",
                    "choiceNumber": 4,
                    "correctTaken": 16722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 6,
                    "correctTaken": 178,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "828,987,true,-1,1*1141,1543,true,-1,1*1837,2055,true,-1,1*168,332,true,-1,1*469,572,true,-1,1*67,122,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26595641",
                    "mediaDataId": 0,
                    "title": "Frontotemporal dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26595641",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21810890",
                    "mediaDataId": 0,
                    "title": "Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21810890",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21147039",
                    "mediaDataId": 0,
                    "title": "Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21147039",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 45,
            "notes": null,
            "peopleTaken": 18702,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 89,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1304,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 3058,
            "questionIndex": 3058,
            "questionText": "<p>A 71-year-old man is brought to the office by his daughter due to a change in behavior over the past year.&nbsp; He began having memory problems several years ago and frequently forgot his grandchildren&#39;s names.&nbsp; Also, the patient often had difficulty finding words.&nbsp; Several times recently, he was found roaming his apartment building because he was lost.&nbsp; The patient insists that there is nothing wrong with him and jokingly makes excuses for the symptoms his daughter is reporting.&nbsp; He has never used alcohol or illicit drugs.&nbsp; Blood pressure is 155/85 mm Hg, pulse is 90/min, and respirations are 15/min.&nbsp; Plantar reflexes are downgoing bilaterally.&nbsp; The remainder of the neurologic examination is within normal limits.&nbsp; Montreal Cognitive Assessment score is 15 on a scale of 30 (normal: &#8805;26).&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">13.5 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">41%</td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">4,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">230,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">83 &#956;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">9.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">137 mEq/dL</td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">4.0 mEq/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">100 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">3 &#956;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Total cholesterol</td><td style=\"vertical-align:middle;\">180 mg/dL</td></tr></tbody></table><p>Which of the following abnormalities is most likely to be seen on this patient&#39;s MRI?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s cognitive impairment (Montreal Cognitive Assessment score of &lt;26) with diminished daily functioning is most consistent with <strong>Alzheimer disease</strong> (AD).&nbsp; AD occurs almost exclusively in individuals age &gt;60, and the risk increases with age.&nbsp; AD typically presents with <strong>early and prominent memory loss</strong> that progresses over time.&nbsp; Other common findings include <strong>word-finding difficulty</strong> and loss of visuospatial skills and <strong>executive function</strong> (eg, getting lost in familiar surroundings).</p><p>Neuroimaging is typically performed to exclude alternate diagnoses such as a lesion (eg, tumor, subdural hematoma, infarction) or normal-pressure hydrocephalus (NPH).&nbsp; In patients with early AD, MRI may be normal.&nbsp; However, <strong>temporal lobe atrophy</strong>, which is most prominent in the hippocampi and surrounding medial temporal lobes, is typically seen in later stages.</p><p><strong>(Choice A)</strong>&nbsp; Vascular dementia is associated with focal neurologic signs and evolves in a stepwise fashion.&nbsp; Multiple hypointense cortical and subcortical lesions corresponding to old infarcts may be seen on T1-weighted MRI sequences.</p><p><strong>(Choice B)</strong>&nbsp; NPH is characterized by the triad of cognitive impairment, gait disturbance, and bladder incontinence.&nbsp; In some dementing syndromes, the ventricles may appear enlarged on neuroimaging due to general cortical atrophy (ie, hydrocephalus ex vacuo); however, ventriculomegaly in the absence of cortical atrophy is more suggestive of NPH.</p><p><strong>(Choice C)</strong>&nbsp; Atrophy of the frontal lobes on neuroimaging is consistent with frontotemporal dementia, which has an earlier age of onset than AD (usually age 50-60) and typically presents with personality changes and loss of social inhibition.&nbsp; Unlike in AD, memory impairment is usually mild in the initial stages of frontotemporal dementia.</p><p><strong>(Choice D)</strong>&nbsp; Atrophy of the parietal lobes may be seen in primary progressive aphasia, a dementing syndrome that primarily affects language early in the disease.</p><p><strong>Educational objective:</strong><br>Alzheimer disease initially presents with memory impairment.&nbsp; Neuroimaging generally demonstrates temporal lobe atrophy, which is most prominent in the hippocampi and surrounding medial temporal lobes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diffuse cortical and subcortical infarctions",
                    "choiceNumber": 1,
                    "correctTaken": 2210,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Enlarged lateral ventricles without cortical atrophy",
                    "choiceNumber": 2,
                    "correctTaken": 1216,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontal lobe atrophy",
                    "choiceNumber": 3,
                    "correctTaken": 3383,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parietal lobe atrophy",
                    "choiceNumber": 4,
                    "correctTaken": 1774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Temporal lobe atrophy",
                    "choiceNumber": 5,
                    "correctTaken": 5351,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1818,1965,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28317647",
                    "mediaDataId": 0,
                    "title": "Clinical validity of medial temporal atrophy as a biomarker for Alzheimer&#39;s disease in the context of a structured 5-phase development framework.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28317647",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 13934,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 545,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 11105,
            "questionIndex": 12247,
            "questionText": "<p>A 55-year-old man comes to the office due to progressive difficulty walking and frequent falls over the past year.&nbsp; Initially the patient had difficulty with balance when walking up and down the stairs.&nbsp; Now he has to brace himself against a wall even when walking on flat surfaces.&nbsp; He has had no urinary incontinence, slurred speech, or headaches.&nbsp; The patient was diagnosed with type 2 diabetes mellitus and hypertension several years ago but is not compliant with medications.&nbsp; He also has a history of long-term, heavy alcohol and tobacco use.&nbsp; Blood pressure is 170/96 mm Hg and pulse is 84/min.&nbsp; The patient is alert and oriented.&nbsp; Bilateral pupils are equal and reactive.&nbsp; Extraocular movements are normal.&nbsp; Muscle bulk, tone, and strength are normal.&nbsp; Proprioception and vibration sensation are normal in the lower extremities.&nbsp; The patient exhibits a wide-based gait and is unable to perform tandem walking.&nbsp; Heel-knee-shin testing is abnormal but finger-nose testing is normal.&nbsp; Which of the following is the most likely cause of his ambulatory dysfunction?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33088\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Alcoholic cerebellar degeneration </strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology </strong></p></td><td><ul><li><strong>&gt;10 years</strong> heavy alcohol use</li><li>Degeneration of Purkinje cells (<strong>cerebellar vermis</strong>)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations </strong></p></td><td><ul><li>Usually develops over weeks to months</li><li><strong>Wide-based gait </strong></li><li>Incoordination in legs</li><li>Cognition usually intact</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li><strong>Clinical</strong>:<ul style=\"list-style-type:circle;\"><li>Impaired tandem walking/heel-knee-shin</li><li>Preserved finger-nose testing</li></ul></li><li>CT/MRI - cerebellar atrophy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li><strong>Alcohol cessation </strong></li><li>Nutritional supplements</li><li>Ambulatory assistance devices (eg, walker)</li></ul></td></tr></tbody></table></div><p>This patient with a long history of heavy alcohol use has slowly progressive postural gait dysfunction, suggestive of <strong>cerebellar degeneration</strong> due to <strong>alcohol neurotoxicity</strong>.</p><p>Cerebellar degeneration typically occurs after &gt;10 years of heavy alcohol use and is due to the degeneration of Purkinje cells in the cerebellar vermis.&nbsp; As these neurons are largely responsible for <strong>truncal coordination</strong>, patients with cerebellar degeneration usually develop slowly progressive <strong>wide-based gait</strong> and <strong>postural instability</strong>.&nbsp; Physical examination typically shows evidence of postural incoordination (eg, inability to tandem walk, abnormal heel-knee-shin testing) with relatively preserved limb coordination (normal finger-nose testing).&nbsp; Cognitive function is usually preserved.&nbsp; Although alcohol cessation and nutritional supplementation prevent disease progression, ambulatory difficulties do not typically improve.&nbsp; Patients therefore usually benefit from ambulatory assist devices such as canes or walkers.</p><p><strong>(Choice B)</strong>&nbsp; Impaired absorption of cerebrospinal fluid is seen with normal-pressure hydrocephalus.&nbsp; Manifestations include progressive imbalance, cognitive decline, and urinary incontinence.&nbsp; This patient has normal cognition and no urinary incontinence.</p><p><strong>(Choice C)</strong>&nbsp; Spondylotic myelopathy is associated with osteophyte-mediated spinal cord compression.&nbsp; Manifestations include gait dysfunction, extremity weakness, vibratory/proprioception abnormalities, and both lower and upper motor neuron findings.&nbsp; This patient has no lower motor neuron findings (eg, muscle atrophy, weakness) and no loss of vibration/proprioception.</p><p><strong>(Choice D)</strong>&nbsp; Diabetes mellitus may cause small vessel injury with resultant peripheral nerve ischemia.&nbsp; Patients typically manifest a distal symmetric polyneuropathy of both small fibers (pain/temperature) and large fibers (vibration/proprioception).&nbsp; Gait is usually preserved.</p><p><strong>(Choice E)</strong>&nbsp; Wernicke encephalopathy is characterized by thiamine deficiency-induced thalamic neuronal loss and usually causes gait ataxia, oculomotor dysfunction (eg, horizontal nystagmus), and encephalopathy.&nbsp; This patient&#39;s cognition and oculomotor function is unaffected.</p><p><strong>(Choice F)</strong>&nbsp; Vascular dementia is caused by multiple small infarctions.&nbsp; Manifestations typically develop in a stepwise fashion over years and include cognitive changes; a short, shuffling gait; and postural instability.</p><p><strong>(Choice G)</strong>&nbsp; Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency may cause spinal cord degeneration.&nbsp; Early manifestations include ataxia, symmetric paresthesia, and a loss of vibration and proprioception sensation.&nbsp; This patient&#39;s vibration and proprioception are normal.</p><p><strong>Educational objective:</strong><br>Alcoholic cerebellar degeneration is caused by damage to the Purkinje cells of the cerebellar vermis.&nbsp; Manifestations typically include the slowly progressive onset of ambulation difficulties, including wide-based gait and postural instability.&nbsp; Truncal coordination (eg, tandem gait) is impaired, but limb coordination (eg, finger-nose test) is relatively intact.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 13545,
            "topic": "Cerebellar degeneration",
            "titleId": 13545,
            "title": "Cerebellar degeneration",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerebellar degeneration due to alcohol neurotoxicity",
                    "choiceNumber": 1,
                    "correctTaken": 11533,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased cerebrospinal fluid accumulation due to impaired absorption",
                    "choiceNumber": 2,
                    "correctTaken": 316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteophytes causing progressive spinal cord compression",
                    "choiceNumber": 3,
                    "correctTaken": 150,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral nerve ischemia due to small vessel injury",
                    "choiceNumber": 4,
                    "correctTaken": 1294,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiamine deficiency-induced thalamic neuronal loss",
                    "choiceNumber": 5,
                    "correctTaken": 2234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular disease causing multiple minor infarcts",
                    "choiceNumber": 6,
                    "correctTaken": 1214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin deficiency-induced spinal cord degeneration",
                    "choiceNumber": 7,
                    "correctTaken": 1588,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "298,366,true,-1,1*1254,1485,true,-1,1*2833,2883,true,-1,1*2515,2600,true,-1,1*1050,1211,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27423619",
                    "mediaDataId": 0,
                    "title": "Population-based study of alcoholic cerebellar degeneration: the Atahualpa Project.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27423619",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26848494",
                    "mediaDataId": 0,
                    "title": "Early-stage alcoholic cerebellar degeneration: diagnostic imaging clues.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26848494",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25933648",
                    "mediaDataId": 0,
                    "title": "Effects of ethanol on the cerebellum: advances and prospects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25933648",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 18329,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 783,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 3373,
            "questionIndex": 3373,
            "questionText": "<p>A 74-year-old woman is brought to the office by her daughter due to behavioral changes.&nbsp; Over the past month, the patient has become more withdrawn.&nbsp; She no longer watches her favorite television shows and seems less interested in her family.&nbsp; The daughter has noticed increasing forgetfulness over the past 3 years but assumed it &#x22;comes with aging.&#x22;&nbsp; Over the past year, the patient has stopped doing the daily crossword, has had difficulty remembering to eat and clean herself, and has occasionally failed to recognize her grandchildren.&nbsp; Montreal Cognitive Assessment is 22/30 (normal: &#8805;26).&nbsp; Serum TSH and vitamin B<font size=\"2\"><sub>12</sub></font> levels are normal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Dementia</strong> (also known as major neurocognitive disorder) may be diagnosed in patients with progressive cognitive decline that impairs activities of daily living (eg, bathing, dressing, preparing meals).&nbsp; The most common subtype of dementia is <strong>Alzheimer disease</strong> (AD), which typically presents with prominent but relatively isolated impairments in memory early in the disease course.&nbsp; As AD progresses, apathy, social withdrawal, and loss of interest in activities frequently develop and can mimic depression.&nbsp; This patient&#39;s 3-year history of cognitive decline preceding the development of behavioral symptoms is most consistent with AD.</p><p>Although the etiology of AD is not well understood, histopathologic examination of brain tissue in affected patients indicates a selective loss of cholinergic neurons.&nbsp; The first-line treatment for cognitive symptoms of AD is a <strong>cholinesterase inhibitor</strong>, which may improve quality of life and cognitive function (eg, memory, language, thought, reasoning), although drugs in this class have not been shown to alter the disease course in any type of dementia.&nbsp; <strong>Donepezil</strong>, galantamine, and <strong>rivastigmine</strong> are effective in patients with mild to moderate AD.&nbsp; Memantine, an NMDA receptor antagonist, is approved for moderate to severe dementia.</p><p><strong>(Choice A)</strong>&nbsp; Amantadine, thought to possess dopaminergic and NMDA receptor antagonist properties, is frequently used in the treatment of Parkinson disease.&nbsp; The evidence of its benefit in the treatment of AD is limited and it would not be considered as a first-line treatment in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Fluoxetine is an antidepressant used in the treatment of depression.&nbsp; Depression may present with cognitive impairment that can, if severe enough, masquerade as dementia.&nbsp; However, this patient does not meet criteria for <a href=\"17482\">major depressive disorder</a>, and she experienced cognitive deficits and related functional impairment (eg, forgetfulness, difficulty recognizing relatives) years before the onset of any depressive-like symptoms (eg, social withdrawal, decreased interest), making AD more likely.&nbsp; Depressive symptoms are commonly seen as AD progresses.</p><p><strong>(Choice D)</strong>&nbsp; Selegiline is a monoamine oxidase inhibitor that is sometimes used as a second-line treatment in AD for its antioxidant properties, although current evidence is weak.</p><p><strong>(Choice E)</strong>&nbsp; This patient is already experiencing cognitive decline sufficient to impair functioning.&nbsp; As a result, reassurance and follow-up, without consideration of a trial of a cholinesterase inhibitor, are inappropriate.</p><p><strong>Educational objective:</strong><br>Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine may provide moderate symptomatic relief of cognitive symptoms and temporarily improve functioning in Alzheimer disease; however, these medications have not been shown to alter the disease course.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Initiate amantadine",
                    "choiceNumber": 1,
                    "correctTaken": 3034,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate fluoxetine",
                    "choiceNumber": 2,
                    "correctTaken": 4939,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate rivastigmine",
                    "choiceNumber": 3,
                    "correctTaken": 8417,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate selegiline",
                    "choiceNumber": 4,
                    "correctTaken": 901,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance and close follow-up",
                    "choiceNumber": 5,
                    "correctTaken": 872,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "411,664,true,-1,1*1123,1301,true,-1,1*2353,2564,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27250365",
                    "mediaDataId": 0,
                    "title": "Current pharmacotherapy and putative disease-modifying therapy for Alzheimer&#39;s disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27250365",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 45,
            "notes": null,
            "peopleTaken": 18163,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 793,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 3374,
            "questionIndex": 3374,
            "questionText": "<p>A 67-year-old man is brought to the office due to progressively worsening insomnia and impaired concentration and judgment for 2 months.&nbsp; Medical history is significant for early-stage non&ndash;small cell lung cancer that was resected 5 years ago.&nbsp; The patient currently takes no medications.&nbsp; Vitals signs are within normal limits.&nbsp; On examination, he is alert and oriented.&nbsp; The patient has limited language and difficulty remembering objects and names.&nbsp; Horizontal nystagmus is present.&nbsp; Mild spasticity, myoclonus, and hyperreflexia are present.&nbsp; Gait is wide based and unsteady.&nbsp; Cardiopulmonary and abdominal examinations show no abnormalities.&nbsp; MRI of the head reveals cerebral atrophy and diffuse bright signals in the cortical white matter and portions of the basal ganglia; there are no mass lesions.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47159\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Creutzfeldt-Jakob disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Rapidly progressive dementia</li><li>Myoclonus (provoked by startle)</li><li>Cerebellar signs (eg, ataxia)</li><li>Upper motor neuron signs (eg, hyperreflexia)</li><li>Extrapyramidal signs (eg, hypokinesia)</li><li>Mood &amp;/or sleep disturbances</li></ul></td></tr><tr><td><p align=\"center\"><strong>Findings</strong></p></td><td><ul><li>MRI: widespread atrophy (cerebrum &amp; cerebellum), cortical enhancement (ie,&nbsp;cortical ribboning), enhancement of putamen &amp; caudate head (hockey stick sign)</li><li>CSF: normal routine analysis, positive 14-3-3 protein titers, positive RT-QuIC test</li><li>EEG: sharp, triphasic, synchronous discharges</li><li>Neuropath: spongiform degeneration without inflammation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management &amp; prognosis</strong></p></td><td><ul><li>Symptomatic treatment, counseling, social services referral</li><li>No effective disease-modifying therapy, fatal in &lt;12 months</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CSF</strong> = cerebrospinal fluid; <strong>EEG</strong> = electroencephalography; <strong>RT-QuIC</strong> = real-time quaking-induced conversion.</p></td></tr></tbody></table></div><p>This patient&#39;s rapid neurologic decline is concerning for <strong>Creutzfeldt-Jakob disease</strong>, a fatal transmissible spongiform encephalopathy caused by a prion.&nbsp; Prions induce protein misfolding that leads to the accumulation of neurotoxic fibrils.&nbsp; This results in spongiform neurodegeneration with widespread neuronal loss.&nbsp; Clinical manifestations of Creutzfeldt-Jakob disease are diverse and often include:</p><ul><li><p><strong>Neuropsychiatric</strong> decline:&nbsp; behavioral abnormalities, personality changes, sleep disturbances (eg, insomnia, hypersomnia), and <strong>rapidly progressive dementia</strong>.&nbsp; This may progress to a loss of speech and inability to care for oneself.</p></li><li><p><strong>Myoclonus</strong>:&nbsp; classically provoked by a startle</p></li><li><p><strong>Cerebellar signs</strong>:&nbsp; nystagmus, ataxia (wide-based gait)</p></li><li><p>Upper motor neuron signs (eg, hyperreflexia, upgoing Babinski) due to degeneration of the corticospinal tracts</p></li><li><p>Extrapyramidal signs:&nbsp; hypokinesia, dystonia</p></li></ul><p>MRI of the brain often reveals <strong>hyperintensity of the cerebral cortex</strong> (ie, cortical ribboning), <strong>putamen, and head of the caudate</strong> (ie, hockey stick sign).&nbsp; Electroencephalogram classically shows sharp, triphasic, and synchronous discharges.</p><p><strong>(Choice A)</strong>&nbsp; Some patients with significant prior carbon monoxide (CO) poisoning can present with neuropsychiatric symptoms (cognitive dysfunction, personality changes, movement disorders).&nbsp; MRI can show hemorrhagic infarction of the basal ganglia, although this is typically limited to the globus pallidus.&nbsp; Cerebellar signs (eg, nystagmus) are uncommon.</p><p><strong>(Choice B)</strong>&nbsp; Leptomeningeal carcinomatosis can also present with subacute cognitive impairment; infiltration into the cerebellum can also lead to ataxia.&nbsp; However, most patients present with headache and demonstrate cranial nerve deficits.&nbsp; Focal cortical signs such as aphasia and hemiparesis are uncommon.&nbsp; In addition, MRI would show enhancement of the meninges, not cortical ribboning and enhancement of the basal ganglia.</p><p><strong>(Choice D)</strong>&nbsp; Wernicke encephalopathy due to thiamine deficiency can also present with confusion and ataxia (often with nystagmus).&nbsp; However, myoclonus is less typical; and MRI classically reveals mamillary body atrophy and periaqueductal gray matter hyperintensity.</p><p><strong>(Choice E)</strong>&nbsp; Wilson disease can also cause subacute, progressive dementia with movement disorders and MRI can show basal ganglia changes.&nbsp; However, it typically presents in children or adolescents and is accompanied by liver dysfunction.</p><p><strong>Educational objective:</strong><br>Creutzfeldt-Jakob disease is a rapidly fatal prion disease that presents with rapidly progressive dementia, myoclonus, mood symptoms, and sleep disturbances.&nbsp; MRI of the brain often reveals hyperintensity of the cerebral cortex (ie, cortical ribboning) and the putamen and caudate head (ie, hockey stick sign).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 17883,
            "topic": "Prion disease",
            "titleId": 17883,
            "title": "Prion disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Carbon monoxide poisoning",
                    "choiceNumber": 1,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Leptomeningeal carcinomatosis",
                    "choiceNumber": 2,
                    "correctTaken": 2476,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prion disease",
                    "choiceNumber": 3,
                    "correctTaken": 7826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiamine deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 2461,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wilson disease",
                    "choiceNumber": 5,
                    "correctTaken": 980,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1026,1191,true,-1,1*2197,2313,true,-1,1*2373,2788,true,-1,1*1556,1610,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 14065,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 648,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 9756,
            "questionIndex": 10348,
            "questionText": "<p>A 74-year-old woman is brought to the office by her son.&nbsp; He is concerned because his mother had an unprovoked fall a year ago and has since relied on him to coordinate her activities and make decisions about everyday matters.&nbsp; The patient&#39;s symptoms seemed to improve until she had another significant fall approximately 6 months ago.&nbsp; Since then, she has become mildly forgetful, experiences occasional mood swings, and now seems sad most of the time.&nbsp; The patient has a long history of hypertension, stress urinary incontinence, and depression.&nbsp; She has a family history of colorectal cancer and Alzheimer disease.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 141/87 mm Hg, pulse is 82/min, and respirations are 14/min.&nbsp; Neurologic examination shows weakness and sensory deficits on the right side.&nbsp; Mental status examination is significant for low-volume speech and flat affect.&nbsp; The remainder of the examination is within normal limits.&nbsp; Neuroimaging would most likely reveal which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"46050\" src=\"https://www.uworld.com/media/L71701.png\"  ></p><p>This patient had a relatively abrupt functional decline with executive dysfunction (eg, planning activities, making decisions) after a fall.&nbsp; After a second fall, she also developed mood changes and localizing neurologic findings (eg, weakness and sensory deficits on the right side).&nbsp; This presentation with a <strong>stepwise decline</strong> is suspicious for <strong>vascular dementia</strong> (VaD) due to unrecognized <strong>infarctions</strong>, which likely caused the falls.</p><p>MRI of the head should be ordered for patients with suspected VaD and often reveals multiple abnormalities, which may include the following:</p><ul><li><p>Multiple areas of T2 hyperintensity in the white matter that represent areas of demyelination or axon loss due to multiple small infarctions</p></li><li><p>Microbleeds, especially in the subcortical areas, basal ganglia, and cerebellum</p></li><li><p>Focal atrophy (in patients with a large infarction) or diffuse atrophy (in patients with a large burden of microvascular disease)</p></li></ul><p><strong>Cortical</strong> infarctions may affect behavior (eg, mood) and higher cognitive functions (eg, decision-making), as well as focal motor or sensory areas referable to the homunculus.&nbsp; <strong>Subcortical</strong> infarctions (eg, internal capsule, thalamus, brainstem)&nbsp;can cause more extensive motor or sensory deficits (eg, right-sided weakness), depending on the site of the lesion.&nbsp; Strokes can also lead to vocal (eg, low-volume speech) and communication difficulties.</p><p>Management of VaD aims to stop progression of dementia by preventing further infarctions.&nbsp; It consists of risk factor modification (eg, controlling hypertension, hypercholesterolemia, and diabetes), antiplatelet therapy, and, sometimes, cholinesterase inhibitors.</p><p><strong>(Choice B)</strong>&nbsp; Frontal and temporal lobe atrophy is characteristic of frontotemporal dementia, which presents with progressive personality changes such as disinhibition and compulsive behavior.&nbsp; Although this patient has had mood swings, her stepwise decline with localizing neurologic deficits is more consistent with VaD.</p><p><strong>(Choice C)</strong>&nbsp; Patients with Alzheimer disease often have medial temporal lobe atrophy.&nbsp; Although these individuals have progressive memory loss with functional impairments, this patient&#39;s stepwise deterioration that includes executive dysfunction with only mild memory loss and localizing neurologic signs is more consistent with VaD.</p><p><strong>(Choice D)</strong>&nbsp; Major depression may be accompanied by or present with cognitive impairment in the elderly; it is not typically associated with neuroimaging abnormalities.&nbsp; Despite this patient&#39;s history of depression, her prominent neurologic dysfunction (eg, focal neurologic deficits) and disease course are more consistent with VaD than depression-related cognitive impairment.</p><p><strong>(Choice E)</strong>&nbsp; Ventriculomegaly is characteristic of normal pressure hydrocephalus (NPH), which initially presents with ataxia that can result in falls, followed by dementia and urinary incontinence.&nbsp; However, this patient&#39;s focal neurologic findings and discrete time points of worsening (ie, stepwise decline) are more characteristic of VaD.&nbsp; In addition, stress incontinence is not typical of NPH, and its onset predates the onset of her cognitive and balance problems.</p><p><strong>Educational objective:</strong><br>Vascular dementia classically presents as a sudden or stepwise decline in executive function with mild memory loss.&nbsp; Patients can have focal neurologic deficits on examination, and neuroimaging classically demonstrates multiple small infarctions.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8985,
            "topic": "Vascular dementia",
            "titleId": 8985,
            "title": "Vascular dementia",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cortical and/or subcortical infarctions",
                    "choiceNumber": 1,
                    "correctTaken": 8290,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontal and temporal lobe atrophy",
                    "choiceNumber": 2,
                    "correctTaken": 3061,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medial temporal lobe atrophy",
                    "choiceNumber": 3,
                    "correctTaken": 662,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No abnormalities",
                    "choiceNumber": 4,
                    "correctTaken": 812,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventriculomegaly",
                    "choiceNumber": 5,
                    "correctTaken": 2622,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "608,1318,true,-1,1*1321,1408,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26595643",
                    "mediaDataId": 0,
                    "title": "Vascular dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26595643",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 86,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 15447,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 953,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 3919,
            "questionIndex": 3919,
            "questionText": "<p>A 73-year-old man comes to the office due to increasing forgetfulness over the past 6 months.&nbsp; He says, &#x22;My mind used to be quite sharp, but now I can&#39;t even concentrate to read a book or newspaper.&nbsp; I&#39;m afraid I&#39;m developing dementia like my father.&#x22;&nbsp; The patient reports he has been losing sleep and has little energy and motivation.&nbsp; He recently took a leave of absence from work because he could no longer concentrate on details and complete his paperwork.&nbsp; His medical history includes hypertension, hypercholesterolemia, diabetes, benign prostatic hyperplasia, and transient ischemic attack.&nbsp; Family history is significant for hypertension and diabetes (mother) and Alzheimer disease (father).&nbsp; The patient does not smoke and drinks wine only occasionally.&nbsp; Vital signs are unremarkable, and physical examination is normal except for slowed speech and movements.&nbsp; The patient declines to perform a serial sevens assessment and says, &#x22;I just can&#39;t do it.&#x22;&nbsp; CT scan of the head is normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s cognitive impairment?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s increasing forgetfulness, low energy and motivation, sleep disturbance, and psychomotor retardation (eg, slowed speech, thinking, movements) are consistent with major depressive disorder (MDD).&nbsp; Older patients who are severely depressed may demonstrate cognitive impairment and slowing rather than depressed mood (previously referred to as <strong>pseudodementia</strong>).&nbsp; Deficits in attention, concentration, memory, and executive functioning can be seen and are often compounded by poor effort during testing, as seen in this patient.&nbsp; Although these patients are at higher risk for developing dementia later, their <strong>depression-related cognitive impairment</strong> is potentially <strong>reversible</strong> and can improve with treatment of the underlying depression.</p><p>Alzheimer disease can be difficult to differentiate from depression-related cognitive impairment because depression can occur in patients with Alzheimer disease.&nbsp; However, this patient does not have other dementia symptoms, such as apraxia, agnosia, and aphasia <strong>(Choice A)</strong>.&nbsp; Patients with Alzheimer disease are typically less concerned about their memory loss and are brought in for evaluation by family members.&nbsp; In contrast to this patient who shows poor effort, they are more likely to try harder but to give incorrect answers or confabulate to compensate for poor memory on mental status testing.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s presentation does not include key features of dementia with Lewy bodies, which include fluctuating cognition, recurrent visual hallucinations, and REM sleep behavior disorder, making this diagnosis less likely.</p><p><strong>(Choice D)</strong>&nbsp; Although normal aging is associated with some cognitive decline, MDD is still more likely in this patient given the presence of associated depressive symptoms (eg, poor sleep, low energy and motivation) that are causing clear functional impairment.</p><p><strong>(Choice E)</strong>&nbsp; Parkinson disease can also present with slow movements and depression.&nbsp; However, patients with parkinsonism usually demonstrate other features, such as rigidity, masked facies, and shuffling gait.&nbsp; This patient&#39;s slow movements are caused by psychomotor retardation, one of the diagnostic criteria for MDD.</p><p><strong>(Choice F)</strong>&nbsp; This patient&#39;s age and medical history of hypertension, hypercholesterolemia, diabetes, and transient ischemic attack make vascular dementia a plausible diagnosis.&nbsp; However, the normal CT scan findings, normal physical examination, and history of gradual memory loss (as opposed to acute, stepwise onset in vascular dementia) make this diagnosis less likely.</p><p><strong>Educational objective:</strong><br>In older patients, cognitive impairment caused by depression often mimics other neurocognitive disorders, such as Alzheimer disease.&nbsp; However, it is accompanied by other symptoms of depression and usually improves with treatment of the underlying depressive disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 659,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 13400,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal aging",
                    "choiceNumber": 4,
                    "correctTaken": 1752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease",
                    "choiceNumber": 5,
                    "correctTaken": 640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 6,
                    "correctTaken": 1811,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "239,400,true,-1,1*514,542,true,-1,1*1007,1037,true,-1,1*1065,1187,true,-1,1*1888,2194,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "101",
                    "mediaDataId": 0,
                    "title": "Major depressive disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31190831",
                    "mediaDataId": 0,
                    "title": "Cognitive impairment in depression: recent advances and novel treatments.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31190831",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25655026",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of depression and cognitive impairment in late life.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25655026",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 84,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 18889,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 706,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 14374,
            "questionIndex": 15783,
            "questionText": "<p>A 63-year-old woman is brought to the office due to a change in behavior over the past year.&nbsp; The patient was a highly successful CEO of a large company but had to step down 3 months ago due to poor performance.&nbsp; She once excelled in organization and strategic planning, but 9 months ago, she began to have significant difficulty planning important meetings.&nbsp; The patient is now unable to shop and cook for herself.&nbsp; She has had recent bouts of sadness and urinary frequency.&nbsp; Medical history is significant for hypertension and type 2 diabetes mellitus.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 132/79 mm Hg, pulse is 76/min, and respirations are 14/min.&nbsp; The patient scores 23/30 (normal: &#8805;26) on the Montreal Cognitive Assessment.&nbsp; Gait is slow and unsteady.&nbsp; Extraocular movements are intact.&nbsp; Reflexes are 3+ in the left upper extremity and 2+ on the right.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T70721\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vascular dementia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><p>Ischemia and/or infarcts due to:</p><ul><li>Large-vessel atherosclerosis</li><li>Small-vessel disease (eg, arteriolosclerosis)</li><li>Cerebral amyloid angiopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>manifestations</strong></p></td><td><ul><li>Early, prominent executive dysfunction</li><li>Subtypes:<ul style=\"list-style-type:circle;\"><li>Multi-infarct: often with stepwise decline</li><li>Strategic infarct: associated with localizing cortical deficits</li><li>Subcortical vascular encephalopathy: associated with subcortical signs (eg, urinary incontinence, gait disturbances)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging<br>findings</strong></p></td><td><ul><li>Cortical infarcts</li><li>Subcortical lacunar infarcts</li><li>White matter hyperintensities</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Risk factor modification (eg, hypertension, diabetes)</li><li>&plusmn; Antiplatelet therapy</li><li>Cholinesterase inhibitor</li></ul></td></tr></tbody></table></div><p>This patient&#39;s relatively abrupt cognitive decline with prominent executive dysfunction (eg, difficulty planning meetings), localizing neurologic findings (eg, asymmetric reflexes, gait abnormalities), and subcortical symptoms (eg, urinary frequency, depressed mood) is strongly suggestive of <strong>vascular dementia (VaD)</strong> due to unrecognized stroke.&nbsp; VaD is caused by cerebral ischemia or infarction in large or small arterial distributions.&nbsp; It is often characterized by:</p><ul><li><p>Prominent <strong>executive dysfunction:</strong>&nbsp; Such tasks include planning, organization, and problem-solving.</p></li><li><p><strong>Progressively worsening</strong> course:&nbsp; Patients with overt strokes (eg, large-vessel distribution) often display a classic <strong>stepwise pattern</strong> (ie, discrete, identifiable episodes of worsening that follow a stroke), whereas some patients with VaD due to small-vessel disease have a smoother decline due to the accumulation of smaller, &#x22;silent&#x22; insults.</p></li><li><p><strong>Localizing neurologic signs</strong>:&nbsp; Ischemia can lead to neurologic signs/symptoms that reflect the specific cortical region involved (eg, middle cerebral artery infarction causing contralateral weakness and sensory impairment).</p></li><li><p><strong>Subcortical deficits</strong>:&nbsp; There is less arteriole collateralization in the subcortical regions compared to the cerebral cortex, so small-artery disease can lead to a subcortical-type VaD, which can include symptoms such as urinary incontinence, gait disturbances, and psychiatric symptoms, as seen in this patient.</p></li></ul><p><strong>(Choice A)</strong>&nbsp; Significant overlap can be seen between Alzheimer dementia (AD) and VaD, especially in the formal evaluation of language, attention, and memory.&nbsp; However, memory loss, rather than executive dysfunction, is typically the presenting symptom in patients with AD.&nbsp; A subtle difference in cognition is often present in which verbal learning and recall are often relatively preserved in patients with VaD compared to those with AD.&nbsp; In addition, although urinary symptoms and abnormal reflexes could occur at late stages, this is more consistent with VaD.</p><p><strong>(Choices B and D)</strong>&nbsp; Dementia with Lewy bodies is characterized by dementia accompanied by at least 2 of the following signs/symptoms: parkinsonism, visual hallucinations, fluctuating cognitive status, and REM sleep behavior disorder.&nbsp; None of these are present in this patient.&nbsp; This type of dementia is distinguished from Parkinson disease dementia primarily by timeline: In Parkinson disease dementia, parkinsonism predates dementia symptoms by &#8805;1 year.</p><p><strong>(Choice C)</strong>&nbsp; Frontotemporal dementia is characterized by early personality changes (eg, disinhibition) and hyperorality.&nbsp; It is not associated with focal neurologic deficits (eg, asymmetric reflexes).</p><p><strong>Educational objective:</strong><br>Vascular dementia is caused by cerebral ischemia or infarction and commonly presents with executive dysfunction, focal neurologic findings, and subcortical symptoms/signs.&nbsp; It typically follows a progressively declining course.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8985,
            "topic": "Vascular dementia",
            "titleId": 8985,
            "title": "Vascular dementia",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 1000,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 2332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontotemporal dementia",
                    "choiceNumber": 3,
                    "correctTaken": 2746,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease dementia",
                    "choiceNumber": 4,
                    "correctTaken": 1023,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 5,
                    "correctTaken": 7053,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "224,262,true,-1,1*3085,3168,true,-1,1*1840,2151,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26595643",
                    "mediaDataId": 0,
                    "title": "Vascular dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26595643",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 14154,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1916,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 11333,
            "questionIndex": 12486,
            "questionText": "<p>A 79-year-old man with Parkinson disease for the past 3 years comes to the office due to poor appetite, weight loss, increased generalized weakness, &#x22;difficulty thinking,&#x22; and impaired sleep over the past 4 months.&nbsp; The patient has become increasingly isolated as his functional abilities have declined and says, &#x22;I don&#39;t want to live like this anymore.&nbsp; I hope God takes my life already.&#x22;&nbsp; He is still able to live alone but has stopped seeing his friends and no longer enjoys spending time with his family.&nbsp; The patient has no psychiatric history.&nbsp; He does not use tobacco or alcohol.&nbsp; His only medication is pramipexole.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 144/88 mm Hg, pulse is 74/min, and respirations are 14/min.&nbsp; Examination shows right hand greater than left resting tremor; generalized muscle rigidity; and a slow, shuffling gait, none of which are new.&nbsp; On mental status examination, the patient&#39;s affect is blunted and his mood is depressed.&nbsp; He is oriented, states the months of the year backwards very slowly with 2 mistakes, and recalls 3 of 3 items in 5 minutes.&nbsp; Which of the following is the most likely explanation of the patient&#39;s new symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s depressed mood and associated symptoms of impaired sleep, appetite, energy, concentration, interest, and suicidality are consistent with <strong>major depressive disorder (MDD)</strong>.&nbsp; Depression is the most common psychiatric disturbance seen in Parkinson disease (PD).&nbsp; MDD occurs in 10%-20% of patients with PD, and sub-syndromal depressive symptoms occur in up to half of patients.</p><p>The diagnosis of MDD is difficult in patients with PD as blunted affect and psychomotor slowing seen in depression are similar to bradykinesia and masked facies seen in PD.&nbsp; The presence of <strong>depressed mood</strong> and <strong>anhedonia</strong> (inability to experience pleasure in previously enjoyed activities) can assist in diagnosis.&nbsp; In addition, this patient&#39;s <strong>hopelessness</strong>, <strong>suicidality</strong>, and temporal association of his mood changes with worsening neurovegetative symptoms make MDD more likely.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorders are characterized by significant distress due to an identifiable stressor, within 3 months of the onset of that stressor.&nbsp; This diagnosis is not used if symptoms meet criteria for another psychiatric disorder.</p><p><strong>(Choice B)</strong>&nbsp; Commonly used treatments for PD include levodopa, dopamine agonists (eg, pramipexole, bromocriptine, ropinirole), and monoamine oxidase type B inhibitors (eg, selegiline).&nbsp; Although these medications may cause psychosis, none of them cause depression.</p><p><strong>(Choice C)</strong>&nbsp; Apathy is characterized primarily by a loss of motivation, more specifically a decreased motivation to speak or act.&nbsp; It is a common finding in patients with PD and may occur with or without depression.&nbsp; Apathy by itself would not explain this patient&#39;s depressed mood and other depressive symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Although cognitive dysfunction and dementia are common in PD, this patient has prominent mood symptoms (which can include impaired concentration) and is not exhibiting marked deficits in executive functioning and memory impairment.</p><p><strong>(Choice F)</strong>&nbsp; Persistent depressive disorder (ie, dysthymia or dysthymic disorder) is characterized by depressed mood for 2 years, associated with 2 or more changes in sleep, appetite, energy, self-esteem, concentration, and hopelessness.</p><p><strong>Educational objective:</strong><br>Major depressive disorder may occur in up to 20% of patients with Parkinson disease (PD).&nbsp; Although the diagnosis of major depression may be difficult due to overlapping symptoms with PD, the presence of depressed mood, anhedonia, hopelessness, and/or suicidality often suggests major depression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adverse effects due to pramipexole",
                    "choiceNumber": 2,
                    "correctTaken": 353,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Apathy due to Parkinson disease",
                    "choiceNumber": 3,
                    "correctTaken": 941,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cognitive impairment due to Parkinson disease",
                    "choiceNumber": 4,
                    "correctTaken": 692,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 14486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 6,
                    "correctTaken": 364,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1409,1528,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22245219",
                    "mediaDataId": 0,
                    "title": "Psychosis, apathy, depression and anxiety in Parkinson&#39;s disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22245219",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21560065",
                    "mediaDataId": 0,
                    "title": "Depression in Parkinson&#39;s disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21560065",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17063,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 379,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 17752,
            "questionIndex": 19212,
            "questionText": "<p>A 65-year-old woman comes to the office reporting progressively increasing orthopnea, daytime fatigue, and morning headache for the last month.&nbsp; She has had no chest pain or problems with swallowing or speech.&nbsp; Medical conditions include myocardial infarction, type 2 diabetes, hypertension, and amyotrophic lateral sclerosis.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 130/70 mm Hg, pulse is 88/min, and respirations are 16/min.&nbsp; Pulse oximetry shows 95% on room air.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows normal jugular venous pressure, clear lungs, and normal heart sounds.&nbsp; There is no peripheral edema.&nbsp; Neurologic examination shows 3/5 power in right lower extremity and 4/5 power in left lower extremity and muscle atrophy, unchanged from her last examination 2 months ago.&nbsp; Laboratory results are as follows:</p>&nbsp;<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">12 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">B-type natriuretic peptide (BNP), plasma</td><td style=\"vertical-align:middle;\">90 pg/mL</td><td style=\"vertical-align:middle;\">(normal: &lt;100, but variable)</td></tr></tbody></table><p>Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with <strong>amyotrophic lateral sclerosis</strong> (ALS) (asymmetric muscle strength, muscle atrophy) has manifestations of early respiratory insufficiency.&nbsp; Patients with ALS, a terminal neurodegenerative disease that affects both upper and lower motor neuron function, most often die of <strong>respiratory failure</strong>, which is caused by multiple factors:</p><ul><li>Inspiratory muscle (eg, <strong>diaphragm</strong>) atrophy and weakness, which leads to poor inspiratory strength</li><li>Expiratory muscle weakness, which leads to an <strong>ineffective cough</strong> and poor bronchial clearance</li><li>Bulbar muscle weakness, which leads to dysphagia and <strong>chronic aspiration</strong></li></ul><p>Because gravity is not assisting with lung expansion, respiratory symptoms are often more pronounced when patients are supine.&nbsp; In addition, sleep further contributes to respiratory insufficiency because the accessory respiratory muscles are less active during REM sleep, and relaxation of the weakened upper airway musculature results in airway collapse and obstruction.&nbsp; Therefore, early respiratory insufficiency may manifest as <strong>orthopnea</strong> and appear <strong>similar to obstructive sleep apnea</strong> (eg, daytime fatigue, morning headache), as seen in this patient.</p><p>Treatment focuses on improving respiratory function, which both prolongs survival and improves quality of life.&nbsp; <strong>Noninvasive positive-pressure ventilation (NIPPV)</strong> improves respiratory function by opening the upper airway and providing positive end-expiratory pressure to improve atelectasis.&nbsp; NIPPV is considered <strong>first-line</strong> therapy for ALS patients with respiratory insufficiency; it can be used intermittently at night but may need to be used more frequently as the disease progresses.&nbsp; Hypoxia and hypercarbia are late signs of respiratory failure; treatment should be initiated prior to the development of abnormal vital signs or CO<font size=\"2\"><sub>2</sub></font> retention.</p><p><strong>(Choice A)</strong>&nbsp; Furosemide is used to treat heart failure, which can present with orthopnea and fatigue.&nbsp; However, this patient has no jugular venous distension, no peripheral edema, and a normal b-type natriuretic peptide level, making heart failure unlikely.</p><p><strong>(Choice B)</strong>&nbsp; Home oxygen therapy is not recommended in patients with ALS due to the risk of decreasing the ventilatory drive, which may worsen carbon dioxide retention and potentially lead to hypercapnic coma.</p><p><strong>(Choice C)</strong>&nbsp; Modafinil is sometimes used to treat fatigue associated with ALS.&nbsp; However, this patient&#39;s symptoms of orthopnea, fatigue, and headache are more likely related to respiratory insufficiency, which is better treated with NIPPV.</p><p><strong>(Choice E)</strong>&nbsp; Tiotropium is a long-acting bronchodilator used in patients with chronic obstructive pulmonary disease or asthma, but this patient&#39;s symptoms are due to respiratory muscle weakness rather than bronchoconstriction.</p><p><strong>(Choice F)</strong>&nbsp; Tracheostomy and invasive mechanical ventilation can be considered for patients with contraindications to NIPPV (eg, inability to clear secretions, severe bulbar dysfunction) or those with progressive respiratory failure despite NIPPV.&nbsp; Most patients with advanced disease choose to forgo these options given the associated complications (eg, increased caregiver burden) and terminal nature of ALS.</p><p><strong>Educational objective:</strong><br>Amyotrophic lateral sclerosis can cause respiratory insufficiency due to respiratory muscle weakness.&nbsp; Noninvasive positive-pressure ventilation prolongs survival and improves quality of life.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3838,
            "topic": "Amyotrophic lateral sclerosis",
            "titleId": 3838,
            "title": "Amyotrophic lateral sclerosis",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Furosemide",
                    "choiceNumber": 1,
                    "correctTaken": 931,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Home oxygen therapy",
                    "choiceNumber": 2,
                    "correctTaken": 3108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Modafinil",
                    "choiceNumber": 3,
                    "correctTaken": 1276,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Noninvasive positive-pressure ventilation",
                    "choiceNumber": 4,
                    "correctTaken": 10520,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tiotropium",
                    "choiceNumber": 5,
                    "correctTaken": 729,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tracheostomy",
                    "choiceNumber": 6,
                    "correctTaken": 325,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "374,636,true,-1,1*1679,1838,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29990478",
                    "mediaDataId": 0,
                    "title": "Respiratory failure in amyotrophic lateral sclerosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29990478",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 87,
            "notes": null,
            "peopleTaken": 16889,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 755,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 14618,
            "questionIndex": 16032,
            "questionText": "<p>A 78-year-old woman is brought to the emergency department by her daughter, who is concerned about the patient&#39;s increasing forgetfulness and ability to live on her own.&nbsp; The daughter says, &#x22;Over the past month, my mother seems to ask me the same questions over and over.&nbsp; When I visited last week, she seemed slowed down overall and couldn&#39;t remember if she had taken a shower that day.&nbsp; She has also stopped shopping for groceries and cooking for herself, although she did eat all the meals that I prepared.&#x22;&nbsp; The patient takes medications for type 2 diabetes mellitus, hypertension, and urinary incontinence.&nbsp; Over the past several months, she has had difficulty sleeping due to a burning sensation in her feet from diabetic neuropathy.&nbsp; After recently discussing these symptoms with her primary care physician, the patient was prescribed a new medication that provided significant relief.&nbsp; Blood pressure is 138/86 mm Hg and pulse is 84/min and regular.&nbsp; The lungs are clear on auscultation and heart sounds are normal.&nbsp; The abdomen is soft and nontender.&nbsp; The patient&#39;s gait is slow, but there are no focal neurologic deficits.&nbsp; Montreal Cognitive Assessment score is 24/30 (normal: &#8805;26) with deficits in orientation, attention, and recall.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This elderly patient&#39;s acute onset of cognitive impairment after the recent addition of medication for diabetic neuropathy to an already complex drug regimen is consistent with a <strong>polypharmacy-related adverse effect</strong>.&nbsp; The elderly are especially vulnerable to the <strong>cumulative adverse cognitive effects</strong> of multiple drugs, which may produce <strong>cognitive impairment</strong> that can mimic dementia.&nbsp; Cumulative adverse effects may be further complicated by drug-drug interactions (eg, cytochrome P450 inhibitors), resulting in higher blood levels of impairing drugs.&nbsp; The most common medications associated with cognitive impairment in the elderly have anticholinergic properties; examples include oxybutynin for urinary incontinence and amitriptyline for diabetic neuropathy.&nbsp; Drugs without anticholinergic properties, especially sedating drugs (eg, benzodiazepines), may also contribute to the adverse effect burden of polypharmacy.</p><p>This patient is taking more than one medication that may cause adverse effects in cognition.&nbsp; The tricyclic antidepressant amitriptyline is frequently used as a first-line agent for diabetic neuropathy and has strong anticholinergic properties.&nbsp; In addition, anticholinergic medications (eg, oxybutynin) are frequently used in the treatment of incontinence, potentially adding to the anticholinergic burden.&nbsp; Given this patient&#39;s high risk for polypharmacy-related adverse effects, her medication regimen should be reviewed prior to further diagnostic workup or treatment for dementia.&nbsp; Reducing or <strong>discontinuing</strong> the use of <strong>anticholinergic</strong> and <strong>sedating medications</strong> would be a priority in this patient.</p><p><strong>(Choice A)</strong>&nbsp; It would be premature to recommend placement in an assisted living facility without first evaluating the patient for reversible causes of cognitive decline.</p><p><strong>(Choice B)</strong>&nbsp; Donepezil, a cholinesterase inhibitor, is frequently used in treating dementia.&nbsp; However, adding this medication before determining the origin of this patient&#39;s cognitive impairment would be inappropriate and may further exacerbate issues related to polypharmacy.</p><p><strong>(Choices C and E)</strong>&nbsp; Screening for depression and hearing and vision loss may be considered part of the evaluation for apparent cognitive impairment but would not be the immediate next step in a patient with no reported mood changes or visual or hearing symptoms.</p><p><strong>(Choice D)</strong>&nbsp; This patient has no focal neurologic deficits.&nbsp; A <a href=\"13039\">dementia workup</a> performed to rule out reversible causes of dementia, commonly includes an MRI of the brain and laboratory testing (eg, complete blood count, complete metabolic panel, TSH and vitamin B<font size=\"2\"><sub>12</sub></font> levels) but would not precede a comprehensive medication review.</p><p><strong>Educational objective:</strong><br>The elderly are especially vulnerable to the cumulative adverse effect burden of polypharmacy.&nbsp; In particular, medications with anticholinergic properties are strongly associated with the risk for cognitive impairment, which may produce a medication-induced syndrome that mimics dementia.&nbsp; Review of medications is an important first step in evaluating a patient on a complex medication regimen with new-onset or worsening cognitive impairment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "6",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arrange placement in an assisted living facility",
                    "choiceNumber": 1,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin donepezil and home health care",
                    "choiceNumber": 2,
                    "correctTaken": 1238,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Evaluate with the Geriatric Depression Scale",
                    "choiceNumber": 3,
                    "correctTaken": 1766,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain an MRI of the brain with gadolinium",
                    "choiceNumber": 4,
                    "correctTaken": 667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform hearing and vision screening",
                    "choiceNumber": 5,
                    "correctTaken": 449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Review the patient&#39;s current medications",
                    "choiceNumber": 6,
                    "correctTaken": 13757,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "581,788,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29746153",
                    "mediaDataId": 0,
                    "title": "Association between polypharmacy and dementiaa systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29746153",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29318004",
                    "mediaDataId": 0,
                    "title": "Poly-de-prescribing to treat polypharmacy: efficacy and safety.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29318004",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28056068",
                    "mediaDataId": 0,
                    "title": "The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28056068",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24293516",
                    "mediaDataId": 0,
                    "title": "Long-term cognitive and functional effects of potentially inappropriate medications in older women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24293516",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 199,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 18199,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1213,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 18009,
            "questionIndex": 19472,
            "questionText": "<p>A 56-year-old woman comes to the office for a routine health maintenance evaluation.&nbsp; The patient is physically well but reports feeling upset that she had to place her 79-year-old father in a nursing home.&nbsp; She says, &#x22;I&#39;ve cared for him since he developed Alzheimer disease 5 years ago, but I couldn&#39;t manage him at home anymore.&#x22;&nbsp; The patient&#39;s medical conditions include hypertension and type 2 diabetes mellitus.&nbsp; She underwent menopause at age 51.&nbsp; She does not use tobacco or alcohol and takes yoga classes 3 times a week.&nbsp; Blood pressure is 140/85 mm Hg and pulse is 77/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is unremarkable.&nbsp; The patient expresses concern about developing Alzheimer disease like her father and asks if there is anything to do.&nbsp; Which of the following is the most appropriate response to the patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Alzheimer disease</strong> (AD) is the most common form of dementia (ie, major neurocognitive disorder), and patients with a family history of AD will frequently have questions and concerns about their risk of developing the disease.&nbsp; Although this patient is at increased risk based on her father&#39;s history, addressing <strong>modifiable risk factors</strong> can reduce the likelihood of developing AD.&nbsp; Evidence shows that aggressive treatment of cardiovascular risk factors (eg, hypertension, diabetes, obesity/physical inactivity), especially in mid-life, can help reduce risk.&nbsp; For this patient, optimizing control of hypertension and diabetes, encouraging weight loss, and suggesting increased physical activities are all potentially helpful interventions to reduce her risk of developing AD.</p><p>In addition to controlling this patient&#39;s cardiovascular risk factors, engaging in cognitively stimulating activities and maintaining social relationships may also modify the progression of cognitive impairment in patients at risk for AD.&nbsp; There is no convincing evidence that taking supplements (eg, vitamin E, other antioxidant vitamins, gingko biloba) can prevent the development of AD <strong>(Choice B)</strong>.&nbsp; There is conflicting evidence of symptomatic benefit for the use of vitamin E in patients already diagnosed with mild to moderate AD.</p><p><strong>(Choice A)</strong>&nbsp; Although early-onset AD (onset age &#8804;65) is more heritable than late-onset forms (onset age &gt;65), this response suggests genetic risk does not play a role in late-onset AD, which is untrue.&nbsp; It also ignores this patient&#39;s modifiable risk factors.</p><p><strong>(Choice C)</strong>&nbsp; Although this response begins empathically, it may engender feelings of helplessness and fails to address modifiable risk factors.&nbsp; The physician should help the patient feel empowered by encouraging her to take steps to reduce her risk of developing AD by getting better control of her medical conditions and adopting a healthy lifestyle.</p><p><strong>(Choice D)</strong>&nbsp; The genetics of late-onset AD is complex and although patients who carry the <em>APOE</em> &#949;4 allele are at increased risk, almost 40% of patients with AD do not carry this allele.&nbsp; The physician would not be able to reassure this patient based on a negative result.&nbsp; At this time, <em>APOE</em> genotyping is mostly used as a research tool.</p><p><strong>Educational objective:</strong><br>Patients with a family history of Alzheimer disease are at increased risk of developing the disease but can mitigate risk by addressing modifiable risk factors.&nbsp; Aggressive treatment of cardiovascular risk factors (eg, hypertension, diabetes, obesity/physical inactivity), especially in mid-life, can help reduce risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Although Alzheimer disease cannot be prevented, family history is only a risk factor if your father had the early-onset form of the disease.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 501,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Although family history is a risk factor, taking supplements like vitamin E can help reduce your risk.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 91,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I imagine it was difficult to watch your father decline, but there is nothing anyone can do to prevent Alzheimer disease from developing.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 592,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I understand your concern and suggest getting an <em>APOE</em> genetic test to determine if you are at risk for Alzheimer disease.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;While family history is a risk factor for developing Alzheimer disease, getting good control of your medical conditions now can help reduce your risk.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 3170,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1351,1597,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "329",
                    "mediaDataId": 0,
                    "title": "Alzheimer disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31072403",
                    "mediaDataId": 0,
                    "title": "Alzheimer&#39;s disease: risk factors and potentially protective measures.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31072403",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28532183",
                    "mediaDataId": 0,
                    "title": "Treatment options and considerations for hypertensive patients to prevent dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28532183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 5008,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 662,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 14378,
            "questionIndex": 15787,
            "questionText": "<p>A 37-year-old woman comes to the office due to increased tearfulness.&nbsp; She describes herself as &#x22;a happy person&#x22; at baseline but has felt low for the past 6 months.&nbsp; The patient frequently goes a week without leaving home and has to force herself to eat and clean.&nbsp; She has no suicidal thoughts or hallucinations.&nbsp; The patient&#39;s father died by suicide at age 41, and her paternal grandfather is said to have died of a &#x22;mental disease&#x22; at age 49.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 121/77 mm Hg, pulse is 68/min, and respirations are 14/min.&nbsp; The patient seems restless during the examination, shifting frequently in her chair.&nbsp; She repeatedly raises her right arm in an abrupt, twisting motion that ends with smoothing her hair.&nbsp; Extraocular movement testing shows delayed initiation of voluntary saccades.&nbsp; Deep tendon reflexes are 3+ in both upper and lower extremities.&nbsp; She scores 25/30 on the Montreal Cognitive Assessment (normal: &#8805;26), losing points on measures of executive function and memory.&nbsp; The patient&#39;s disease is associated primarily with degeneration of neurons producing which of the following neurotransmitters?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T46869\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:65.0%;\"><p align=\"center\"><strong>Huntington disease</strong></p></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:65.0%;\"><ul><li>Motor: chorea, delayed saccade</li><li>Psychiatric: depression, irritability, psychosis, obsessive-compulsive symptoms</li><li>Cognitive: executive dysfunction</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Findings</strong></p></td><td style=\"width:65.0%;\"><ul><li>Genetic: autosomal dominant CAG trinucleotide repeat expansion disorder</li><li>Neuropathology: loss of GABA-ergic neurons</li><li>Imaging: caudate nucleus &amp; putamen atrophy</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><strong>Management &amp; prognosis</strong></p></td><td style=\"width:65.0%;\"><ul><li>Treatment: supportive</li><li>Survival: 10-20 years</li></ul></td></tr></tbody></table></div><p>This patient&#39;s psychiatric symptoms (eg, feeling low, amotivation), cognitive impairment (eg, executive dysfunction, memory loss), family history (eg, paternal transmission of &#x22;mental disease&#x22;), and neurologic findings (eg, chorea, hyperreflexia) are consistent with <strong>Huntington disease (HD)</strong>.&nbsp; HD is caused by an autosomal dominant <strong>CAG trinucleotide repeat</strong> expansion in the huntingtin (<em>HTT</em>) gene on chromosome 4p, with generational transmission often leading to growing CAG repeats and a progressively younger age of symptom onset (ie, <a href=\"54411\">anticipation</a>).</p><p>The increasing CAG repeats cause increasing polyglutamine additions within the huntingtin protein, leading to abnormal protein conformation and&nbsp;aggregation as well as intracellular pathway disruption.&nbsp; These changes are responsible for <strong>cell death and atrophy&nbsp;</strong>that particularly affect the <strong>caudate nucleus</strong> and <strong>putamen</strong> (ie, neostriatum), which are rich in <strong>GABA-producing neurons</strong>.&nbsp; Degeneration of these neurons results in the characteristic features (particularly movement) associated with HD.</p><p>Early in the disease course, chorea may be mild and mistaken for restlessness, and patients may try to hide movements as purposeful (eg, smoothing one&#39;s hair).&nbsp; Other common neurologic findings in HD include hyperreflexia, delayed initiation of voluntary saccades (ie, normally quick coordinated eye movements between fixed points), and eventually dementia.</p><p><strong>(Choice A)</strong>&nbsp; Loss of dopamine-producing neurons in the substantia nigra is associated with Parkinson disease, which causes a resting tremor, bradykinesia, and rigidity.</p><p><strong>(Choice C)</strong>&nbsp; Glutamate is the major excitatory neurotransmitter in the CNS.&nbsp; Excess glutamate is implicated in neurodegenerative conditions (ie, glutamate excitotoxicity), but degeneration of glutamate-producing neurons is not associated with HD.</p><p><strong>(Choices D and E)</strong>&nbsp; Norepinephrine (produced in the locus coeruleus) and serotonin (produced in the raphe nuclei) are implicated in major depressive disorder.&nbsp; Although this patient should be thoroughly assessed for depression because of its comorbidity with HD, degeneration of GABA-producing neurons is associated primarily with her predominant disease process.</p><p><strong>Educational objective:</strong><br>Huntington disease is an autosomal dominant disease of CAG trinucleotide repeat expansion characterized by psychiatric symptoms, cognitive impairment, and chorea.&nbsp; It is associated with preferential degeneration of GABA-producing neurons in the caudate nucleus and putamen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 1550,
            "topic": "Huntington disease",
            "titleId": 1550,
            "title": "Huntington disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dopamine",
                    "choiceNumber": 1,
                    "correctTaken": 3766,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "GABA",
                    "choiceNumber": 2,
                    "correctTaken": 11169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glutamate",
                    "choiceNumber": 3,
                    "correctTaken": 2772,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Norepinephrine",
                    "choiceNumber": 4,
                    "correctTaken": 213,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin",
                    "choiceNumber": 5,
                    "correctTaken": 1099,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "74,97,true,-1,1*292,377,true,-1,1*1486,1843,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27080129",
                    "mediaDataId": 0,
                    "title": "Manifestation of Huntington&#39;s disease pathology in human induced pluripotent stem cellderived neurons.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27080129",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 221,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 19026,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1465,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 14540,
            "questionIndex": 15950,
            "questionText": "<p>A 40-year-old woman comes to the office due to worsening gait disturbances over the past several months.&nbsp; The patient has had difficulty taking steps, as if her feet were stuck to the floor, and she feels unsteady while walking.&nbsp; She has had no falls, headache, vertigo, vision loss, or focal weakness or numbness.&nbsp; Three years ago, the patient had subarachnoid hemorrhage (SAH) from ruptured posterior communicating artery aneurysm, which was treated with endovascular coiling; she has had no recurrent bleeding.&nbsp; She has no other medical conditions and takes no medications.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows flat affect and psychomotor retardation.&nbsp; The pupils are equal and reactive to light.&nbsp; The cranial nerves and funduscopic examination are unremarkable.&nbsp; Muscle strength, deep tendon reflexes, and sensation are normal throughout.&nbsp; The gait is slow and wide-based with small steps.&nbsp; MRI of the head is shown in the <a href=\"22070\">exhibit</a>.&nbsp; Lumbar puncture reveals normal opening pressure, and the cerebrospinal fluid cell counts and laboratory studies are within normal limits.&nbsp; Which of the following is the most likely cause of this patient&#39;s gait disturbance?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47802\"><table class=\"table-default-style\" style=\"width:75.0%\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%\"><p align=\"center\"><strong>Normal pressure hydrocephalus</strong></p></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:78.12%\"><ul><li>Gait instability (wide-based) with frequent falls</li><li>Cognitive dysfunction</li><li>Urinary urgency/incontinence</li><li>Depressed affect (frontal lobe compression)</li><li>Upper motor neuron signs in lower extremities</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:78.12%\"><ul><li>Marked improvement in gait with spinal fluid removal: Miller Fisher (lumbar tap) test</li><li>Enlarged ventricles out of proportion to the underlying brain atrophy on MRI</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:78.12%\"><ul><li>Ventriculoperitoneal shunting</li></ul></td></tr></tbody></table></div><p>Normal pressure hydrocephalus is characterized by the accumulation of cerebrospinal fluid (CSF) leading to <strong>ventriculomegaly</strong> with <strong>normal opening pressure</strong> on lumbar puncture.&nbsp; Most cases are idiopathic and occur in the elderly; however, <strong>secondary</strong> disease can occur in those with prior neurologic insults (eg, <strong>subarachnoid hemorrhage</strong> [SAH], trauma, meningitis) that result in scarring and destruction of the arachnoid granulations responsible for CSF resorption.</p><p>Symptoms are classically described as a triad of <strong>incontinence</strong>, <strong>cognitive impairment</strong> (eg, psychomotor retardation, apathy), and <strong>gait abnormalities</strong>; however, all symptoms may not be present in early disease.&nbsp; A <strong>magnetic gait</strong> with slow, wide-based steps that appear as though the patient&#39;s feet are stuck to the ground is characteristic and typically appears early in the disease process.&nbsp; Upper motor neuron signs (eg, spasticity, hyperreflexia) may also occur.&nbsp; The diagnosis is confirmed with improvement of symptoms with large-volume lumbar puncture; ventriculoperitoneal shunt placement is the definitive therapy.</p><p><strong>(Choice A)</strong>&nbsp; Aqueductal stenosis can also occur after SAH and causes ventricular enlargement; however, symptoms of elevated intracranial pressure (eg, headache, nausea/vomiting) predominate.</p><p><strong>(Choice B)</strong>&nbsp; Cerebellar degeneration (eg, alcoholic cerebellar degeneration) can cause a wide-based, shuffling gait, but it is also commonly associated with dysarthria and postural instability.&nbsp; Neuroimaging may show cerebellar atrophy, but ventriculomegaly is unexpected.</p><p><strong>(Choice D)</strong>&nbsp; Vasospasm is a common complication of SAH and results in cerebral ischemia and stroke, but this characteristically occurs within 8 days of the primary bleed.&nbsp; Symptoms develop acutely, correspond to the location of the stroke, and would not progress over a period of months.</p><p><strong>(Choice E)</strong>&nbsp; Secondary parkinsonism can rarely result from cerebrovascular disease that interferes with the striatonigral pathway.&nbsp; Although gait disturbances are common, they are classically described as shuffling or festinating (quick, short steps).&nbsp; Rigidity, bradykinesia, and pill-rolling tremors are also expected, but ventricular enlargement is not common.</p><p><strong>Educational objective:</strong><br>Normal pressure hydrocephalus (NPH) is characterized by ventriculomegaly with normal opening pressure on lumbar puncture.&nbsp; It classically presents with a triad of incontinence, cognitive impairment, and gait abnormalities; however, all symptoms may not be present in early disease.&nbsp; NPH can be idiopathic or occur secondary to neurologic insults (eg, subarachnoid hemorrhage, trauma, meningitis) that result in scarring of the arachnoid granulations responsible for cerebrospinal fluid resorption.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 23402,
            "topic": "Normal pressure hydrocephalus",
            "titleId": 23402,
            "title": "Normal pressure hydrocephalus",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aqueductal stenosis",
                    "choiceNumber": 1,
                    "correctTaken": 1612,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerebellar degeneration",
                    "choiceNumber": 2,
                    "correctTaken": 270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pressure hydrocephalus",
                    "choiceNumber": 3,
                    "correctTaken": 11103,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "SAH-induced cerebral ischemia",
                    "choiceNumber": 4,
                    "correctTaken": 128,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Secondary parkinsonism",
                    "choiceNumber": 5,
                    "correctTaken": 1203,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1148,1397,true,-1,1*1569,1746,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 14316,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 603,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 11104,
            "questionIndex": 12246,
            "questionText": "<p>A 65-year-old woman is brought to the office by her family due to increasing forgetfulness over the past year.&nbsp; The patient previously had trouble remembering where she left her keys or glasses, and lately she has had difficulty recalling familiar names.&nbsp; She says, &#x22;I&#39;m just getting older and slowing down,&#x22; but her daughter became concerned when her mother couldn&#39;t remember the steps to make a favorite dish that she had previously cooked from memory for years.&nbsp; The patient has a history of well-controlled hypertension.&nbsp; She does not use tobacco but has 2 glasses of wine daily.&nbsp; Her husband unexpectedly died of a myocardial infarction a year ago.&nbsp; The patient&#39;s mother died of Alzheimer disease in her 80s.&nbsp; Blood pressure is 130/85 mm Hg and pulse is 85/min.&nbsp; The patient is alert, oriented, and cooperative.&nbsp; Muscle strength, sensation, deep tendon reflexes, and gait are normal.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T37600\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Initial workup of suspected cognitive impairment</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cognitive<br>testing</strong></p></td><td><ul><li>MMSE (score &lt;24/30 suggestive of MCI/dementia)</li><li>Montreal Cognitive Assessment (score &lt;26/30)</li><li>Mini-Cog (abnormal 3-word recall &amp;/or clock-drawing test)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>testing</strong></p></td><td><ul><li>Routine: CBC, vitamin B<sub>12</sub>, TSH, CMP</li></ul><ul><li>Selective (specific risk factors): folate, syphilis, vitamin D level</li><li>Atypical (early onset): CSF</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>Routine: CT scan or MRI of the brain</li><li>Atypical: EEG</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBC</strong> = complete blood count; <strong>CMP</strong> = complete metabolic panel; <strong>CSF</strong> = cerebrospinal fluid; <strong>EEG</strong> = electroencephalogram; <strong>MCI</strong> = mild cognitive impairment; <strong>MMSE</strong> = Mini-Mental State Examination.</p></td></tr><tr><td colspan=\"2\"></td></tr></tbody></table></div><p>This patient&#39;s year-long history of increasing forgetfulness and executive dysfunction is concerning for <strong>mild cognitive impairment</strong> (MCI).&nbsp; The first step in evaluation of suspected MCI is to perform a standardized cognitive examination using a cognitive screening tool such as the <strong>Montreal Cognitive Assessment</strong> (MoCA) or mini-mental state examination (MMSE).</p><p>The MoCA is a widely used 30-point scale that assesses orientation, attention/concentration, language, delayed word recall, and visuospatial/executive function.&nbsp; Scores of <strong>&lt;26/30</strong> on the MoCA are suggestive of clinically significant cognitive impairment.&nbsp; For many of these tools, patients in the classic study cohorts were generally age 65-80 with ~12 years of education and were tested in their native language.</p><p>If the results of the MoCA suggest clinically significant cognitive impairment, the patient should undergo a workup for potentially reversible causes of cognitive impairment, which includes depression screening, laboratory evaluation (eg, vitamin B<font size=\"2\"><sub>12 </sub></font>level, TSH, complete blood count, complete metabolic panel), and neuroimaging (eg, MRI).</p><p><strong>(Choice A)</strong>&nbsp; The apolipoprotein E (<em>APOE</em>) gene is associated with greater risk for late-onset Alzheimer disease (AD), but the test&#39;s positive predictive value is low and of limited clinical utility at this time.&nbsp; For example, up to 40% of patients with AD do not carry the <em>APOE</em> &#949;4 allele.&nbsp; Routine genetic testing is not recommended for late-onset AD at this time.</p><p><strong>(Choice B)</strong>&nbsp; An MRI of the head can be helpful to evaluate for cerebrovascular disease.&nbsp; However, this patient has a nonfocal neurological examination.&nbsp; A cognitive screening test should be performed prior to neuroimaging.</p><p><strong>(Choice D)</strong>&nbsp; Thiamine deficiency can cause Wernicke syndrome, which is characterized by encephalopathy (eg, confusion), oculomotor dysfunction (eg, horizontal nystagmus), and gait ataxia.&nbsp; This condition is most commonly seen in patients with long-term nutritional deficiency (eg, anorexia, chronic alcohol use).</p><p><strong>(Choices E and F)</strong>&nbsp; Thyroid function tests and vitamin B<font size=\"2\"><sub>12</sub></font> levels are part of the workup to rule out reversible causes of dementia, but a brief, inexpensive cognitive screening tool such as the MoCA should be performed first.</p><p><strong>Educational objective:</strong><br>The first step in evaluation of suspected mild cognitive impairment is to perform a standardized cognitive examination using a cognitive screening tool such as the Montreal Cognitive Assessment (MoCA).&nbsp; Patients with evidence of possible cognitive impairment on the MoCA should undergo a workup for potentially reversible causes, which includes depression screening, laboratory evaluation, and neuroimaging.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Apolipoprotein E testing",
                    "choiceNumber": 1,
                    "correctTaken": 217,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the head",
                    "choiceNumber": 2,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Montreal Cognitive Assessment",
                    "choiceNumber": 3,
                    "correctTaken": 13838,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiamine blood test",
                    "choiceNumber": 4,
                    "correctTaken": 253,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function tests",
                    "choiceNumber": 5,
                    "correctTaken": 550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> and folate levels",
                    "choiceNumber": 6,
                    "correctTaken": 805,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1766,2119,true,-1,1*1417,1756,true,-1,1*302,398,true,-1,1*444,457,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30426911",
                    "mediaDataId": 0,
                    "title": "Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer&#39;s Disease (AD) in the elderly?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30426911",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 15921,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 619,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 4651,
            "questionIndex": 4651,
            "questionText": "<p>A 65-year-old woman comes to the office for evaluation of progressively worsening memory.&nbsp; The patient lives alone and considers herself &#x22;very independent&#x22;; however, she has recently forgotten to pay her bills on several occasions and also lost her way while driving in a previously familiar neighborhood 2 weeks ago.&nbsp; Review of systems reveals no other symptoms except for mild urinary urgency.&nbsp; The patient has a history of hypertension and hyperlipidemia.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 130/90 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; The lungs are clear to auscultation, and a grade 2/6 systolic ejection murmur is present.&nbsp; Abdominal examination shows no tenderness or masses.&nbsp; The cranial nerves are intact, funduscopy is normal, and there is no tremor.&nbsp; The patient immediately recalls all 3 of 3 items read to her, but 5 minutes later she can remember none of them.&nbsp; Her gait is broad-based and shuffling.&nbsp; Blood cell count and serum chemistry studies are within normal limits.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47802\"><table class=\"table-default-style\" style=\"width:75.0%\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%\"><p align=\"center\"><strong>Normal pressure hydrocephalus</strong></p></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:78.12%\"><ul><li>Gait instability (wide-based) with frequent falls</li><li>Cognitive dysfunction</li><li>Urinary urgency/incontinence</li><li>Depressed affect (frontal lobe compression)</li><li>Upper motor neuron signs in lower extremities</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:78.12%\"><ul><li>Marked improvement in gait with spinal fluid removal: Miller Fisher (lumbar tap) test</li><li>Enlarged ventricles out of proportion to the underlying brain atrophy on MRI</li></ul></td></tr><tr><td style=\"width:21.88%\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width:78.12%\"><ul><li>Ventriculoperitoneal shunting</li></ul></td></tr></tbody></table></div><p>This patient has <strong>normal pressure hydrocephalus</strong> (NPH), a clinical syndrome characterized by <strong>gait abnormalities</strong> (broad-based gait, shuffling), <strong>cognitive impairment</strong> (memory deficits, impaired executive function), and urinary incontinence (often presenting as <strong>urinary urgency</strong> in early disease).</p><p>NPH is thought to be due to <strong>decreased cerebrospinal fluid (CSF) absorption</strong> by the arachnoid granulations.&nbsp; Idiopathic NPH is associated with chronic periventricular ischemia and increased venous resistance, which may alter normal arachnoid function.&nbsp; NPH may also occur secondary to a variety of neurologic insults (eg, meningitis, subarachnoid hemorrhage) due to scarring and dysfunction of the granulations.</p><p>As CSF accumulates, the ventricles expand to prevent elevation in intracranial pressure, resulting in the characteristic imaging findings of ventriculomegaly out of proportion to sulcal enlargement.&nbsp; Lumbar puncture demonstrates normal CSF studies and opening pressure, and clinical improvement after large volume CSF removal is diagnostic.&nbsp; Ventricular shunting is the definitive management.</p><p><strong>(Choice A)</strong>&nbsp; Accumulation of alpha-synuclein within dopaminergic neurons is consistent with Parkinson disease.&nbsp; Parkinson can cause a shuffling gait but also typically causes bradykinesia, rigidity, and a pill-rolling tremor; cognitive impairment is a late-stage finding, and urinary urgency would be unexpected.</p><p><strong>(Choice C)</strong>&nbsp; Amyloid deposition occurs in Alzheimer disease.&nbsp; Cognitive deficits present early in the disease; gait impairment and urinary incontinence may occur but typically much later in the disease course.&nbsp; Urinary urgency (as seen in this patient) is not associated with Alzheimer disease.</p><p><strong>(Choice D)</strong>&nbsp; Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency can cause dementia and subacute combined degeneration with ataxia and incontinence.&nbsp; However, patients typically also develop bilateral lower extremity paresthesias, glossitis, and macrocytic anemia.</p><p><strong>(Choice E)</strong>&nbsp; Frontotemporal dementia (loss of frontotemporal neurons) causes progressive dementia, but it is characterized by both prominent changes in personality/behavior and aphasia.&nbsp; Gait abnormalities and urinary urgency are uncommon.</p><p><strong>Educational objective:</strong><br>Normal pressure hydrocephalus is characterized by gait abnormalities, cognitive impairment, and urinary incontinence that often presents as urgency in early disease.&nbsp; It is thought to result from decreased CSF absorption with increased ventricular compliance, allowing for ventricular enlargement without chronically increasing intracranial pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 23402,
            "topic": "Normal pressure hydrocephalus",
            "titleId": 23402,
            "title": "Normal pressure hydrocephalus",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alpha-synuclein dysfunction in dopaminergic neurons",
                    "choiceNumber": 1,
                    "correctTaken": 2778,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased cerebrospinal fluid absorption",
                    "choiceNumber": 2,
                    "correctTaken": 7913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excessive cerebral amyloid peptide deposition",
                    "choiceNumber": 3,
                    "correctTaken": 2771,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neurocognitive effects of vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selective loss of frontotemporal neurons",
                    "choiceNumber": 5,
                    "correctTaken": 213,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1587,1887,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 14077,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 432,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 2990,
            "questionIndex": 2990,
            "questionText": "<p>A 60-year-old man is brought to the office due to a 2-week history of involuntary muscle spasms in his arms, especially when he is startled.&nbsp; Over the past 2 months, the patient has experienced worsening insomnia and confusion and gotten lost in his surroundings.&nbsp; He has no fever, headache, or urinary symptoms.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 130/76 mm Hg, and pulse is 82/min.&nbsp; The patient is alert but poorly groomed.&nbsp; Examination is notable for frequent irregular jerks of the upper and lower extremities, increased muscle tone, brisk deep tendon reflexes, and bilateral extensor plantar responses.&nbsp; On cognitive testing, the patient recalls 0 of 3 delayed recall items and is unable to draw a clock.&nbsp; A noncontrast head CT scan is normal.&nbsp; Electroencephalography reveals periodic sharp-wave complexes.&nbsp; Which of the following is the most likely outcome for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47159\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Creutzfeldt-Jakob disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Rapidly progressive dementia</li><li>Myoclonus (provoked by startle)</li><li>Cerebellar signs (eg, ataxia)</li><li>Upper motor neuron signs (eg, hyperreflexia)</li><li>Extrapyramidal signs (eg, hypokinesia)</li><li>Mood &amp;/or sleep disturbances</li></ul></td></tr><tr><td><p align=\"center\"><strong>Findings</strong></p></td><td><ul><li>MRI: widespread atrophy (cerebrum &amp; cerebellum), cortical enhancement (ie,&nbsp;cortical ribboning), enhancement of putamen &amp; caudate head (hockey stick sign)</li><li>CSF: normal routine analysis, positive 14-3-3 protein titers, positive RT-QuIC test</li><li>EEG: sharp, triphasic, synchronous discharges</li><li>Neuropath: spongiform degeneration without inflammation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management &amp; prognosis</strong></p></td><td><ul><li>Symptomatic treatment, counseling, social services referral</li><li>No effective disease-modifying therapy, fatal in &lt;12 months</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CSF</strong> = cerebrospinal fluid; <strong>EEG</strong> = electroencephalography; <strong>RT-QuIC</strong> = real-time quaking-induced conversion.</p></td></tr></tbody></table></div><p>This patient exhibits sleep disturbances with rapidly progressive dementia, myoclonus (eg, startle-induced involuntary muscle spasm), upper motor neuron signs (eg, extensor plantar reflexes), and <strong>periodic sharp-wave complexes</strong> (biphasic or triphasic) on an electroencephalogram (EEG).&nbsp; These findings are consistent with <strong>Creutzfeldt-Jakob disease</strong> (CJD), a fatal transmissible spongiform encephalopathy.</p><p>CJD is caused by <strong>prions</strong>, the only known infectious agents that lack nucleic acids (eg, DNA, RNA).&nbsp; Prions are abnormally folded proteins that can induce similar conformational changes in other proteins, which leads to the accumulation of neurotoxic fibrils.&nbsp; This results in noninflammatory spongiform <strong>neurodegeneration</strong> with <strong>widespread loss of neurons</strong> throughout the cerebrum and cerebellum.&nbsp; Head CT is often normal, especially early in the disease course.&nbsp; MRI is more sensitive and often shows hyperintensity in the cortex, caudate, and anterior putamen early, with evidence of generalized atrophy and ventricular dilatation becoming more apparent as the disease progresses.</p><p>CJD is most commonly sporadic, but it can be hereditary, iatrogenic (due to contaminated transplants or surgical instruments), or due to oral consumption of contaminated neural tissue.&nbsp; Although CJD has a long incubation period (estimated mean of 10 years), once symptoms occur, patients experience an <strong>inexorable decline</strong> (eg, loss of speech, loss of ability for self-care, coma) until <strong>death</strong>, which occurs <strong>less than 12 months after diagnosis</strong>.&nbsp; Only supportive treatment is available, which should include symptom-based management, compassionate education, and referral to social services.</p><p><strong>(Choice B)</strong>&nbsp; Severe hypothyroidism can present with rapidly worsening cognitive decline and can be rapidly improved with thyroid hormone supplementation.&nbsp; However, dementia due to hypothyroidism is usually accompanied by fatigue, cold intolerance, and constipation.&nbsp; Upper motor neuron signs, startle-induced myoclonus, and periodic sharp waves on an EEG make CJD much more likely.</p><p><strong>(Choice C)</strong>&nbsp; Symptoms resulting from normal pressure hydrocephalus (NPH) rapidly improve after surgical restoration of cerebrospinal fluid drainage (eg, ventricular shunt).&nbsp; Although NPH can cause significant cognitive impairment and gait disturbance (and in some cases hyperreflexia and spasticity), it also classically causes urinary incontinence and ventricular enlargement on CT scan and would not explain the patient&#39;s EEG findings.</p><p><strong>(Choice D)</strong>&nbsp; Although cholinesterase inhibitors can improve mental functioning in Alzheimer disease, frontotemporal dementia, and Lewy body dementia, patients progressively worsen despite therapy.&nbsp; In contrast to CJD, Alzheimer disease has a more gradual onset of cognitive dysfunction (years vs months).&nbsp; In addition, myoclonus, upper motor neuron signs, and EEG periodic sharp waves are more characteristic of CJD.</p><p><strong>(Choice E)</strong>&nbsp; Depression-related cognitive impairment (ie, pseudodementia) refers to cognitive changes associated with major depressive disorder, and these changes often slowly improve with pharmacotherapy.&nbsp; However, this patient does not meet the criteria for <a href=\"17482\">major depressive disorder</a>.&nbsp; In addition, myoclonus and upper motor neuron signs make CJD more likely.</p><p><strong>Educational objective:</strong><br>Creutzfeldt-Jakob disease is a fatal prion disease that presents with rapidly progressive dementia, myoclonus, mood changes, and sleep disturbances.&nbsp; There is no effective disease-modifying treatment.&nbsp; Patients rapidly decline until death, which occurs less than 12 months after diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 17883,
            "topic": "Prion disease",
            "titleId": 17883,
            "title": "Prion disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Death within a year regardless of therapy",
                    "choiceNumber": 1,
                    "correctTaken": 13563,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid symptomatic improvement with pharmacotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 730,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid symptomatic improvement with surgery",
                    "choiceNumber": 3,
                    "correctTaken": 123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Slow symptomatic progression despite pharmacotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 4040,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Slow symptomatic resolution with pharmacotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 493,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1277,1668,true,-1,1*1955,2395,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28028861",
                    "mediaDataId": 0,
                    "title": "Creutzfeldt-Jakob disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28028861",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27453757",
                    "mediaDataId": 0,
                    "title": "Role of the biomarkers for the diagnosis of Creutzfeldt-Jakob disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27453757",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 40,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 18949,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 692,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 14667,
            "questionIndex": 16082,
            "questionText": "<p>A 69-year-old woman is brought to the office by her husband due to forgetfulness.&nbsp; The patient is a retired law professor who taught classes until a year ago when she began to have difficulty remembering lesson plans.&nbsp; Since then, her memory has worsened, and she has gotten lost during her normal neighborhood walk on more than one occasion.&nbsp; Her husband has taken over responsibility for all cooking and cleaning; moreover, the patient is unable to drive or use public transportation on her own.&nbsp; Medical history is significant for hypertension and type 2 diabetes mellitus for which she takes lisinopril and metformin.&nbsp; The patient has no family history of memory problems.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 134/74 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; She scores a 22/30 on Montreal Cognitive Assessment (normal: &#8805;26).&nbsp; There are no focal neurologic deficits.&nbsp; Which of the following is the most appropriate next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t37600\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Initial workup of suspected cognitive impairment</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cognitive<br>testing</strong></p></td><td><ul><li>MMSE (score &lt;24/30 suggestive of MCI/dementia)</li><li>Montreal Cognitive Assessment (score &lt;26/30)</li><li>Mini-Cog (abnormal 3-word recall &amp;/or clock-drawing test)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>testing</strong></p></td><td><ul><li>Routine: CBC, vitamin B<sub>12</sub>, TSH, CMP</li></ul><ul><li>Selective (specific risk factors): folate, syphilis, vitamin D level</li><li>Atypical (early onset): CSF</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>Routine: CT scan or MRI of the brain</li><li>Atypical: EEG</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBC</strong> = complete blood count; <strong>CMP</strong> = complete metabolic panel; <strong>CSF</strong> = cerebrospinal fluid; <strong>EEG</strong> = electroencephalogram; <strong>MCI </strong>= mild cognitive impairment; <strong>MMSE</strong> = Mini-Mental State Examination.</p></td></tr><tr><td colspan=\"2\"></td></tr></tbody></table></div><p>This patient&#39;s year-long history of progressive cognitive decline and associated impairment in activities of daily living (eg, cooking, cleaning, using transportation) meets criteria for <strong>dementia</strong> (also known as major neurocognitive disorder).&nbsp; Her prominent memory symptoms, insidious disease course, and lack of associated neurological findings make Alzheimer disease (AD) more likely than other subtypes of dementia (eg, vascular dementia, frontotemporal dementia, dementia with Lewy bodies).</p><p>AD, the most common form of dementia in older patients, is inevitably progressive and irreversible.&nbsp; However, before a definitive diagnosis is made, all patients should undergo a <strong>workup</strong> for potentially <strong>reversible causes</strong> of cognitive impairment.&nbsp; No matter which subtype is suspected, the initial evaluation of suspected dementia is similar.&nbsp; Evaluation involves <strong>neuropsychological testing</strong> (eg, Montreal Cognitive Assessment), laboratory testing <strong>(complete blood count, vitamin B</strong><font size=\"2\"><sub><strong>12</strong></sub></font><strong>, TSH, complete metabolic panel)</strong>, and <strong>neuroimaging</strong>.</p><p>The apolipoprotein E epsilon 4 allele is associated with an increased risk for AD.&nbsp; However, genetic testing is contraindicated for the routine evaluation of suspected dementia because it exposes patients to the potential psychological harms of false positives and false negatives without providing sufficient clinical utility.</p><p><strong>(Choices A and B)</strong>&nbsp; Cerebrospinal fluid testing and electroencephalogram are only indicated in patients with specific risk factors.&nbsp; Cerebrospinal fluid testing may be indicated when a suspected underlying infection or malignancy is believed to be contributing to the presentation.&nbsp; Electroencephalogram may be considered in patients with an underlying seizure disorder or in those exhibiting seizure like activity.</p><p><strong>(Choices C and F)</strong>&nbsp; Folate and vitamin D levels are not routinely obtained; they are indicated only in specific risk groups.&nbsp; For example, patients with alcohol use disorder may have folate deficiencies that can contribute to cognitive impairment.&nbsp; Some conditions may place a patient at risk for vitamin D deficiency (eg, celiac disease, chronic kidney disease) and may also justify targeted testing.</p><p><strong>(Choice D)</strong>&nbsp; Syphilis testing is indicated only in patients with specific risk factors such as those with a known exposure.</p><p><strong>Educational objective:</strong><br>The initial workup of suspected dementia should include neuropsychological testing (eg, Montreal Cognitive Assessment), selected laboratory testing (complete blood count, complete metabolic panel, TSH, vitamin B<font size=\"2\"><sub>12</sub></font>), and neuroimaging (eg, MRI).&nbsp; Patients in specific risk groups may warrant additional targeted testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerebrospinal fluid testing",
                    "choiceNumber": 1,
                    "correctTaken": 2871,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electroencephalogram",
                    "choiceNumber": 2,
                    "correctTaken": 2803,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Folate level",
                    "choiceNumber": 3,
                    "correctTaken": 1251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Syphilis testing",
                    "choiceNumber": 4,
                    "correctTaken": 2076,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> level",
                    "choiceNumber": 5,
                    "correctTaken": 8601,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin D level",
                    "choiceNumber": 6,
                    "correctTaken": 1494,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1671,1997,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28797371",
                    "mediaDataId": 0,
                    "title": "Dementia for the primary care provider.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28797371",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22010769",
                    "mediaDataId": 0,
                    "title": "Evaluation of suspected dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22010769",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 19098,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 335,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 13578,
            "questionIndex": 14962,
            "questionText": "<p>A 74-year-old man is brought to the office by his wife due to a change in behavior.&nbsp; Over the last year, the patient has had difficulty recognizing his grandchildren and has gotten lost in his local grocery store more than once.&nbsp; He enjoys playing Sudoku in the Sunday newspaper but has had increasing difficulty completing the puzzles.&nbsp; He has also been increasingly distractible during conversation and says that he sometimes sees animals in the house despite the couple not owning any.&nbsp; The patient has not seen a doctor in &gt;20 years and takes no medications.&nbsp; His wife says that he started &#x22;slowing down&#x22; and talking about stiffness and a tremor approximately 4 years ago, which was before he experienced any behavioral symptoms; they never sought medical care because they assumed it was &#x22;just part of getting older.&#x22;&nbsp; Examination shows intact cranial nerves as well as pinprick and light touch sensations.&nbsp; There is rigidity in the bilateral upper and lower extremities that is worse on the left.&nbsp; Tremor is present in both hands at rest and is worse in the left hand.&nbsp; Movement and speech are slowed.&nbsp; Gait is unsteady and marked by a shortened stride.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s &gt;4-year history of asymmetric rigidity, resting tremor, and bradykinesia is consistent with undiagnosed Parkinson disease.&nbsp; Approximately one-third of patients with Parkinson disease develop <strong>Parkinson disease dementia</strong> (PDD).&nbsp; Risk factors include age, duration, and severity of symptoms of Parkinson disease.&nbsp; Although signs/symptoms of PDD are similar to those of dementia with Lewy bodies, by definition, PDD is diagnosed when parkinsonism predates cognitive impairment by &gt;1 year; this pattern is clearly evident in this patient.</p><p>PDD typically presents with <strong>executive and visuospatial dysfunction</strong> (eg, impaired attention and planning, inability to recognize familiar people [eg, grandchildren], getting lost in familiar locations [eg, grocery store]) with only mild memory impairment at first.&nbsp; Although <strong>visual hallucinations</strong>, delusions, and sleep disorders may occur in Parkinson disease without dementia, these symptoms occur at higher rates in PDD.</p><p>The cognitive impairment of PDD may be treated symptomatically with cholinesterase inhibitors (eg, donepezil).&nbsp; Psychotic symptoms of PDD may be treated by a dose reduction of antiparkinsonian agents and/or low-potency antipsychotics (eg, pimavanserin, quetiapine).</p><p><strong>(Choice A)</strong>&nbsp; Alzheimer disease presents with early, prominent memory impairment accompanied by executive and visuospatial dysfunction.&nbsp; Motor symptoms are rare early in the disease process.</p><p><strong>(Choice B)</strong>&nbsp; Dementia with Lewy bodies presents with dementia plus &#8805;2 of the following features: visual hallucinations, parkinsonism, fluctuating cognition, and REM sleep behavior disorder.&nbsp; Cognitive impairment would develop in this condition before or at the same time as parkinsonism, not years later, as seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Progressive supranuclear palsy is a rare syndrome that presents with falls, impaired vertical gaze, and parkinsonism.&nbsp; This patient has preserved extraocular movements.</p><p><strong>(Choice E)</strong>&nbsp; Vascular dementia classically presents with mild memory impairments, prominent executive dysfunction, and focal neurologic deficits corresponding to cerebrovascular pathology.&nbsp; This patient&#39;s presentation is more consistent with PDD.</p><p><strong>Educational objective:</strong><br>Parkinson disease dementia (PDD) is characterized by executive and visuospatial dysfunction with relatively mild memory impairment at first.&nbsp; PDD may be distinguished from dementia with Lewy bodies by the timing of symptom onset: If parkinsonism predates cognitive impairment by &gt;1 year, PDD should be diagnosed.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 4157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease dementia",
                    "choiceNumber": 3,
                    "correctTaken": 9886,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progressive supranuclear palsy",
                    "choiceNumber": 4,
                    "correctTaken": 43,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 5,
                    "correctTaken": 85,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1000,1265,true,-1,1*1794,1915,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27502301",
                    "mediaDataId": 0,
                    "title": "Parkinson disease and dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27502301",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 14271,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 581,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 3771,
            "questionIndex": 3771,
            "questionText": "<p>A 56-year-old woman is evaluated for a monthlong history of intermittent weakness of the right foot and a 3-month history of progressive left arm weakness.&nbsp; The patient has no dysphagia, dysarthria, sensory loss, or bowel or bladder impairment.&nbsp; Other medical conditions include type 2 diabetes mellitus, hypercholesterolemia, and hypertension.&nbsp; She takes metformin, atorvastatin, and lisinopril.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 130/78 mm Hg, pulse is 80/min, and respirations are 14/min.&nbsp; Neurologic examination reveals normal speech, language, and mental status.&nbsp; Moderate weakness and atrophy of the distal muscles in the right leg and left arm is noted.&nbsp; Fasciculations are present in the right leg.&nbsp; Deep tendon reflexes are brisk in the upper and lower limbs.&nbsp; Sensory examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Creatine kinase, serum</td><td style=\"vertical-align:middle;\">160 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Hemoglobin A1c</td><td style=\"vertical-align:middle;\">7.1%</td></tr><tr><td style=\"vertical-align:middle;\">Vitamin B<font size=\"2\"><sub>12</sub></font>, serum</td><td style=\"vertical-align:middle;\">450 pg/mL (normal: 200-800 pg/mL)</td></tr><tr><td style=\"vertical-align:middle;\">Free T<font size=\"2\"><sub>4</sub></font></td><td style=\"vertical-align:middle;\">1.6 ng/dL (normal: 0.8-1.7)</td></tr><tr><td style=\"vertical-align:middle;\">Thyroid stimulating hormone</td><td style=\"vertical-align:middle;\">7 &micro;U/mL</td></tr></tbody></table><p>Which of the following would be most helpful in treating this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t59708\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Amyotrophic lateral sclerosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Upper motor neuron signs<ul style=\"list-style-type:circle;\"><li>Spasticity</li><li>Hyperreflexia</li><li>Pathologic reflexes (eg, jaw jerk, extensor plantar reflex)</li></ul></li><li>Lower motor neuron signs<ul style=\"list-style-type:circle;\"><li>Atrophy</li><li>Fasciculations</li></ul></li><li>Bulbar symptoms<ul style=\"list-style-type:circle;\"><li>Dysarthria</li><li>Dysphagia</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Clinical evaluation</li><li>EMG</li><li>MRI of brain &amp; spinal cord (to exclude other causes)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Riluzole</li><li>Respiratory support (eg, NIPPV)</li><li>Nutritional support (eg, PEG tube)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>EMG</strong> = electromyography; <strong>NIPPV</strong> = noninvasive positive pressure ventilation; <strong>PEG</strong> = percutaneous endoscopic gastrostomy.</p></td></tr></tbody></table></div><p>This patient has progressive weakness and signs of both upper motor neuron (UMN) (ie, hyperreflexia) and lower motor neuron (LMN) (ie, atrophy, fasciculations) deficits.&nbsp; In association with normal sensation, this presentation is consistent with <strong>amyotrophic lateral sclerosis</strong> (ALS).&nbsp; ALS is diagnosed clinically; although there are no confirmatory laboratory tests, mild creatine kinase (CK) elevation is sometimes seen, which may be due to denervation or hypermetabolism of atrophied muscles.</p><p>ALS is universally fatal; therefore, management is largely focused on slowing progression and controlling symptoms.&nbsp; <strong>Riluzole</strong>, a glutamate inhibitor, is a first-line therapy shown to improve survival, possibly by reducing <strong>glutamate-mediated excitotoxicity</strong>.&nbsp; It is often used in combination with edaravone, an antioxidant, which likely slows disease progression, particularly in patients early in the disease course.&nbsp; Further management includes aggressive respiratory support (eg, noninvasive positive-pressure ventilation), nutritional support, and multidisciplinary symptomatic management.&nbsp; Palliative care strategies are usually introduced early.</p><p><strong>(Choice A)</strong>&nbsp; Patients with poorly controlled diabetes are at increased risk of neuropathy; however, it typically presents as symmetric sensory polyneuropathy (eg, glove and stocking pattern) rather than asymmetric limb weakness.&nbsp; Hyperreflexia, an UMN sign, does not occur.</p><p><strong>(Choice B)</strong>&nbsp; Interferon beta is used to treat multiple sclerosis, which can cause a variety of neurologic deficits (eg, asymmetric extremity weakness) that can be intermittent or progressive.&nbsp; However, neurologic defects result from lesions in the CNS; therefore, atrophy and fasciculations (LMN signs) are typically absent.</p><p><strong>(Choice C)</strong>&nbsp; Hypothyroidism can cause muscle weakness in severe cases.&nbsp; However, although this patient has an elevated TSH level, the free T4 is normal, suggesting subclinical hypothyroidism.&nbsp; Subclinical hypothyroidism is highly unlikely to cause symptoms.&nbsp; In addition, hyperreflexia and fasciculations would be unexpected with hypothyroidism.</p><p><strong>(Choice D)</strong>&nbsp; Prednisone is used to treat multiple inflammatory myopathies (eg, polymyositis, inclusion body myositis), which can cause muscle weakness and elevated CK.&nbsp; However, myopathies usually cause a symmetric weakness, and hyperreflexia would not occur.</p><p><strong>(Choice F)</strong>&nbsp; Statin-induced myopathy causes muscle weakness and an elevated CK, and management involves statin discontinuation.&nbsp; However, it typically presents with proximal, symmetric muscle weakness and muscle pain.&nbsp; UMN signs are unexpected.</p><p><strong>Educational objective:</strong><br>Amyotrophic lateral sclerosis presents with both upper and lower motor neuron signs; sensation is typically normal.&nbsp; Medical management includes riluzole (a glutamate inhibitor) and edaravone (an antioxidant), which improves survival and slows disease progression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3838,
            "topic": "Amyotrophic lateral sclerosis",
            "titleId": 3838,
            "title": "Amyotrophic lateral sclerosis",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Intensive blood glucose control",
                    "choiceNumber": 1,
                    "correctTaken": 330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interferon beta",
                    "choiceNumber": 2,
                    "correctTaken": 695,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levothyroxine",
                    "choiceNumber": 3,
                    "correctTaken": 1682,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 4,
                    "correctTaken": 2493,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Riluzole",
                    "choiceNumber": 5,
                    "correctTaken": 6574,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Statin discontinuation",
                    "choiceNumber": 6,
                    "correctTaken": 2328,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 100,
            "notes": null,
            "peopleTaken": 14102,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 420,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 4620,
            "questionIndex": 4620,
            "questionText": "<p>A 76-year-old woman is brought to the office by her daughter due to progressively worsening memory and language difficulties.&nbsp; The patient first started having memory problems and word-finding difficulties 5 years ago.&nbsp; She then began having difficulty balancing her checkbook and buying groceries.&nbsp; The patient became lost while driving to church last year and no longer drives.&nbsp; She is now dependent on her daughter for cooking and cleaning.&nbsp; Over the past 6 months, the patient&#39;s personality has changed from seeming apathetic to becoming more paranoid and agitated; she frequently claims to have seen her niece stealing from her purse.&nbsp; The patient recently developed urinary incontinence.&nbsp; She has a history of hyperlipidemia&nbsp;and osteoarthritis of the left hip and both knees.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 90/min.&nbsp; Deep tendon reflexes are 2+ throughout, and she has preserved motor strength.&nbsp; The patient recalls none of 3 objects on memory testing and cannot draw a clock.&nbsp; Laboratory studies show normal electrolytes, lipid panel, TSH, vitamin B<font size=\"2\"><sub>12</sub></font>, and complete blood count.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38431\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of Alzheimer disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Early<br>findings</strong></p></td><td><ul><li>Anterograde memory loss (ie, immediate recall affected, distant memories preserved)</li><li>Visuospatial deficits (eg, lost in own neighborhood)</li><li>Language difficulties (eg, difficulty finding words)</li><li>Cognitive impairment with progressive decline</li></ul></td></tr><tr><td><p align=\"center\"><strong>Late<br>findings</strong></p></td><td><ul><li>Neuropsychiatric (eg, hallucinations, wandering)</li><li>Dyspraxia (eg, difficulty performing learned motor tasks)</li><li>Lack of insight regarding deficits</li><li>Noncognitive neurologic deficits (eg, pyramidal &amp; extrapyramidal motor, myoclonus, seizures)</li><li>Urinary incontinence</li></ul></td></tr></tbody></table></div><p>This patient has evidence of <strong>dementia</strong> (ie, major neurocognitive disorder), including cognitive deficits that have led to impairment in activities of daily living (eg, preparing meals, cleaning).&nbsp; Her <strong>early</strong> and prominent <strong>memory symptoms</strong>, age of onset, and symptom evolution are classic for <strong>Alzheimer disease</strong> (AD).</p><p>AD is the most common cause of dementia in the United States and usually occurs after age 65.&nbsp; Death usually occurs within 10 years of diagnosis regardless of the treatment offered.&nbsp; Patients experience a <strong>progressive</strong> functional decline over the course of their disease.&nbsp; <strong>Later findings</strong> usually include <strong>personality</strong> and behavioral changes (eg, apathy, agitation), <strong>neuropsychiatric changes</strong> (eg, delusions, paranoia), neurologic manifestations (eg, myoclonus, seizures), and <strong>apraxia</strong> (eg, difficulty with motor tasks).&nbsp; Urinary <strong>incontinence</strong> may develop in later stages of AD, secondary to severe cognitive dysfunction.</p><p><strong>(Choice B)</strong>&nbsp; In addition to the presence of dementia, a diagnosis of dementia with Lewy bodies requires the presence of &#8805;2 of the following clinical features: parkinsonism, fluctuating cognition, visual hallucinations, and rapid eye movement sleep behavior disorder.</p><p><strong>(Choice C)</strong>&nbsp; Frontotemporal dementia typically presents with early and prominent behavioral/personality change and only later with prominent memory deficits.&nbsp; It typically manifests around age 60, demonstrably earlier than AD.</p><p><strong>(Choice D)</strong>&nbsp; Normal pressure hydrocephalus (NPH) is characterized by abnormal gait, cognitive impairment, and urinary incontinence.&nbsp; Gait impairment is the most prominent clinical feature of NPH and appears early in its course; the gait is broad-based and shuffling.&nbsp; Gait impairment is not a classic characteristic of&nbsp;early AD (although&nbsp;it is commonly seen in older patients due to other conditions [eg, osteoarthritis]).</p><p><strong>(Choice E)</strong>&nbsp; Vascular dementia typically presents with cortical- or subcortical-predominant symptom clusters, depending on the location of the precipitating vascular pathology.&nbsp; A stepwise decline is classic; however, deficits in executive function are much more severe than memory deficits early in the course of the disease.&nbsp; Vascular dementia is less likely in this patient due to the disease course (eg, memory deficits) and the absence of previous cerebral vascular disease.</p><p><strong>Educational objective:</strong><br>Alzheimer disease, the most common type of dementia in the United States, is characterized by early and prominent memory impairment.&nbsp; The differential includes dementia with Lewy bodies, frontotemporal dementia, and vascular dementia, as well as nondementing syndromes such as normal pressure hydrocephalus.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3932,
            "topic": "Alzheimer disease",
            "titleId": 3932,
            "title": "Alzheimer disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 10773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 849,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Frontotemporal dementia",
                    "choiceNumber": 3,
                    "correctTaken": 2005,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pressure hydrocephalus",
                    "choiceNumber": 4,
                    "correctTaken": 1532,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vascular dementia",
                    "choiceNumber": 5,
                    "correctTaken": 1513,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2141,2275,true,-1,1*1173,1516,true,-1,1*383,440,true,-1,1*476,589,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26921134",
                    "mediaDataId": 0,
                    "title": "Alzheimer&#39;s disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26921134",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24398425",
                    "mediaDataId": 0,
                    "title": "Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24398425",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16672,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1050,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 12887,
            "questionIndex": 14196,
            "questionText": "<p>A 55-year-old man comes to the office due to difficulty chewing food over the past 2 months.&nbsp; The patient initially experienced coughing while drinking liquids and has recently had difficulty ingesting solid foods.&nbsp; In addition, several people have told him they have difficulty understanding his speech.&nbsp; Review of systems is positive for a 5-kg (11-lb) weight loss over the past 3 months.&nbsp; The patient smoked a pack of cigarettes daily for 35 years.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 120/70 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On examination, there is pooling of secretions in the oral cavity.&nbsp; Involuntary muscle twitching is noted over the chin, tongue, and upper and lower limbs.&nbsp; Power is 4/5 in both upper extremities.&nbsp; Deep tendon reflexes are 3+ throughout.&nbsp; Bilateral Babinski is present.&nbsp; Mental and sensory examinations are normal.&nbsp; Which of the following is most likely present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2299\" src=\"https://www.uworld.com/media/L13908.jpg\" ></p><p>This patient with bulbar symptoms (eg, dysphagia, dysarthria), muscle wasting and fasciculations, and hyperreflexia with positive Babinski has <strong>amyotrophic lateral sclerosis</strong> (ALS).&nbsp; ALS is a progressive disease that results from <strong>degeneration of upper motor neurons</strong> (UMNs) (eg, motor nuclei in the precentral gyrus and their projections in the <strong>corticospinal tract</strong> and corticobulbar tract) and <strong>lower motor neurons</strong> (LMNs) (eg, cranial nerves, spinal nerves).</p><p>Because any motor neuron can be involved, the initial presentation may vary widely but typically includes <strong>weakness</strong> in <strong>multiple muscle groups</strong>, with both LMN (eg, <strong>muscle atrophy, fasciculations</strong>) and UMN (eg, increased muscle tone, <strong>hyperreflexia, upgoing Babinski</strong>) signs.&nbsp; In 20% of patients, cranial nerves (eg, hypoglossal, ambiguus, motor trigeminal) are affected first, which results in <strong>bulbar symptoms</strong> (eg, coughing or choking when eating, weight loss); these patients have a worse prognosis.</p><p><strong>(Choices A and B)</strong>&nbsp; Disorders of the neuromuscular junction include myasthenia gravis, which results from antibodies against postsynaptic acetylcholine receptors, and Lambert-Eaton myasthenic syndrome, which results from antibodies against presynaptic Ca channels and is associated with malignancy (eg, weight loss, smoking history).&nbsp; These disorders can present with asymmetric muscle weakness, including of the bulbar muscles.&nbsp; However, symptoms are typically fluctuating, and, because they affect the neuromuscular junction, UMN signs would not be present.</p><p><strong>(Choice C)</strong>&nbsp; Brainstem compression can result in bulbar symptoms and UMN signs in the extremities.&nbsp; However, compression would typically also affect other cranial nerves (eg, III, V, VII, XI) and would likely also affect the respiratory drive (due to medullary compression).&nbsp; LMN signs such as fasciculations are not common with brainstem compression.</p><p><strong>(Choice E)</strong>&nbsp; Inflammatory myopathies (eg, polymyositis) cause widespread muscle weakness.&nbsp; However, because they affect the musculature (rather than motor) neurons, hyporeflexia may occur but UMN signs (eg, hyperreflexia, abnormal Babinski) would be unexpected.</p><p><strong>Educational objective:</strong><br>Amyotrophic lateral sclerosis leads to degeneration of the upper motor neurons (eg, motor nuclei in the precentral gyrus and their projections in the corticospinal and corticobulbar tracts) and lower motor neurons (eg, cranial nerves, spinal nerves).&nbsp; Because any motor neuron can be involved, patients may have a variety of symptoms, including bulbar muscle weakness.&nbsp; Examination shows both upper motor neuron and lower motor neuron signs.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 3838,
            "topic": "Amyotrophic lateral sclerosis",
            "titleId": 3838,
            "title": "Amyotrophic lateral sclerosis",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antibodies against postsynaptic acetylcholine receptors",
                    "choiceNumber": 1,
                    "correctTaken": 1175,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antibodies against presynaptic Ca channels",
                    "choiceNumber": 2,
                    "correctTaken": 2732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brainstem compression",
                    "choiceNumber": 3,
                    "correctTaken": 1985,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Degeneration of corticospinal tract",
                    "choiceNumber": 4,
                    "correctTaken": 5507,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammatory muscle disease",
                    "choiceNumber": 5,
                    "correctTaken": 315,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "261,486,true,-1,1*760,981,true,-1,1*1749,1890,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 11714,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 997,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 4652,
            "questionIndex": 4652,
            "questionText": "<p>A 79-year-old woman is brought to the office due to recurrent falls.&nbsp; Over the past year, the patient has become increasingly unsteady while walking and has had several falls.&nbsp; The patient has had no headaches, vision changes, nausea, or vomiting.&nbsp; Medical history is significant for hypertension, for which she takes losartan.&nbsp; Vital signs are within normal limits.&nbsp; Cardiopulmonary and abdominal examinations are unremarkable.&nbsp; Neurological examination shows normal cranial nerves and fundoscopy.&nbsp; There is increased tone and hyperreflexia of the lower extremities.&nbsp; Sensation to light touch and vibration is intact.&nbsp; When instructed to walk, the patient moves slowly with small steps and a wide base; she takes several steps to turn around.&nbsp; CT scan of the brain is shown below.</p><p><img draggable=\"false\" id=\"22663\" src=\"https://www.uworld.com/media/L48628.jpg\" ></p><p>This patient&#39;s symptoms would most likely improve with which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with recurrent falls has hyperreflexia and a wide-based gait.&nbsp; In association with the CT of the head demonstrating <a href=\"43258\">ventriculomegaly out of proportion to cerebral atrophy</a> (eg, normal sulci), this presentation suggests <strong>normal pressure hydrocephalus</strong> (NPH).&nbsp; NPH is characterized by abnormal cerebrospinal fluid (CSF) accumulation and results in increased ventricular size without persistent elevations in intracranial pressure.</p><p>Symptoms of NPH are classically described as a triad of urinary incontinence, cognitive impairment, and gait abnormalities.&nbsp; However, <strong>all 3 features are not required</strong> for diagnosis; in fact, only <strong>gait dysfunction</strong>, typically the most prominent symptom, is mandatory.&nbsp; In addition, <strong>upper-motor neuron signs</strong>, such as lower-extremity spasticity, hyperreflexia, and extensor plantar responses, may occur.</p><p>The diagnosis is confirmed with <strong>high-volume lumbar puncture</strong>, which allows for both confirmation of normal opening pressure and gait testing.&nbsp; Improvement of gait function after the CSF removal is diagnostic.&nbsp; Alternatively, a temporary lumbar drain may be placed to assess for gait improvement over a period of days.&nbsp; Definitive therapy is <strong>ventricular shunt placement</strong> to divert excess CSF into the abdomen (ventriculoperitoneal shunt) or heart (ventriculoatrial shunt).</p><p><strong>(Choice A)</strong>&nbsp; Acetazolamide is used to treat patients with idiopathic intracranial hypertension (ie, pseudotumor cerebri).&nbsp; However, this typically occurs in young, obese women and is characterized by headache, vision change, and papilledema.&nbsp; Ventriculomegaly and gait dysfunction are unexpected.</p><p><strong>(Choice B)</strong>&nbsp; Cholinesterase inhibitors (eg, donepezil) are used to treat Alzheimer dementia.&nbsp; Despite generalized brain atrophy (eg, hydrocephalus ex vacuo) being common, ventriculomegaly without sulcal enlargement suggests NPH.&nbsp; In addition, hyperreflexia is unexpected.</p><p><strong>(Choice C)</strong>&nbsp; High-dose glucocorticoids are used in the treatment of multiple sclerosis, which can cause upper motor neuron signs and falls but typically occurs in young women with relapsing and remitting symptoms rather than the progressive symptoms seen in this patient.&nbsp; Ventriculomegaly is unexpected.</p><p><strong>(Choice E)</strong>&nbsp; Levodopa and carbidopa are used to treat Parkinson disease (PD), which can cause gait abnormalities.&nbsp; However, although shuffling is common in PD, the gait is usually festinating (short, quick steps).&nbsp; In addition, PD typically causes a pill-rolling tremor and cogwheel rigidity.</p><p><strong>Educational objective:</strong><br>Normal pressure hydrocephalus is characterized by abnormal gait, urinary incontinence, and cognitive impairment; however, only gait dysfunction is required for diagnosis.&nbsp; Neuroimaging demonstrates ventriculomegaly out of proportion to cerebral atrophy.&nbsp; The diagnosis is confirmed with high-volume lumbar puncture demonstrating improvement of gait with cerebrospinal fluid removal.&nbsp; Definitive treatment is ventricular shunt placement.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 23402,
            "topic": "Normal pressure hydrocephalus",
            "titleId": 23402,
            "title": "Normal pressure hydrocephalus",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetazolamide",
                    "choiceNumber": 1,
                    "correctTaken": 3981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cholinesterase inhibitors",
                    "choiceNumber": 2,
                    "correctTaken": 244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-dose prednisone",
                    "choiceNumber": 3,
                    "correctTaken": 173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-volume lumbar puncture",
                    "choiceNumber": 4,
                    "correctTaken": 8951,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levodopa and carbidopa",
                    "choiceNumber": 5,
                    "correctTaken": 905,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1184,1337,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 14254,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 642,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 4619,
            "questionIndex": 4619,
            "questionText": "<p>A 67-year-old woman is brought to the office by her son.&nbsp; He reports that his mother has had periodic confusion, memory loss, and poor sleep and seems &#x22;kind of out of it sometimes.&#x22;&nbsp; These symptoms have gradually worsened over the past 1-2 years.&nbsp; The patient occasionally sees &#x22;strangers in the backyard,&#x22; who are not there when her son looks for them.&nbsp; More recently, she has begun walking more slowly and has fallen twice in the past month without any significant injuries.&nbsp; The patient has a history of hypertension and depression.&nbsp; She does not drink alcohol or use illicit drugs.&nbsp; On physical examination, she walks slowly and has mild bilateral hand tremors and mild bilateral lower limb rigidity.&nbsp; On cognitive examination, the patient appears to be oriented to person and place, and can recall 1 of 3 items in 5 minutes; she can state the days of the week forward but does not cooperate with stating them backward.&nbsp; Chemistries, complete blood count, vitamin B<font size=\"2\"><sub>12</sub></font>, and thyroid function tests are normal.&nbsp; Serum treponemal test is nonreactive.&nbsp; MRI of the brain shows mild generalized cortical atrophy.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s 1- to 2-year history of periodic confusion accompanied by visual hallucinations and parkinsonian motor symptoms (eg, tremors, rigidity)&nbsp;is suggestive of <strong>dementia with Lewy bodies</strong> (DLB), the cause of 10%-20% of dementias in the United States.&nbsp; DLB is characterized by <strong>alterations in consciousness</strong>, <strong>fluctuations in cognition</strong>, <strong>visual hallucinations</strong>, <strong>parkinsonism</strong>, and relatively early compromise of executive functions.&nbsp; Repeated falls and sleep disturbance are characteristic.</p><p>At autopsy, Lewy bodies, <strong>eosinophilic intracytoplasmic inclusions</strong> representing accumulations of alpha-synuclein protein, may be seen in neurons of the substantia nigra, locus coeruleus, dorsal raphe nucleus, and substantia innominata.&nbsp; Pharmacotherapy of DLB consists of carbidopa-levodopa for parkinsonism and cholinesterase inhibitors for cognitive impairment.&nbsp; If psychotic symptoms persist, a low-dose&nbsp;second-generation antipsychotic, rather than a first-generation antipsychotic, is preferred due to the severe neuroleptic sensitivity seen in these patients.</p><p><strong>(Choice A)</strong>&nbsp; Alzheimer disease typically presents with early and prominent memory loss.&nbsp; The core clinical features of cognitive fluctuations, visual hallucinations, and parkinsonism in this patient make DLB more likely.</p><p><strong>(Choice C)</strong>&nbsp; Major depressive disorder is characterized by persistent depressed mood and syndromal neuro-vegetative symptoms.&nbsp; Although mild cognitive impairment and psychotic features can occur in major depression, this patient&#39;s parkinsonism and fluctuating cognition would not be consistent with depression.</p><p><strong>(Choice D)</strong>&nbsp; Normal-pressure hydrocephalus is characterized by cognitive changes (eg, decreased attention and concentration, apathy), changes in gait, and urinary incontinence.&nbsp; Visual hallucinations and sleep impairment are not common.&nbsp; MRI characteristically shows ventriculomegaly that is out of proportion to the degree of sulcal widening.</p><p><strong>(Choice E)</strong>&nbsp; Lewy bodies are a pathologic finding also present in Parkinson disease.&nbsp; The key distinction between these 2 conditions is the early appearance of cognitive fluctuations and dementia in DLB, whereas dementia occurs late in the course of Parkinson disease (much later than the emergence of motor symptoms).&nbsp; In addition, visual hallucinations are not common in Parkinson disease unless they are due to dopaminergic medications given to treat the underlying illness.</p><p><strong>Educational objective:</strong><br>Dementia with Lewy bodies causes cognitive fluctuations, visual hallucinations, and parkinsonism.&nbsp; Cognitive symptoms may precede, or appear along with, parkinsonian features.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 17990,
            "topic": "Dementia with lewy bodies",
            "titleId": 17990,
            "title": "Dementia with lewy bodies",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "2",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alzheimer disease",
                    "choiceNumber": 1,
                    "correctTaken": 2020,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 12858,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 74,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal-pressure hydrocephalus",
                    "choiceNumber": 4,
                    "correctTaken": 365,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease",
                    "choiceNumber": 5,
                    "correctTaken": 2449,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "520,753,true,-1,1*884,1083,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29629495",
                    "mediaDataId": 0,
                    "title": "Lewy body disease:  clinical and pathological &quot;overlap syndrome&quot; between synucleinopathies (Parkinson disease) and tauopathies (Alzheimer disease).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29629495",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24150834",
                    "mediaDataId": 0,
                    "title": "Clinical presentation and differential diagnosis of dementia with Lewy bodies:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24150834",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 17787,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 490,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 4322,
            "questionIndex": 4322,
            "questionText": "<p>A 79-year-old man is brought to the office by his daughter because he has been losing weight and appears withdrawn.&nbsp; The patient is a retired bus driver and has lived alone since his wife died 5 years ago.&nbsp; The daughter reports that he has difficulty with meal preparation and requires frequent assistance with bathing and dressing.&nbsp; The patient has fallen backward twice in the past 3 months and fears falling again.&nbsp; Vital signs are within normal limits.&nbsp; The patient appears withdrawn with low energy and has a monotonous, soft voice.&nbsp; He sits with a stooped posture, dabs at his mouth with a handkerchief regularly, and has little facial expression.&nbsp; He has a tremor in the right hand.&nbsp; Which of the following additional examination findings is most likely in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81685\"><div align=\"center\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Abnormal gait patterns</strong></p></td></tr><tr><td><p align=\"center\"><strong>Parkinsonian</strong><br>(PD, MSA, DLB, VD)</p></td><td><ul><li>Narrow based</li><li>Shuffling (reduced stride length)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Weakness with spasticity</strong><br>(myelopathy)</p></td><td><ul><li>Narrow based</li><li>Scissoring</li><li>Toes scrape the floor</li></ul></td></tr><tr><td><p align=\"center\"><strong>Myopathic</strong><br>(myopathies, MG)</p></td><td><ul><li>Waddling</li><li>Abnormal pelvic tilt (limb girdle weakness)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Magnetic</strong><br>(NPH)</p></td><td><ul><li>Difficulty initiating steps</li></ul></td></tr><tr><td><p align=\"center\"><strong>Vestibular</strong><br>(BPPV, M&eacute;ni&egrave;re disease)</p></td><td><ul><li>Stumbling or veering to one side (usually the affected side)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cerebellar ataxia</strong><br>(stroke, drug toxicity,</p><p align=\"center\">alcohol, hereditary)</p></td><td><ul><li>Wide based</li><li>Stumbling, lurching</li><li>May be one sided or bilateral depending on etiology</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sensory ataxia</strong><br>(sensory neuropathy,</p><p align=\"center\">vitamin B<sub>12</sub> deficiency)</p></td><td><ul><li>Wide based</li><li>High stepping/stamping</li><li>Worse in the dark</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>BPPV</strong> = benign positional paroxysmal vertigo; <strong>DLB =</strong> dementia with Lewy bodies; <strong>MG</strong> = myasthenia gravis; <strong>MSA</strong> = multiple system atrophy; <strong>NPH</strong> = normal pressure hydrocephalus; <strong>PD</strong> = Parkinson disease; <strong>VD</strong> = vascular dementia.</p></td></tr></tbody></table></div></div><p>This patient has an asymmetric resting hand tremor, masked facies (little facial expression), hypophonia (soft voice), drooling (frequently dabbing at the mouth), and a stooped posture.&nbsp; This combination is strongly suspicious for <strong>parkinsonism</strong>.&nbsp; Patients with parkinsonism have <strong>bradykinesia</strong>, sometimes called a &#x22;poverty of movement,&#x22; that can manifest in the face (masked facies), the voice (hypophonia), and decreased swallowing strength and frequency (drooling).</p><p>Bradykinesia is often most obvious in the classic, <a href=\"54870\">hypokinetic gait</a>, features of which often include the following:</p><ul><li><p>A <strong>narrow base</strong></p></li><li><p>Difficulty with initiation of gait&nbsp; (If severe, this can result in freezing of gait, which is an inability to initiate at all.)</p></li><li><p><strong>Short steps</strong>, which may result in <strong>shuffling</strong> (dragging the feet) or <strong>festination</strong> (progressive quickening of steps with shortening of strides)</p></li><li><p>Reduced arm movement (typically asymmetric)</p></li><li><p>En bloc turning (head, trunk, and legs all rotate together)</p></li></ul><p>Falls are somewhat unusual in early idiopathic Parkinson disease, so this patient&#39;s history of early falls is concerning for an atypical parkinsonian disorder (ie, Parkinson-plus syndrome) such as multiple system atrophy, progressive supranuclear palsy, or corticobasal degeneration.</p><p><strong>(Choices A and E)</strong>&nbsp; A <a href=\"61186\">wide-based gait</a>&nbsp;can be seen in either cerebellar or sensory ataxia.&nbsp; Cerebellar ataxia results in stumbling or lurching that can be ipsilateral (ie, falling to one side).&nbsp; In addition to a wide-based gait, patients with sensory ataxia often have a high-stepping, stamping gait, which may be an attempt to increase sensory feedback; it worsens significantly in the dark (decreased visual cues).</p><p><strong>(Choice B)</strong>&nbsp; A <a href=\"61187\">narrow-based, scissoring gait</a> is caused by bilateral leg weakness (<em>diplegia</em>) with spasticity that results from upper motor neuron lesions (eg, cerebral palsy, spinal cord injury).&nbsp; Hip flexor weakness requires hip circumduction to help the toes clear the ground; spasticity can result in leg scissoring (ie, crossing) due to increased tone in the hip adductors which tend to be stronger than the abductors.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"61213\">A waddling gait</a> is classically caused by myopathic weakness.&nbsp; Myopathies tend to impact the proximal muscles more than the distal; weakness of the pelvic girdle muscles (eg, iliopsoas, gluteus muscles) results in excessive pelvic tilt that shifts with each step, leading to a waddle.</p><p><strong>Educational objective:</strong><br>Parkinsonism often leads to a hypokinetic gait characterized by difficulty initiating steps, a narrow base, shuffling or festinating strides, asymmetrically reduced arm movement, and en bloc turning.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 8040,
            "topic": "Parkinson disease",
            "titleId": 8040,
            "title": "Parkinson disease",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "High-stepping, stamping gait",
                    "choiceNumber": 1,
                    "correctTaken": 179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Narrow-based, scissoring gait",
                    "choiceNumber": 2,
                    "correctTaken": 681,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Narrow-based, small-stride gait",
                    "choiceNumber": 3,
                    "correctTaken": 8564,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Waddling gait",
                    "choiceNumber": 4,
                    "correctTaken": 434,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wide-based gait",
                    "choiceNumber": 5,
                    "correctTaken": 2157,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1822,1880,true,-1,1*1882,2165,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32580330",
                    "mediaDataId": 0,
                    "title": "Gait analysis in Parkinson&#39;s disease: an overview of the most accurate markers for diagnosis and symptoms monitoring.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32580330",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 45,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 12015,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1377,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 3923,
            "questionIndex": 3923,
            "questionText": "<p>A 68-year-old man is brought to the emergency department after a fall at home while walking to the kitchen.&nbsp; Prior to the fall, the patient did not have lightheadedness, chest pain, or palpitations, and he did not hit his head or lose consciousness during the fall or afterward.&nbsp; His wife says the patient has become increasingly weak over the past 6 months and has fallen several times.&nbsp; The patient has also become forgetful, and his wife thinks he even forgets to go to the bathroom, as he has urinated on himself on several occasions.&nbsp; He has a history of hypertension and osteoarthritis.&nbsp; The patient has never smoked but used to drink heavily until stopping 10 years ago.&nbsp; Blood pressure is 130/86 mm Hg and pulse is 80/min with no orthostatic changes.&nbsp; On physical examination, there is no carotid bruit, and cardiac examination is unremarkable.&nbsp; Neurological examination shows normal cranial nerves and fundoscopy.&nbsp; Bilateral lower extremity muscle strength is normal, but tone and reflexes are increased.&nbsp; Sensation to light touch, pain, and vibration are intact.&nbsp; Gait is slow and wide based, and the patient takes several small steps to turn around.&nbsp; Mini-Mental State Examination score is 21 of 30.&nbsp; Further evaluation of this patient is most likely to reveal which of the following findings?</p>",
            "questionHeader": "",
            "explanationText": "<p>This elderly patient with recurrent falls and memory impairment has the classic symptom triad of <strong>normal pressure hydrocephalus</strong> (NPH):</p><ul><li><p><strong>Gait dysfunction</strong> is often the most pronounced feature.&nbsp; Patients typically take small steps in a broad-based gait, often described as appearing that the feet are stuck to the floor (magnetic gait).</p></li><li><p><strong>Urinary incontinence</strong> is common and often of the urgency variety; however, incontinence with apathy occurs as the disease progresses.</p></li><li><p><strong>Dementia</strong> typically occurs slowly over a period of years and is associated with apathy and impaired executive function.</p></li></ul><p>Other common features include <strong>upper motor neuron signs</strong> (eg, hyperreflexia, spasticity, upgoing plantar reflexes).</p><p>NPH is characterized by enlargement of the ventricles <a href=\"3631\">(ventriculomegaly)</a> out of proportion to the sulci on neuroimaging (eg, CT scan, MRI).&nbsp; It is associated with reduced cerebrospinal fluid (CSF) reabsorption, which may occur due to elevated central pressures or chronic periventricular ischemia.&nbsp; The diagnosis is confirmed with improvement after <strong>high volume lumbar puncture</strong> or lumbar drain placement.&nbsp; As the name suggests, the cerebrospinal fluid opening pressure is normal; elevated pressures should alert the physician to other possible pathologies.&nbsp; The definitive treatment of NPH is placement of a <strong>ventricular shunt</strong>.</p><p><strong>(Choice A)</strong>&nbsp; This patient has a risk factor for vascular dementia (hypertension); however, the onset of vascular dementia typically occurs in a stepwise fashion (reflecting new strokes) rather than slowly progressive one.&nbsp; In addition, patients tend to have a narrow-based, shuffling gait.</p><p><strong>(Choice B)</strong>&nbsp; Cord compression from vertebral metastases can cause upper motor neuron signs and incontinence, but it is typically associated with severe back pain and progressive lower extremity weakness and paralysis.</p><p><strong>(Choice C)</strong>&nbsp; Pseudotumor cerebri is caused by elevated intracranial pressure (eg, elevated opening pressure on lumbar puncture).&nbsp; However, it is usually seen in young females with obesity and presents with headaches and double vision, not memory impairment; papilledema&nbsp;is expected on fundoscopic exam.</p><p><strong>(Choice E)</strong>&nbsp; Periodic sharp waves on electroencephalography are seen in Creutzfeldt-Jakob disease, which can cause upper motor neuron signs and ataxia but manifests with rapid-onset dementia and myoclonus.&nbsp; It is not commonly associated with urinary incontinence.</p><p><strong>(Choice F)</strong>&nbsp; Reactive VDRL on CSF analysis suggests neurosyphilis, which causes dementia but is often associated with pupillary abnormalities (eg, Argyll-Robertson pupils), sensory ataxia, and lancinating pains.&nbsp; It is very rare due to widespread antibiotic use.</p><p><strong>Educational objective:</strong><br>Normal pressure hydrocephalus is characterized by the symptom triad of gait disturbance, dementia, and urinary incontinence; upper motor neuron signs may also occur.&nbsp; Neuroimaging demonstrates enlargement of the ventricles out of proportion to the sulci.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 208,
            "system": "Nervous System",
            "topicId": 23402,
            "topic": "Normal pressure hydrocephalus",
            "titleId": 23402,
            "title": "Normal pressure hydrocephalus",
            "topicAttributeId": 330632,
            "topicAttribute": "Neurodegenerative disorders and dementias",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clinically unrecognized infarctions on brain MRI",
                    "choiceNumber": 1,
                    "correctTaken": 972,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cord compressing vertebral metastases on spine MRI",
                    "choiceNumber": 2,
                    "correctTaken": 138,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated opening pressure on lumbar puncture",
                    "choiceNumber": 3,
                    "correctTaken": 1259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Large ventricles with normal sulci on CT scan of the brain",
                    "choiceNumber": 4,
                    "correctTaken": 11095,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Periodic sharp wave complexes on electroencephalography",
                    "choiceNumber": 5,
                    "correctTaken": 558,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive VDRL on cerebrospinal fluid analysis",
                    "choiceNumber": 6,
                    "correctTaken": 122,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "871,1025,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 14144,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 476,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}